<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Mississippi</title>
	<atom:link href="http://www.straightstocks.com/tag/mississippi/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Thu, 26 Nov 2009 16:49:22 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>American Exploration Corp. (AEXP.OB) Adds Guggenheim Energy Opportunities to Expand Haynesville Project Partnership</title>
		<link>http://www.straightstocks.com/investing-lessons/american-exploration-corp-aexp-ob-adds-guggenheim-energy-opportunities-to-expand-haynesville-project-partnership/</link>
		<comments>http://www.straightstocks.com/investing-lessons/american-exploration-corp-aexp-ob-adds-guggenheim-energy-opportunities-to-expand-haynesville-project-partnership/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 15:51:57 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alberta]]></category>
		<category><![CDATA[American Exploration]]></category>
		<category><![CDATA[Calgary]]></category>
		<category><![CDATA[Company President and CEO]]></category>
		<category><![CDATA[gas and oil projects]]></category>
		<category><![CDATA[Guggenheim]]></category>
		<category><![CDATA[Haynesville]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[oil and gas opportunities]]></category>
		<category><![CDATA[shale gas projects]]></category>
		<category><![CDATA[Steve Harding]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.americanexploration.com]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19332</guid>
		<description><![CDATA[Headquartered in Calgary, Alberta, American Exploration has developed a solid and experienced management team with the mission to exploit oil and gas opportunities that remain undeveloped.  The young company took a major step towards enhancing their future with the addition of Guggenheim Energy Opportunities to drill and develop the Haynesville acreage in Mississippi.
Guggenheim now [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/american-exploration-corp-aexp-ob-adds-guggenheim-energy-opportunities-to-expand-haynesville-project-partnership/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthspring Inc. &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/healthspring-inc-value-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/healthspring-inc-value-zacks-rank-buy/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Tracey Ryniec</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Healthcare Reform]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[in Alabama]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[Medicare Advantage;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[PDP;]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Consensus Estimate]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12736/Healthspring+Inc.+-+Value+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Healthspring, Inc.</b> (<a href="http://www.zacks.com/stock/quote/HS">HS</a>) has surprised on estimates 3 out of the last 4 quarters by an average of 6.45%. The stock is cheap. It trades at just 6.7x forward earnings and has a PEG ratio of 0.67.<p ALIGN="left">

<b>Company Description</b></p><p ALIGN="left">

Healthspring coordinates care plans through the Medicare Advantage market in Alabama, Florida, Illinois, Mississippi, Tennessee and Texas. The company also provides a national stand-alone Medicare prescription drug plan.</p><p ALIGN="left">

<b>Healthspring Surprised by 22.22% in the Third Quarter</b></p><p ALIGN="left">

On Oct 29, Healthspring reported its third quarter results and easily beat the Zacks Consensus by 14 cents per share. Earnings per share were 77 cents compared to the Zacks Consensus Estimate of 63 cents. The company reported 53 cents in the year ago period.</p><p ALIGN="left">

Premium revenue rose 26% to $649.8 million compared to the year ago period. Membership in the Medicare Advantage jumped 19.4% compared to the year ago period and was up 15.1% even when compared with the end of 2008. Stand-alone PDP member also grew 11.6% compared to the third quarter of 2008.</p><p ALIGN="left">

As it said in its second quarter results, the company again emphasized that its Florida and Part-D operations have been outperforming.</p><p ALIGN="left">

<b>Raised 2009 Guidance</b></p><p ALIGN="left">

Given that its Florida business continues to be strong, the company raised full year EPS guidance to the range of $2.30 to $2.40 from its prior guidance of $2.10 to $2.25. </p><p ALIGN="left">

It also is bullish on the number of members it expects under the Medicare Advantage program. The range has been adjusted higher to 188,000-189,000 from 186,000-188,000.</p><p ALIGN="left">

<b>Zacks Consensus Estimates Rise</b></p><p ALIGN="left">

Given the raised guidance, analysts have moved to raise estimates. For the fourth quarter, the Zacks Consensus is up 3 cents to 62 cents in the last 30 days.</p><p ALIGN="left">

The full-year Zacks Consensus Estimate rose 7.8% to $2.34 from $2.17 per share just a month ago which is in the company's new guidance range. All 9 analysts raised in that time. Analysts expect 2009 earnings growth of 10.43%.</p><p ALIGN="left">

Analysts are optimistic about 2010, despite the ongoing uncertainty about healthcare reform. They boosted estimates for the full year by 16 cents to $2.22 per share.</p><p ALIGN="left">

<b>Value Fundamentals</b></p><p ALIGN="left">

Healthspring is a Zacks #1 Rank (strong buy) stock. It is trading with a price-to-book of just 1.06. The company has a 5-year average return on equity (ROE) of 14.65%.</p><p ALIGN="left">

<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/healthspring-inc-value-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: AT&amp;T Inc, Centennial Communications Corp, Verizon, JA Solar Holdings Co. Ltd. and AutoNation &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-att-inc-centennial-communications-corp-verizon-ja-solar-holdings-co-ltd-and-autonation-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-att-inc-centennial-communications-corp-verizon-ja-solar-holdings-co-ltd-and-autonation-press-releases/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 12:30:32 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[AutoNation]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Car Loans]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Centennial Communications Corp]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[CNY]]></category>
		<category><![CDATA[Federal Communications Commission]]></category>
		<category><![CDATA[JA Solar Holdings Co. Ltd.]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[Richmond]]></category>
		<category><![CDATA[rival operator]]></category>
		<category><![CDATA[U.S. Department of Justice]]></category>
		<category><![CDATA[U.S. Virgin Islands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[wireless assets]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless coverage]]></category>
		<category><![CDATA[wireless network]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27139/Zacks+Analyst+Blog+Highlights%3A+AT%26T+Inc%2C+Centennial+Communications+Corp%2C+Verizon%2C+JA+Solar+Holdings+Co.+Ltd.+and+AutoNation+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 11, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>AT&#38;T Inc </strong>(<a href="void(0)">T</a>), <strong>Centennial Communications Corp </strong>(<a href="void(0)">CYCL</a>), <strong>Verizon </strong>(<a href="void(0)">VZ</a>), <strong>JA Solar Holdings Co. Ltd.</strong> (<a href="void(0)">JASO</a>) and <strong>AutoNation </strong>(<a href="void(0)">AN</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Tuesday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>AT&#38;T Completes CYCL Acquisition</strong></p>
<p align="left"><strong>AT&#38;T Inc </strong>(<a href="void(0)">T</a>) has reportedly completed its much anticipated acquisition of <strong>Centennial Communications Corp </strong>(<a href="void(0)">CYCL</a>), the eighth largest US wireless carrier by subscribers. This follows the recent approvals of the transaction by the US Department of Justice and US telecom regulator Federal Communications Commission (&#8220;FCC"). The transaction, which was originally set to complete in second-quarter 2009, is now officially closed.</p>
<p align="left">As per the agreement terms, shareholders of Centennial will receive $8.50 in cash for every share they own, equating to approximately $944 million. Including net debt, the aggregate value of the deal is $2.7 billion. AT&#38;T will take appropriate steps to redeem all of Centennial&#8217;s outstanding debts. AT&#38;T expects minimal dilution to earnings and cash flow in 2009 given the upfront integration costs.</p>
<p align="left">The acquisition has expanded AT&#38;T&#8217;s wireless coverage to include the rural areas of the Midwest and Southeast regions of the US as well as Puerto Rico and the US Virgin Islands, adding 893,000 new subscribers. The acquisition will also offer operational synergies and improve the service quality of AT&#38;T&#8217;s wireless network in specific markets.</p>
<p align="left">As per the demand of the US regulators, AT&#38;T will divest certain Centennial assets in eight markets across Louisiana (central and southern) and southwestern Mississippi as the acquisition may potentially hurt consumer interest in these regions. As part of this requirement, AT&#38;T will sell wireless assets in five of the eight markets to its rival operator <strong>Verizon </strong>(<a href="void(0)">VZ</a>) for $240 million. Moreover, AT&#38;T has committed to continue Centennial's existing roaming agreements with other carriers for at least four years.</p>
<p align="left"><strong>JA Solar Gains Strength in Q3</strong></p>
<p align="left"><strong>JA Solar Holdings Co. Ltd.</strong> (<a href="void(0)">JASO</a>) announced adjusted earnings per American Depositary Share (EPADS) of RMB 0.66 (10 cents) in its fiscal third quarter, which exceeded the Zacks Consensus Estimate by 7 cents. The performance improvement came from higher shipments along with growing margins.</p>
<p align="left">In the reported quarter, revenues rose 119.6% to RMB 1.3 billion ($193.3 million), as compared to RMB 600.7 million ($88.0 million) reported in the previous quarter. However, revenues fell 37.8% when compared to year-ago quarterly revenue of RMB 2.1 billion ($310.7 million).</p>
<p align="left">JA Solar&#8217;s shipments were a company record of 177MW in the quarter. In the prior quarter, shipments were only 77MW, representing a sequential growth of 129.9%. In the year-ago quarter also, shipments were only 99MW, representing shipment growth of 78.8%.</p>
<p align="left"><strong>AutoNation Predicts Gloomy 2010</strong></p>
<p align="left"><strong>AutoNation </strong>(<a href="void(0)">AN</a>) has sketched its industry outlook, revealing a gloomy 2010 preceding an improvement in the years following. The company stated that it anticipates a marginal rise in industry sales to 11 million cars and trucks from the current-year rate of 10 million vehicles. This was in stark contrast to an annual rate of more than 16 million vehicles ticked earlier this decade.</p>
<p align="left">AutoNation blamed tight credit for pulling down sales this year. However, sales will hit bottom in 2009. Many banks have kept their credit standards extremely high for car loans, which is depressing the industry sales despite continuous efforts taken by the government to ease credit standards.</p>
<p align="left">Further, job loss and stability in housing prices are also an issue. Thus, the Richmond, Virginia-based automotive retailer -- the largest in the U.S. -- expects the industry to recoup sales gradually by 2011 and beyond.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-att-inc-centennial-communications-corp-verizon-ja-solar-holdings-co-ltd-and-autonation-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BlueFire Ethanol Fuels, Inc. (BFRE.OB) CEO to Address Cellulosic Biofuels Summit, Emphasizing Sector-Wide Financing Initiatives</title>
		<link>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-fuels-inc-bfre-ob-ceo-to-address-cellulosic-biofuels-summit-emphasizing-sector-wide-financing-initiatives/</link>
		<comments>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-fuels-inc-bfre-ob-ceo-to-address-cellulosic-biofuels-summit-emphasizing-sector-wide-financing-initiatives/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 18:35:08 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Arnold Klann]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[BlueFire Ethanol Fuels Inc.]]></category>
		<category><![CDATA[Bob Dinneen]]></category>
		<category><![CDATA[CBS]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[D. C.]]></category>
		<category><![CDATA[Department of Energy]]></category>
		<category><![CDATA[Fulton]]></category>
		<category><![CDATA[Klann]]></category>
		<category><![CDATA[Kristina M. Johnson]]></category>
		<category><![CDATA[Lancaster]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[Renewable Fuels Association]]></category>
		<category><![CDATA[Under Secretary]]></category>
		<category><![CDATA[Washington]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19192</guid>
		<description><![CDATA[BlueFire Ethanol Fuels, Inc., a pioneer in cellulosic ethanol production via its proprietary conversion process utilizing concentrated acid hydrolysis, disclosed today that their CEO, Arnold Klann, will attend the 4th Annual Cellulosic Biofuels Summit (CBS) next week on Nov. 17. The event will be held in Washington, D.C. 
Standing alongside executives from across the cellulosic [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-fuels-inc-bfre-ob-ceo-to-address-cellulosic-biofuels-summit-emphasizing-sector-wide-financing-initiatives/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AT&amp;T Completes CYCL Acquisition &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/att-completes-cycl-acquisition-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/att-completes-cycl-acquisition-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 14:45:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3G services]]></category>
		<category><![CDATA[Alltel Corp.]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[CDMA technology;]]></category>
		<category><![CDATA[Centennial Communications Corp]]></category>
		<category><![CDATA[CYCL]]></category>
		<category><![CDATA[Federal Communications Commission]]></category>
		<category><![CDATA[GSM]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[products/services]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[Retail Locations]]></category>
		<category><![CDATA[rival operator]]></category>
		<category><![CDATA[U.S. Department of Justice]]></category>
		<category><![CDATA[U.S. Virgin Islands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[wireless architecture]]></category>
		<category><![CDATA[wireless assets]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless coverage]]></category>
		<category><![CDATA[wireless network]]></category>
		<category><![CDATA[wireless operations]]></category>
		<category><![CDATA[wireless service plans]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27093/AT%26T+Completes+CYCL+Acquisition+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AT&#38;T Inc</strong> <a href="http://www.zacks.com/stock/T">(T</a>) has reportedly completed its much anticipated acquisition of <strong>Centennial Communications Corp</strong> (<a href="http://www.zacks.com/stock/CYCL">CYCL</a>), the eighth largest US wireless carrier by subscribers. This follows the recent approvals of the transaction by the US Department of Justice and US telecom regulator Federal Communications Commission (&#8220;FCC"). The transaction, which was originally set to complete in second-quarter 2009, is now officially closed. <br />
<br />
As per the agreement terms, shareholders of Centennial will receive $8.50 in cash for every share they own, equating to approximately $944 million. Including net debt, the aggregate value of the deal is $2.7 billion. AT&#38;T will take appropriate steps to redeem all of Centennial&#8217;s outstanding debts. AT&#38;T expects minimal dilution to earnings and cash flow in 2009 given the upfront integration costs. <br />
<br />
The acquisition has expanded AT&#38;T&#8217;s wireless coverage to include the rural areas of the Midwest and Southeast regions of the US as well as Puerto Rico and the US Virgin Islands, adding 893,000 new subscribers. The acquisition will also offer operational synergies and improve the service quality of AT&#38;T&#8217;s wireless network in specific markets. <br />
<br />
As per the demand of the US regulators, AT&#38;T will divest certain Centennial assets in eight markets across Louisiana (central and southern) and southwestern Mississippi as the acquisition may potentially hurt consumer interest in these regions. As part of this requirement, AT&#38;T will sell wireless assets in five of the eight markets to its rival operator <strong>Verizon </strong><a href="http://www.zacks.com/stock/VZ">(VZ</a>) for $240 million. Moreover, AT&#38;T has committed to continue Centennial's existing roaming agreements with other carriers for at least four years. <br />
<br />
Top-tier US carriers are increasingly focused on acquisitions in order to expand subscriber base and coverage zones as the US subscriber population reaches maturity. AT&#38;T was dethroned by Verizon as the largest wireless carrier in North America in early 2009 with the latter&#8217;s acquisition of Alltel Corp. Centennial acquisition brings AT&#38;T on the level playing field, allowing it to more effectively compete with its archrival Verizon. <br />
<br />
AT&#38;T plans to launch its products and services in January 2010 in Centennial&#8217;s more than 100 retail locations across the US . Existing Centennial customers have the option to keep their current wireless service plans or they can switch to AT&#38;T&#8217;s rate plans by paying applicable charges. AT&#38;T will continue Centennial brand in Puerto Rico till mid-2010 and will launch its own products/services during third-quarter 2010. Moreover, AT&#38;T plans to roll out 3G services in more than 200 sites in Centennial&#8217;s markets.<br />
 <br />
However, AT&#38;T is expected to face integration problems as Centennial&#8217;s CDMA technology based wireless operations in Puerto Rico and the US Virgin Islands are not yet compatible with AT&#38;T&#8217;s GSM wireless architecture. This may result in added costs for migrating cellular users to a uniform network platform.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CYCL">Read the full analyst report on "CYCL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/att-completes-cycl-acquisition-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BlueFire Ethanol, Inc. (BFRE.OB) Expands in Mississippi, Fueled by $3.8M Department of Energy Reimbursement</title>
		<link>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-inc-bfre-ob-expands-in-mississippi-fueled-by-3-8m-department-of-energy-reimbursement/</link>
		<comments>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-inc-bfre-ob-expands-in-mississippi-fueled-by-3-8m-department-of-energy-reimbursement/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 17:38:05 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Arnold Klann]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[BlueFire Ethanol Fuels Inc.]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Department of Energy]]></category>
		<category><![CDATA[energy sources]]></category>
		<category><![CDATA[Fulton]]></category>
		<category><![CDATA[Lancaster]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[non-food cellulosic biofuel]]></category>
		<category><![CDATA[non-food-based biofuels]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19078</guid>
		<description><![CDATA[BlueFire Ethanol Fuels, Inc. received a reimbursement from the Department of Energy (DOE) for $3.8 million, signifying a continued commitment by the current administration and the DOE to bolster such alternative energy sources. 
The liquidity provided by this reimbursement will allow BlueFire to capitalize the development of its second ethanol plant, to be located in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/bluefire-ethanol-inc-bfre-ob-expands-in-mississippi-fueled-by-3-8m-department-of-energy-reimbursement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TIE Technologies Announces Award of Smart Levee Project</title>
		<link>http://www.straightstocks.com/investing-lessons/tie-technologies-announces-award-of-smart-levee-project/</link>
		<comments>http://www.straightstocks.com/investing-lessons/tie-technologies-announces-award-of-smart-levee-project/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 14:43:57 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[active concern]]></category>
		<category><![CDATA[Advanced Technologies Institute]]></category>
		<category><![CDATA[Aerospace Corporation]]></category>
		<category><![CDATA[Architron Systems Inc.]]></category>
		<category><![CDATA[communications infrastructure;]]></category>
		<category><![CDATA[communications system;]]></category>
		<category><![CDATA[construction management;]]></category>
		<category><![CDATA[content delivery networks]]></category>
		<category><![CDATA[crisis management;]]></category>
		<category><![CDATA[data broadcasting networks]]></category>
		<category><![CDATA[data communications markets]]></category>
		<category><![CDATA[emergency preparedness applications]]></category>
		<category><![CDATA[energy distribution]]></category>
		<category><![CDATA[Executive Vice President]]></category>
		<category><![CDATA[flood control systems]]></category>
		<category><![CDATA[Geocomp Corporation]]></category>
		<category><![CDATA[Gis]]></category>
		<category><![CDATA[hardened communications solutions]]></category>
		<category><![CDATA[information management]]></category>
		<category><![CDATA[interactive real time displays]]></category>
		<category><![CDATA[James Lee Witt Associates]]></category>
		<category><![CDATA[Lafayette campus]]></category>
		<category><![CDATA[location]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Louisiana Department of Natural Resources]]></category>
		<category><![CDATA[Mark Marangella]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi Levee]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[named sub contractor]]></category>
		<category><![CDATA[National Incident Management Systems]]></category>
		<category><![CDATA[National Incident Management Systems and Advanced Technologies Institute]]></category>
		<category><![CDATA[national leader in the development]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[NIMSAT Institute]]></category>
		<category><![CDATA[Office of Coastal Protection and Restoration]]></category>
		<category><![CDATA[oil and gas industry]]></category>
		<category><![CDATA[program management;]]></category>
		<category><![CDATA[railroad support services]]></category>
		<category><![CDATA[Real Time]]></category>
		<category><![CDATA[real-time monitoring systems]]></category>
		<category><![CDATA[related systems management services]]></category>
		<category><![CDATA[sensor networks]]></category>
		<category><![CDATA[Shannon]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[smart communications portion]]></category>
		<category><![CDATA[smart logistical solution]]></category>
		<category><![CDATA[smart solution]]></category>
		<category><![CDATA[sourced and internal server]]></category>
		<category><![CDATA[technology resources]]></category>
		<category><![CDATA[telecommunication services]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[TIE Technologies Inc.]]></category>
		<category><![CDATA[U.S. Army Corp]]></category>
		<category><![CDATA[United States Air Force]]></category>
		<category><![CDATA[United States Army]]></category>
		<category><![CDATA[University of Louisiana]]></category>
		<category><![CDATA[Wilson]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=2989</guid>
		<description><![CDATA[NEW YORK, Nov. 5, 2009 (GLOBE NEWSWIRE) &#8212; TIE Technologies, Inc. (Pink Sheets:TTCS) today announces its participation in the Intelligent Flood Protection Monitoring, Warning and Response System (IFPRMWRS) DNR RSIQ No. 2503-09-21 project awarded by the State of Louisiana to Geocomp and their &#8216;I-Levee Team&#8217; associates.

TIE Technologies, as a named sub contractor under Geocomp in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/tie-technologies-announces-award-of-smart-levee-project/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, CXW, PWRM, HWFG, AXS, EXBD, TWPG</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 21:28:47 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[AXIS Capital Holdings Limited]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[California Department of Corrections and Rehabilitation]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[corporate executive]]></category>
		<category><![CDATA[Corrections Corporation]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[growth-focused investment bank]]></category>
		<category><![CDATA[Harrington Bank]]></category>
		<category><![CDATA[Harrington West Financial Group Inc.]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Lionel F. Conacher]]></category>
		<category><![CDATA[Los Padres Bank]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Fork Correctional Facility]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[president and chief operating officer]]></category>
		<category><![CDATA[Publicly Held Securities]]></category>
		<category><![CDATA[Red Rock Correctional Center]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Thomas Weisel Partners Group Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[W. Weisel]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4428</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

Power3 Medical Products,  Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer  biomarkers and diagnostic tests, announces further international recognition of  validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, CXW, PWRM, HWFG, AXS, EXBD, TWPG</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 21:28:47 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[AXIS Capital Holdings Limited]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[California Department of Corrections and Rehabilitation]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[corporate executive]]></category>
		<category><![CDATA[Corrections Corporation]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[growth-focused investment bank]]></category>
		<category><![CDATA[Harrington Bank]]></category>
		<category><![CDATA[Harrington West Financial Group Inc.]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Lionel F. Conacher]]></category>
		<category><![CDATA[Los Padres Bank]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Fork Correctional Facility]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[president and chief operating officer]]></category>
		<category><![CDATA[Publicly Held Securities]]></category>
		<category><![CDATA[Red Rock Correctional Center]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Thomas Weisel Partners Group Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[W. Weisel]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4428</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

Power3 Medical Products,  Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer  biomarkers and diagnostic tests, announces further international recognition of  validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-cxw-pwrm-hwfg-axs-exbd-twpg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bally Meets Expectations &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/bally-meets-expectations-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/bally-meets-expectations-analyst-blog/#comments</comments>
		<pubDate>Fri, 30 Oct 2009 20:37:45 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bally Technologies Inc.]]></category>
		<category><![CDATA[casino management]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Gaming]]></category>
		<category><![CDATA[gaming equipment]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[slot accounting]]></category>
		<category><![CDATA[table-management solutions]]></category>
		<category><![CDATA[technology solutions]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vicksburg]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26705/Bally+Meets+Expectations+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Gaming equipment maker <strong>Bally Technologies Inc. </strong>(<a href="http://www.zacks.com/stock/quote/byi">BYI</a>) posted fiscal 2010 first-quarter results yesterday after the closing bell. The company recorded net income of $30.6 million, or 53 cents per share, compared to $30.3 million, or 52 cents in the year-ago period. The results matched the Zacks Consensus Estimate.<br />
<br />
Bally Technologies is a leading gaming systems company, which designs, manufactures, operates and distributes advanced gaming devices, systems and technology solutions worldwide. The company's product line includes reel-spinning slot machines, video slots, wide-area progressives and class II, lottery and central determination games and platforms. The company also offers casino management, slot accounting, bonusing, cashless and table-management solutions and also operates the Rainbow Casino in Vicksburg, Mississippi.<br />
<br />
The Las Vegas-based company&#8217;s sales slipped 17.2% year over year to $196.5 million. The decline was the results of weakness in North American gaming machine replacement market as customers continue to slash discretionary spending.<br />
<br />
In terms of segments, Gaming Equipment plunged 42.2% year over year to $62 million as new gaming device sales slipped 40.3% to 3,936 units, partially offset by a marginal 0.4% rise in average selling price (ASP) to $14,115. Gaming Operations expanded 5.2% to $71.3 million, primarily driven by higher sales of premium revenue units and increased revenue per unit. The Systems segment rose 3.3% to $54 million driven by growth in maintenance and services revenue.<br />
<br />
Bally&#8217;s gross margin (excluding casino operations) grew 580 basis points (bps) year over year to 62.9%, mainly due to higher ASP, lower material costs and decreased inventory write-downs in the Gaming Equipment segment. The margin also benefited from growth in rental, participation and license revenue related to Gaming Operations segment.<br />
<br />
Total operating income dipped 4.8% year over year to $50.9 million, while operating margin grew 340 bps to 25.9%. The operating margin growth was driven by improved gross margin, partially offset by a 150 bps increase in research and development as a percentage of sales to 9.9%.<br />
<br />
During the quarter, the company generated free cash flow of $36.4 million, compared to $21.2 million in the year-ago quarter. The growth in free cash flow was primarily the result of healthy earnings performance coupled with liquidation of inventories, which decreased by 34.6% year over year to $52.9 million at the end of the quarter. Bally also stated that it reduced debt by $6 million and bought back 392,000 shares of its common stock for about $15 million during the quarter.<br />
<br />
Meanwhile, Bally raised its full fiscal 2010 guidance and now expects earnings to range between $2.30 and $2.55 per share, compared to the previous forecast of $2.25 to $2.50. The guidance is in-line with the Zacks Consensus Estimate of $2.42 per share, which has increased by 2 cents over the past month as 2 of 11 covering analysts raised expectations.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BYI">Read the full analyst report on "BYI"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bally-meets-expectations-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioMarin Purchases Huxley &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/biomarin-purchases-huxley-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/biomarin-purchases-huxley-analyst-blog/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 18:43:14 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Assistance Publique Hopitaux de Paris]]></category>
		<category><![CDATA[autoimmune disease]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[BioMarin Pharmaceutical Inc.;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[european commission]]></category>
		<category><![CDATA[Huxley Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Lambert Eaton Myasthenic]]></category>
		<category><![CDATA[Lambert Eaton Myasthenic Syndrome]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Muscle weakness]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[small cell lung cancer]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries;]]></category>
		<category><![CDATA[treatment of Lambert Eaton Myasthenic Syndrome]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26495/BioMarin+Purchases+Huxley+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, <strong>BioMarin Pharmaceutical Inc. </strong>(<a href="http://www.zacks.com/stock/quote/BMRN">BMRN</a>) announced that it has acquired the privately held Huxley Pharmaceuticals Inc., which possessed rights to a proprietary form of 3,4-diaminopyridine amifampridine phosphate ( 3,4-DAP), for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).<br />
 <br />
Under the terms of the transaction, BioMarin has already made an upfront payment of $15 million to Huxley shareholders and will pay an additional $7.5 million upon the final approval of amifampridine for LEMS from the European Commission (EC). The EC is expected to grant its approval in late 2009 or early 2010. Furthermore, Huxley stockholders would receive up to approximately $36 million in milestone payments if certain sales and U.S. development milestones are met.<br />
 <br />
BioMarin intends to launch amifampridine phosphate in Europe in the first quarter and is looking to develop an appropriate strategy for the drug in the U.S. Amifampridine phosphate will be the first drug to be approved for the treatment of LEMS if and when the EC clears the drug. Consequently, it would enjoy an orphan drug status and 10 years of market exclusivity in Europe. The drug has the potential to be used for other indications &#8722; including multiple sclerosis (MS) &#8722; in the US and Europe.<br />
 <br />
As a reminder, Huxley Pharmaceuticals licensed the rights to this form of amifampridine phosphate from EUSA Pharma. EUSA had in turn acquired the right from the original developer, Assistance Publique Hopitaux de Paris.<br />
 <br />
If BioMarin is able to successfully develop the drug for MS, it would make an unspecified milestone payment to EUSA as well. However, it will face tough competition from big players such as <strong>Biogen Idec</strong> (<a href="http://www.zacks.com/stock/quote/BIIB">BIIB</a>), <strong>Pfizer</strong> (<a href="http://www.zacks.com/stock/quote/PFE">PFE</a>) and <strong>Teva Pharmaceutical Industries</strong> (<a href="http://www.zacks.com/stock/quote/TEVA">TEVA</a>) in the MS market.<br />
 <br />
LEMS, a rare autoimmune disease, affects 1,200 to 3,100 people in the US and 2,000 to 5,000 in Europe. Muscle weakness, mainly in the legs and trunk is its main symptom. Approximately half of the diagnosed LEMS patients are affected by small cell lung cancer. LEMS results in other problems as well such as reduced reflexes, drooping of the eyelids, facial weakness and problems in swallowing.<br />
 <br />
Currently, we are Neutral on BioMarin.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMRN">Read the full analyst report on "BMRN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEVA">Read the full analyst report on "TEVA"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biomarin-purchases-huxley-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biogen Reports Higher Earnings &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/biogen-reports-higher-earnings-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/biogen-reports-higher-earnings-analyst-blog/#comments</comments>
		<pubDate>Tue, 20 Oct 2009 16:43:05 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acorda Therapeutics;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Elan]]></category>
		<category><![CDATA[Facet Biotech Corporation]]></category>
		<category><![CDATA[Market Leader]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[multiple sclerosis candidate]]></category>
		<category><![CDATA[Rituxan;]]></category>
		<category><![CDATA[treatment of multiple sclerosis;]]></category>
		<category><![CDATA[Tysabri]]></category>
		<category><![CDATA[U.S. U.S. net]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26154/Biogen+Reports+Higher+Earnings+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Today morning, <strong>Biogen Idec</strong> (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>) reported third quarter earnings per share of $1.12, beating the Zacks Consensus Estimate of $1.02. The company reported earnings of 98 cents in the year-ago period. Revenues increased 3% to $1.12 billion, with Tysabri being the primary growth driver.<br />
<br />
Tysabri sales came in at $207 million, up 21% from the prior period. The company estimates that as of the end of September 2009, about 46,200 patients were on commercial and clinical Tysabri therapy worldwide. This represents an increase from the 43,300 patients reported by the company in the second quarter of 2009.<br />
<br />
Tysabri is an important growth driver and we expect the product, which is partnered with<strong> Elan </strong>(<a href="http://www.zacks.com/stock/quote/eln">ELN</a>), to cross $1 billion in worldwide sales in 2009.<br />
<br />
Meanwhile, Biogen&#8217;s lead multiple sclerosis (MS) product Avonex posted sales of $580 million (up 1%) with U.S. sales growing 8% to $348 million. However, we were disappointed to see Avonex rest of world sales decline 8% to $232 million.<br />
<br />
Biogen recognized $284 million in Rituxan revenues, which is co-promoted with Roche in the U.S. U.S. net sales of Rituxan increased 2% to $670 million. Revenues from other products came in at $15 million, as compared to $14 million in the year-ago period. Royalty revenues remained unchanged at $35 million.<br />
<br />
In order to return cash to shareholders, Biogen&#8217;s Board of Directors authorized a share repurchase program worth $1 billion. This is in addition to the company&#8217;s previous share repurchase program under which 6 million shares remain outstanding. The repurchase of shares should help boost the bottom-line.<br />
<br />
Biogen provided an updated outlook for 2009. The company now expects revenues to grow in the mid-to-high single-digit range as compared to its earlier expectation of high-single-digit growth.<br />
<br />
The company maintained its guidance for operating expenses which are expected in the range of $2.1 to $2.2 billion. Both SG&#38;A and R&#38;D guidance remained unchanged at 19-20% of revenues and 28-30% of revenues, respectively. The company expects to deliver earnings in excess of $3.85 in 2009.<br />
<br />
Biogen is the market leader in therapies for the treatment of multiple sclerosis. We believe the company will continue to retain a leading position in the MS market. We are encouraged to see that the company is working on expanding its MS and oncology pipeline.<br />
<br />
The company recently launched a hostile bid to acquire <strong>Facet Biotech Corporation </strong>(<a href="http://www.zacks.com/stock/quote/fact">FACT</a>). The proposed acquisition of Facet, which should help strengthen Biogen&#8217;s pipeline, is the second major deal announced by the company in 2009. Earlier this year, Biogen signed a licensing deal with <strong>Acorda Therapeutics</strong> (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>) for a multiple sclerosis candidate. We currently have a Neutral rating on Biogen.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ELN">Read the full analyst report on "ELN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACOR">Read the full analyst report on "ACOR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FACT">Read the full analyst report on "FACT"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biogen-reports-higher-earnings-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Entergy Trims Third Quarter Outlook  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/entergy-trims-third-quarter-outlook-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/entergy-trims-third-quarter-outlook-analyst-blog/#comments</comments>
		<pubDate>Fri, 16 Oct 2009 16:15:44 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Entergy Corporation]]></category>
		<category><![CDATA[gas/oil;]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[nuclear-based energy]]></category>
		<category><![CDATA[regulated utilities;]]></category>
		<category><![CDATA[Retail Distribution]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26012/Entergy+Trims+Third+Quarter+Outlook++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Entergy Corporation</strong> (<a href="http://www.zacks.com/stock/quote/ETR">ETR</a>) earlier today announced that it expects GAAP earnings and operational earnings to be approximately $2.31 per share and $2.39 per share, respectively, in the third quarter of 2009. This is low compared to the year-ago GAAP numbers of $2.41 per share and operational results of $2.50 per share.<br />
 <br />
The anticipated decrease in the quarter&#8217;s operational earnings is due primarily to lower results at the Utility, Parent and Other segment, partially offset by increased earnings at Non-nuclear Wholesale Assets segment. Utility, Parent &#38; Other is expected to clock lower year-over-year operational earnings in third quarter 2009, primarily due to the absence of the 2008 adjustment reducing income tax expense and higher operation and maintenance expense. Entergy's Non-nuclear Wholesale Assets quarterly operational results are expected to improve due to the absence of the 2008 adjustment increasing income tax expense on account of the redemption of an investment. <br />
<br />
Entergy however re-affirmed its earnings guidance ranges, with 2009 GAAP earnings guidance to be in the range of $6.00 to $6.60 per share and 2009 operational earnings guidance to be in the range of $6.20 to $6.80 per share. <br />
<br />
New Orleans-based Entergy is primarily engaged in electric power production and retail distribution. With 30,000MW of generating capacity, it distributes electricity to 2.6 million customers in Arkansas , Louisiana , Mississippi and Texas . Of this, 14,631MW are gas/oil based, 2,259MW coal based, 70MW hydro based and the rest nuclear based. With around 13,000MW of nuclear-based energy, the company is the second largest nuclear power generator in the U.S. The company also distributes natural gas to 240,000 customers in Louisiana .<br />
 <br />
Entergy is focusing on its traditional electric utility business with a planned separation of its nuclear business. The company has shown strong resilience during two back-to-back destructive hurricanes in 2008. Going forward, stable earnings from regulated utilities and significant free cash flow available for share repurchases, dividend hikes and/or debt retirement collectively support management&#8217;s focus on creating shareholder value. However, higher outages, an expected slide in power prices and pending regulatory approvals in New York and Vermont for the proposed spin-off of its nuclear business are areas of concern. We maintain our Neutral recommendation on the shares.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/entergy-trims-third-quarter-outlook-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antitrust OKs AT&amp;T-CYCL Merger &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/antitrust-oks-att-cycl-merger-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/antitrust-oks-att-cycl-merger-analyst-blog/#comments</comments>
		<pubDate>Thu, 15 Oct 2009 16:15:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alltel Corp.]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[CDMA technology;]]></category>
		<category><![CDATA[Centennial Communications Corp]]></category>
		<category><![CDATA[CYCL]]></category>
		<category><![CDATA[Deutsche Telekom]]></category>
		<category><![CDATA[Federal Communications Commission]]></category>
		<category><![CDATA[GSM]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[rival operator]]></category>
		<category><![CDATA[Sprint Nextel]]></category>
		<category><![CDATA[U.S. Department of Justice]]></category>
		<category><![CDATA[U.S. Virgin Islands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[wireless architecture]]></category>
		<category><![CDATA[wireless assets]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless coverage]]></category>
		<category><![CDATA[wireless giant]]></category>
		<category><![CDATA[wireless network]]></category>
		<category><![CDATA[wireless operation]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25941/Antitrust+OKs+AT%26T-CYCL+Merger+-+Analyst+Blog</guid>
		<description><![CDATA[<strong>AT&#38;T Inc&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/T">T</a>) much anticipated acquisition of regional wireless and wireline service provider <strong>Centennial Communications Corp</strong> (<a href="http://www.zacks.com/stock/quote/CYCL">CYCL</a>), has progressed a step further as the US wireless giant has reportedly received a conditional approval of the US Department of Justice (&#8220;DOJ"). <br />
<br />
The acquisition is now subject to the approval of the US telecom regulator Federal Communications Commission. The US antitrust approval is based on fulfillment of specific conditions which requires AT&#38;T to divest certain Centennial assets in eight markets across Louisiana (central and southern) and southwestern Mississippi . <br />
<br />
This is due to the fact that the acquisition may potentially hurt consumer interest in these regions. As part of this requirement, AT&#38;T has already committed to sell wireless assets in five of the eight markets to its rival operator <strong>Verizon</strong> (<a href="http://www.zacks.com/stock/quote/VZ">VZ</a>) for $240 million. AT&#38;T announced its acquisition of Centennial for approximately $2.8 billion (including net debt) in November 2008. <br />
<br />
As per the agreement term, shareholders of Centennial are expected to receive $8.50 in cash for every share they own, equating to approximately $944 million. The transaction, which was originally set to close by second-quarter 2009, is now expected to conclude in fourth-quarter 2009. <br />
<br />
AT&#38;T is increasingly focused on acquisitions in order to expand its subscriber base and coverage zones as the US subscriber population reaches maturity. The company was dethroned by Verizon as the largest wireless carrier in North America in early 2009 with the latter&#8217;s acquisition of Alltel Corp. <br />
<br />
Consolidation binge among the top-tier US carrier continues as <strong>Deutsche Telekom</strong> (<a href="http://www.zacks.com/stock/quote/DT">DT</a>) is reportedly considering the merger of T-mobile USA , its US subsidiary, with <strong>Sprint Nextel</strong> (<a href="http://www.zacks.com/stock/quote/S">S</a>). As such, the Centennial deal represents an ideal opportunity for AT&#38;T to stay in competition. <br />
<br />
Successful acquisition of Centennial will expand AT&#38;T&#8217;s wireless coverage to include the rural areas of the Midwest and Southeast regions of the US as well as Puerto Rico and the US Virgin Islands, providing 1.1 million new subscribers. Additionally, the acquisition will offer operational synergies and improve the service quality of AT&#38;T&#8217;s wireless network in specific markets. <br />
<br />
However, AT&#38;T is expected to face integration problems as Centennial&#8217;s CDMA technology based wireless operation in Puerto Rico is not yet compatible with AT&#38;T&#8217;s GSM wireless architecture which may result in added costs for migrating cellular users to a uniform network platform.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CYCL">Read the full analyst report on "CYCL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DT">Read the full analyst report on "DT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/antitrust-oks-att-cycl-merger-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comstock&#8217;s Positive Update  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/comstocks-positive-update-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/comstocks-positive-update-analyst-blog/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 16:30:12 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[bank credit facility;]]></category>
		<category><![CDATA[Comstock Resources Inc.]]></category>
		<category><![CDATA[DeSoto]]></category>
		<category><![CDATA[East Texas/North Louisiana]]></category>
		<category><![CDATA[Frisco]]></category>
		<category><![CDATA[general corporate purposes]]></category>
		<category><![CDATA[gulf of mexico]]></category>
		<category><![CDATA[Haynesville]]></category>
		<category><![CDATA[Logansport]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[oil and gas properties]]></category>
		<category><![CDATA[South Texas]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25585/Comstock%27s+Positive+Update++-+Analyst+Blog</guid>
		<description><![CDATA[Yesterday, oil and natural gas firm <strong>Comstock Resources Inc</strong>. (<a href="http://www.zacks.com/stock/quote/CRK">CRK</a>) provided an operational update about its recently completed third quarter. <br />
<br />
Average production was up 9% sequentially to about 184 million cubic feet equivalent per day (MMcfe/d), reflecting the success of Comstock&#8217;s enhanced onshore drilling programs. The company drilled a total of 9 wells during the quarter, with a 100% success rate. <br />
<br />
This year, Comstock&#8217;s drilling programs are focused on developing its Haynesville shale properties in East Texas and North Louisiana . As part of that effort, the company drilled 7 successful wells in DeSoto Parish , North Louisiana during the third quarter (3 wells are in Toledo Bend North field, 3 in the Logansport field and one is in the Mansfield field), which had an average per well initial production rate of approximately 15.6 MMcfe/d. These results were up 23% from the 7 wells that were reported with the second quarter results. Comstock is currently drilling 6 operated horizontal Haynesville Shale wells. <br />
<br />
The company plans to report its third quarter financial results on November 2, 2009.<br />
 <br />
In a separate development, Comstock announced yesterday that it plans to offer $200 million principal amount of senior notes due 2017. The company intends to use the proceeds from the offering to pay back debt under its bank credit facility and for other general corporate purposes.<br />
 <br />
Frisco, Texas-based Comstock Resources Inc. is an independent oil and gas exploration and production company engaged in the acquisition, exploration, and development of oil and gas properties. The company&#8217;s operations are concentrated primarily in four regions in the U.S. : the Gulf of Mexico, East Texas/North Louisiana, Mississippi , and South Texas . <br />
<br />
We currently rate Comstock shares as Neutral.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CRK">Read the full analyst report on "CRK"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/comstocks-positive-update-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>KMP Completes Crosstex Buy &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/kmp-completes-crosstex-buy-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/kmp-completes-crosstex-buy-analyst-blog/#comments</comments>
		<pubDate>Tue, 06 Oct 2009 16:00:13 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[carbon dioxide marketer]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[contracted natural gas treating services]]></category>
		<category><![CDATA[Crosstex Energy Inc;]]></category>
		<category><![CDATA[Crosstex Energy L.P.]]></category>
		<category><![CDATA[Crosstex Energy L.P.;]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[General Partner]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[independent owner]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Kinder Morgan]]></category>
		<category><![CDATA[Kinder Morgan Energy Partners LP;]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas liquids]]></category>
		<category><![CDATA[natural gas treating]]></category>
		<category><![CDATA[natural gas treatment plants]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[petroleum product]]></category>
		<category><![CDATA[petroleum products]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25538/KMP+Completes+Crosstex+Buy+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Late last week, <strong>Kinder Morgan Energy Partners</strong> LP (<a href="http://www.zacks.com/stock/quote/KMP">KMP</a>) closed the previously announced acquisition of natural gas treating business from Dallas-based <strong>Crosstex Energy LP</strong> (<a href="http://www.zacks.com/stock/quote/XTEX">XTEX</a>) and its general partner <strong>Crosstex Energy Inc.</strong> (<a href="http://www.zacks.com/stock/quote/XTXI">XTXI)</a> for approximately $266 million. <br />
<br />
As part of the transaction, Kinder Morgan purchased approximately 290 amine-treating and dew-point control plants from natural gas company Crosstex. These plants are primarily located in Texas and Louisiana , with additional facilities in Mississippi , Oklahoma , Arkansas and Kansas. <br />
<br />
Kinder Morgan will use these natural gas treatment plants in servicing its Texas Intrastate customers and to other producers in various supply basins, including the fast growing shale plays. Following the deal, Kinder Morgan has become the largest provider of contracted natural gas treating services in the country. <br />
<br />
The Crosstex asset acquisition will allow the partnership to expand its natural gas business through the inclusion of additional fee-based assets that produce stable cash flows. Kinder Morgan expects the transaction to be immediately accretive and to add value to its business. <br />
<br />
Houston-based Kinder Morgan Energy Partners L.P. is the largest independent owner and operator of petroleum product pipelines in the U.S. , transporting nearly 2 million barrels per day of gasoline, jet fuel, diesel fuel, and natural gas liquids. The partnership also has capacity to transport 7 billion cubic feet/day (Bcf/d) of natural gas. It owns or operates more than 26,000 miles of pipeline and approximately 170 terminals. The terminals store petroleum products and chemicals, besides handling bulk materials like coal and petroleum coke. Kinder Morgan is also the largest carbon dioxide marketer and transporter in the country. <br />
<br />
We currently rate Kinder Morgan units as Neutral.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=KMP">Read the full analyst report on "KMP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=XTEX">Read the full analyst report on "XTEX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=XTXI">Read the full analyst report on "XTXI"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/kmp-completes-crosstex-buy-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/30/09, SALN, CCNI, ZHNE, ADPT, TRR, AEP</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-93009-saln-ccni-zhne-adpt-trr-aep/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-93009-saln-ccni-zhne-adpt-trr-aep/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 13:09:02 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(GE)]]></category>
		<category><![CDATA[Adaptec Inc.]]></category>
		<category><![CDATA[AEP Ohio]]></category>
		<category><![CDATA[American Electric Power;]]></category>
		<category><![CDATA[Baton Rouge]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Command Center Inc.]]></category>
		<category><![CDATA[construction support services]]></category>
		<category><![CDATA[Dimension Data]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[independent financial advisor]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[labor solutions]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Louisiana Department of Transportation]]></category>
		<category><![CDATA[major IT  solutions provider]]></category>
		<category><![CDATA[media offerings]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River Bridge]]></category>
		<category><![CDATA[network access solutions]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Robert Loarie]]></category>
		<category><![CDATA[Salon City Inc.]]></category>
		<category><![CDATA[Steel Partners II L.P.]]></category>
		<category><![CDATA[Strategic  Committee]]></category>
		<category><![CDATA[Sundi  Sundaresh]]></category>
		<category><![CDATA[telecommunications consortium]]></category>
		<category><![CDATA[TRC Companies Inc.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zhone Technologies Inc]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3730</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Wednesday September 30, 2009
DrStockPick.com Stock Report!
**************************************************************

Salon City, Inc. (PINKSHEETS: SALN) announced today that 3rd quarter sales resulting from new media offerings and  August&#8217;s launch of Beauty Entertainment (BE!) Magazine has helped to contribute  to the Company&#8217;s overall revenue increases as compared to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-93009-saln-ccni-zhne-adpt-trr-aep/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Entergy Spin-Off Delayed &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/entergy-spin-off-delayed-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/entergy-spin-off-delayed-analyst-blog/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 18:49:11 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Covert]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electricity generating capacity]]></category>
		<category><![CDATA[Enexus Energy Corp.]]></category>
		<category><![CDATA[Entergy Corp.]]></category>
		<category><![CDATA[Indian Point Energy Center]]></category>
		<category><![CDATA[James A. Fitzpatrick station]]></category>
		<category><![CDATA[law judges]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[New York Public Service Commission]]></category>
		<category><![CDATA[New;]]></category>
		<category><![CDATA[Oswego County]]></category>
		<category><![CDATA[Palisades plant]]></category>
		<category><![CDATA[Plymouth]]></category>
		<category><![CDATA[regulated utilities;]]></category>
		<category><![CDATA[retail distribution operations;]]></category>
		<category><![CDATA[spin-off]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Vernon]]></category>
		<category><![CDATA[Westchester County]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25262/Entergy+Spin-Off+Delayed+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Entergy Corp.&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/etr">ETR</a>) proposed spin-off of its Non-utility Nuclear power business has been relegated to fiscal 2010.<br />
<br />
Recently, the New York Public Service Commission&#8217;s two administrative law judges in a ruling stated their apprehension regarding the new company having the financial viability to operate three units located in the state of New York. Of this, two units are located in the Indian Point Energy Center in Westchester County and a reactor at the James A. Fitzpatrick station in Oswego County.<br />
<br />
The New York Public Service Commission expressed its apprehension that the $3.5 billion worth of long-term unsecured bonds that Entergy plans to issue for the spin-off will drag down the bond rating of the new company, affecting its financial capacity. The Commission has also relegated its next hearing to December 2009 followed by a final decision on the spin-off in January 2010.<br />
<br />
Entergy has been contemplating the spin-off since fiscal 2007 to separate its regulated utilities and open-market generation units. The new company &#8211; Enexus Energy Corp. will take over nuclear plants located in Pilgrim in Plymouth, MA; Vermont Yankee in Vernon, VT; Indian Point in Westchester County, NY; Fitzpatrick in Oswego County, NY; and the Palisades plant in Covert, MI.<br />
<br />
New Orleans-based Entergy is primarily engaged in electric power production and retail distribution operations. The company owns and operates power plants with approximately 30,000MW of electricity generating capacity. Entergy delivers electricity to 2.7 million utility customers in Arkansas, Louisiana, Mississippi and Texas. Entergy Nuclear is the second largest nuclear generator in the U.S., with interests in six nuclear plants. We maintain our market Neutral recommendation on the shares.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/entergy-spin-off-delayed-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genzyme&#8217;s MS Drug Shows Promise &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/genzymes-ms-drug-shows-promise-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/genzymes-ms-drug-shows-promise-analyst-blog/#comments</comments>
		<pubDate>Tue, 15 Sep 2009 20:40:14 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[B-cell chronic lymphocytic leukemia]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[European Committee for Treatment and Research]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[leading player]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[National Multiple Sclerosis Society]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Rebif]]></category>
		<category><![CDATA[Teva Pharmaceuticals]]></category>
		<category><![CDATA[treatment of B-cell chronic lymphocytic leukemia]]></category>
		<category><![CDATA[Tysabri]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24858/Genzyme%27s+MS+Drug+Shows+Promise+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
On Friday, <strong>Genzyme Corp.</strong> (<a href="http://www.zacks.com/stock/quote/GENZ">GENZ</a>) presented encouraging four-year follow-up phase II data on alemtuzumab, which is being developed for the treatment of multiple sclerosis (MS). Results showed durable reductions in relapse rate and sustained accumulation of disability even three years after patients received their last course of alemtuzumab.
<p align="left">The company presented these efficacy and safety data at the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis in Germany. This CAMMS223 study was conducted in early, relapsing-remitting MS patients, who were randomized to receive either alemtuzumab or <strong>Pfizer</strong>/Serono's (<a href="http://www.zacks.com/stock/quote/PFE">PFE</a>) Rebif.</p>
<p align="left">Patients taking once-yearly cycles of alemtuzumab reduced their risk of relapse by 72% and the risk of sustained accumulation of disability by 73% compared to patients receiving Rebif. Additionally, the annualized relapse rate and disability risk measured from year three to four remained at the same low level observed in prior years of the study. These results confirm the ability of alemtuzumab to extend the duration of response in patients with relapsing MS.</p>
<p align="left">Alemtuzumab (trade name Campath) is available in the U.S. as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL), and outside the U.S. for the treatment of B-CLL in patients who have been treated with alkylating agents and for whom fludarabine combination therapy is not appropriate.</p>
<p align="left">Alemtuzumab is currently in two pivotal phase III studies for the MS indication. Positive results from these studies, expected in 2011, could lead to approval in 2012. The MS market is huge - according to the National Multiple Sclerosis Society, there are approximately 400,000 MS patients in the US. Worldwide, MS is estimated to affect more than 2.5 million people.</p>
<p align="left">Currently available treatments include <strong>Biogen Idec</strong>'s (<a href="http://www.zacks.com/stock/quote/BIIB">BIIB</a>) Avonex and Tysabri, <strong>Teva Pharmaceuticals</strong>' (<a href="http://www.zacks.com/stock/quote/TEVA">TEVA</a>) Copaxone and Pfizer/Serono's Rebif. Biogen is a leading player in the MS market with its Avonex posting sales of $2,203 million in 2008.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GENZ">Read the full analyst report on "GENZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEVA">Read the full analyst report on "TEVA"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genzymes-ms-drug-shows-promise-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/15/09, FE, ATSI, MAR, CRVW, CALM, JCP</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91509-fe-atsi-mar-crvw-calm-jcp/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91509-fe-atsi-mar-crvw-calm-jcp/#comments</comments>
		<pubDate>Tue, 15 Sep 2009 18:20:46 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ATS Medical Inc.]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Australian Indigenous  Minority Supplier Council]]></category>
		<category><![CDATA[Cal-Maine Foods Inc.;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cardiac surgery]]></category>
		<category><![CDATA[cardiac surgery products]]></category>
		<category><![CDATA[CareView Communications Inc.]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Dallas/Fort Worth International Airport]]></category>
		<category><![CDATA[Dana Point;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[FirstEnergy Corp.]]></category>
		<category><![CDATA[Grand Hyatt Hotel]]></category>
		<category><![CDATA[Healthcare Industry]]></category>
		<category><![CDATA[information ;]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[J. C. Penney Company Inc.]]></category>
		<category><![CDATA[Jackson]]></category>
		<category><![CDATA[Lewisville]]></category>
		<category><![CDATA[Marriott International Inc.;]]></category>
		<category><![CDATA[Michael Dale]]></category>
		<category><![CDATA[Mid-Atlantic]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[producer]]></category>
		<category><![CDATA[server systems]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[UBS]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3417</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Tuesday September 15, 2009



**************************************************************
The Board of Directors of FirstEnergy Corp.  (NYSE: FE) today declared an unchanged quarterly dividend of 55 cents  per share of outstanding common stock. The dividend will be payable December 1,  2009, to shareholders of record as of November 6, 2009.
ATS Medical, Inc. (Nasdaq:  ATSI), [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91509-fe-atsi-mar-crvw-calm-jcp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Pain Treatment Triumphs Morphine (OTC:NPHC)</title>
		<link>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 05:52:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adrenoleukodystrophy]]></category>
		<category><![CDATA[Adrenomyeloneuropathy;]]></category>
		<category><![CDATA[AMN]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[anticholinergic therapeutic protein products]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[autoimmune disorders]]></category>
		<category><![CDATA[biologic product]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biopharmaceuticals]]></category>
		<category><![CDATA[Biotech Company]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[covering]]></category>
		<category><![CDATA[covering technologies]]></category>
		<category><![CDATA[cramps]]></category>
		<category><![CDATA[Decision Resources Inc.]]></category>
		<category><![CDATA[designer]]></category>
		<category><![CDATA[Designer Diagnostics Inc.]]></category>
		<category><![CDATA[drug addiction;]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[drug discovery subsidiary;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HIV technologies]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[joint pain]]></category>
		<category><![CDATA[lower back pain]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[migraines;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myasthenia gravis]]></category>
		<category><![CDATA[Nanologix Inc.]]></category>
		<category><![CDATA[neck aches]]></category>
		<category><![CDATA[neuralgia]]></category>
		<category><![CDATA[neurological disorder]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[Nutra Pharma Inc.]]></category>
		<category><![CDATA[Orange channel]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[prized product]]></category>
		<category><![CDATA[ReceptoPharm Inc.]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rik J Deitsch;]]></category>
		<category><![CDATA[RPI-MN]]></category>
		<category><![CDATA[severe chronic]]></category>
		<category><![CDATA[shared aerosol delivery technology]]></category>
		<category><![CDATA[Should Nutra Pharma Corp.]]></category>
		<category><![CDATA[shoulder pain]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[suggested retail price]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[tuberculosis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>
		<category><![CDATA[Webinar]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=489</guid>
		<description><![CDATA[Nutra Pharma Corp.
(Public, OTC:NPHC)
Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma#8217;s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Entergy Arkansas Wants Rate Hike &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/entergy-arkansas-wants-rate-hike-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/entergy-arkansas-wants-rate-hike-analyst-blog/#comments</comments>
		<pubDate>Tue, 08 Sep 2009 20:48:59 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Arkansas Public Service Commission]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Entergy Arkansas]]></category>
		<category><![CDATA[Entergy Corporation]]></category>
		<category><![CDATA[gas/oil;]]></category>
		<category><![CDATA[location]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[Natural Gas Prices]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[nuclear-based energy]]></category>
		<category><![CDATA[Ouachita plant]]></category>
		<category><![CDATA[regulated utilities;]]></category>
		<category><![CDATA[Retail Distribution]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[utility subsidiary]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24572/Entergy+Arkansas+Wants+Rate+Hike+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Entergy Corporation&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/etr">ETR</a>) utility subsidiary Entergy Arkansas has requested from the Arkansas Public Service Commission a $223 million hike in the base rate late last week.<br />
<br />
Entergy Arkansas supplies electricity to 684,000 customers spread across 63 counties in the state of Arkansas. The requested hike was to cover the cost of purchase of the Ouachita plant and restoration costs associated with the January 2009 ice storm in northern Arkansas. As per company estimations, this would raise the bill of an average residential customer with a monthly consumption of 1,000 kilowatt-hours by $7.86.<br />
<br />
Entergy Arkansas officials, however, feel that the actual burden would be much less. The improvement is expected to stem from lower fuel costs, which would improve on account of a decrease in natural gas prices.<br />
<br />
New Orleans-based Entergy is primarily engaged in electric power production and retail distribution of power. With 30,000MW of generating capacity, it distributes electricity to 2.6 million customers in Arkansas, Louisiana, Mississippi and Texas. Of this, 14,631MW are gas/oil based, 2,259MW coal based, 70MW hydro-based and the rest nuclear based. With around 13,000MW of nuclear-based energy, the company is the second largest nuclear power generator in the U.S. The company also distributes natural gas to 240,000 customers in Louisiana.<br />
<br />
Entergy is focusing on its traditional electric utility business with a planned separation of its nuclear business. The company has shown strong resilience during two back-to-back destructive hurricanes in 2008. Going forward, stable earnings from regulated utilities and significant free cash flow available for share repurchases, dividend hikes and/or debt retirement collectively support management&#8217;s focus on creating shareholder value.<br />
<br />
However, higher outages, an expected slide in power prices and pending regulatory approvals in New York and Vermont for the proposed spin-off of its nuclear business are areas of concern. We maintain our Neutral recommendation on the shares.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/entergy-arkansas-wants-rate-hike-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Blockbuster Drugs Seeking NDA (AMEX:AEN)</title>
		<link>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/</link>
		<comments>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 06:15:47 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adeona Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[Betaseron]]></category>
		<category><![CDATA[Betaseron®]]></category>
		<category><![CDATA[cardiovascular diseases]]></category>
		<category><![CDATA[care for MS]]></category>
		<category><![CDATA[Cha]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Chief Executive Officer and co-founder]]></category>
		<category><![CDATA[Chief Operating Officer]]></category>
		<category><![CDATA[chronic inflammatory]]></category>
		<category><![CDATA[Co Founder]]></category>
		<category><![CDATA[cognitive impairment]]></category>
		<category><![CDATA[Colwell Clinical Laboratories]]></category>
		<category><![CDATA[Cordex Pharma Inc.]]></category>
		<category><![CDATA[CPA;]]></category>
		<category><![CDATA[Crystal Research Associates]]></category>
		<category><![CDATA[David Newsome]]></category>
		<category><![CDATA[dementia;]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[dnaJP1]]></category>
		<category><![CDATA[drug therapy]]></category>
		<category><![CDATA[Esq   Chairman & Chief Executive Officer]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fibromyalgia]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Hartlab LLC]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[James S. Kuo]]></category>
		<category><![CDATA[Jeffrey J. Kraws]]></category>
		<category><![CDATA[Jeffrey Wolf]]></category>
		<category><![CDATA[leading clinical scientist]]></category>
		<category><![CDATA[legal blindness]]></category>
		<category><![CDATA[M.B.A.]]></category>
		<category><![CDATA[M.S.]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Max Lyon]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MS therapies]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[National Eye Institute]]></category>
		<category><![CDATA[National MS Society]]></category>
		<category><![CDATA[National Multiple Sclerosis Society]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[Nicholas Stergis]]></category>
		<category><![CDATA[oral therapies]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Post-partum Depression]]></category>
		<category><![CDATA[Postpartum depression]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[progressive disease]]></category>
		<category><![CDATA[reduced vision]]></category>
		<category><![CDATA[relapsing-remitting multiple sclerosis;]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Steve H. Kanzer]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[the American College;]]></category>
		<category><![CDATA[Treatment for Multiple Sclerosis]]></category>
		<category><![CDATA[treatment of MS]]></category>
		<category><![CDATA[treatment of unmet medical diseases]]></category>
		<category><![CDATA[Trimesta™]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice Chairman]]></category>
		<category><![CDATA[Vice Chairman of our board]]></category>
		<category><![CDATA[Vice Chairman of the Board]]></category>
		<category><![CDATA[vice president of business development]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zinthionein]]></category>
		<category><![CDATA[ZMC]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=432</guid>
		<description><![CDATA[Adeona Pharmaceuticals, Inc. 

(Public, AMEX:AEN)

StocksHaven Investments takes a look at Adeona Pharmaceuticals, Inc. which currently has three blockbuster drugs in phase III, and are coming close to NDA status. The first being Trimesta, which tackles Multiple Sclerosis (MS) and Post-partum Depression. Secondly, Zinthionein, a product seeking treatment for Age Related Macular Degeneration (AMD). Lastly, Oral [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gentiva Acquires Rush Home &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/gentiva-acquires-rush-home-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/gentiva-acquires-rush-home-analyst-blog/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 21:10:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Amedisys Inc.]]></category>
		<category><![CDATA[American Homepatient Inc.]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Apria Healthcare Group Inc.]]></category>
		<category><![CDATA[Carolina]]></category>
		<category><![CDATA[Donelson]]></category>
		<category><![CDATA[Emerald Coast]]></category>
		<category><![CDATA[Gentiva Health Services Inc.]]></category>
		<category><![CDATA[Gilbert's]]></category>
		<category><![CDATA[Gilbertown]]></category>
		<category><![CDATA[Healthfield]]></category>
		<category><![CDATA[Heritage]]></category>
		<category><![CDATA[home healthcare services;]]></category>
		<category><![CDATA[Horizon]]></category>
		<category><![CDATA[Hospice of Charleston]]></category>
		<category><![CDATA[Lazarus House]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Meridian]]></category>
		<category><![CDATA[Mid South]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nicholas County Board of Health]]></category>
		<category><![CDATA[Nicholas County Commission]]></category>
		<category><![CDATA[Ogeechee]]></category>
		<category><![CDATA[Physicians]]></category>
		<category><![CDATA[Rush Home Care Inc.]]></category>
		<category><![CDATA[Tar Heel]]></category>
		<category><![CDATA[Total Care]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[West Virginia]]></category>
		<category><![CDATA[Wiregrass]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24470/Gentiva+Acquires+Rush+Home+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Yesterday, <strong>Gentiva Health Services Inc.</strong> (<a href="http://www.zacks.com/stock/quote/gtiv">GTIV</a>) announced the completion of its acquisition of Rush Home Care Inc., which operates as Magna Home Health. While the financial terms of the transaction were undisclosed, the company announced that it funded the deal with its existing cash reserves.<br />
<br />
The agreement to purchase Magna Home Health, a part of the Rush Health System, was signed by Gentiva in July this year. The addition of Magna's locations in Meridian, Mississippi and Gilbertown, Alabama should enable Gentiva to expand its coverage in seven new certificate of need (CON) counties to participate in the delivery of home health services.<br />
<br />
We believe this deal will consolidate Gentiva&#8217;s position as the largest provider of comprehensive home healthcare services in the U.S. and enable them to serve a wider patient population. The transaction is not expected to affect Gentiva&#8217;s 2009 operations materially.<br />
<br />
Gentiva, which derives its revenues from commercial insurance, federal and state government programs and individual consumers, has successfully grown by acquisition. It recently purchased the assets of a homecare operation from the Nicholas County Commission on behalf of the Nicholas County Board of Health in West Virginia . It continues to be on the lookout for profitable acquisitions.<br />
<br />
The Gentiva family includes more than a dozen companies, including Carolina, Donelson, Emerald Coast, Gentiva, Gilbert's, Healthfield, Heritage, Horizon, Hospice of Charleston, Lazarus House, Medical, Mid South, Ogeechee, Physicians, Tar Heel, Total Care and Wiregrass.<br />
<br />
The company competes mainly with <strong>Amedisys Inc</strong>. (<a href="http://www.zacks.com/stock/quote/amed">AMED</a>), American Homepatient Inc. and the privately held Apria Healthcare Group Inc. in the Home Health Care industry.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GTIV">Read the full analyst report on "GTIV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMED">Read the full analyst report on "AMED"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gentiva-acquires-rush-home-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PennyOmega.com Stock Report! 9/03/09, AKAM, VICL, DCTH, UPI, TRMB, CYD</title>
		<link>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/</link>
		<comments>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 11:39:42 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Akamai Technologies Inc.]]></category>
		<category><![CDATA[alternative fuel technologies]]></category>
		<category><![CDATA[Boo Guan Saw]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Yuchai International Limited]]></category>
		<category><![CDATA[Chinese Government]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[diesel engine products]]></category>
		<category><![CDATA[fuel technologies]]></category>
		<category><![CDATA[Guangxi Yuchai Machinery Company Limited]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[innovative proprietary]]></category>
		<category><![CDATA[innovative proprietary products]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[main  operating subsidiary]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[overactive bladder]]></category>
		<category><![CDATA[Paul Sagan]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[Percutaneous Hepatic Perfusion (PHP(TM)) System]]></category>
		<category><![CDATA[Percutaneous Hepatic Perfusion (PHP) System]]></category>
		<category><![CDATA[PHP]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[Queensbury]]></category>
		<category><![CDATA[Special General]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[trimble]]></category>
		<category><![CDATA[Trimble VRS Now]]></category>
		<category><![CDATA[Trimble(R) VRS Now(TM) service]]></category>
		<category><![CDATA[urge incontinence]]></category>
		<category><![CDATA[Urgent PC System]]></category>
		<category><![CDATA[Uroplasty Inc;]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vical Incorporated]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=881</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/03/09, AKAM, VICL, DCTH, UPI, TRMB, CYD</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 11:30:20 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Akamai Technologies Inc.]]></category>
		<category><![CDATA[alternative fuel technologies]]></category>
		<category><![CDATA[Boo Guan Saw]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Yuchai International Limited]]></category>
		<category><![CDATA[Chinese Government]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[diesel engine products]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[fuel technologies]]></category>
		<category><![CDATA[Guangxi Yuchai Machinery Company Limited]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[innovative proprietary]]></category>
		<category><![CDATA[innovative proprietary products]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[main  operating subsidiary]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[overactive bladder]]></category>
		<category><![CDATA[Paul Sagan]]></category>
		<category><![CDATA[Percutaneous Hepatic Perfusion (PHP(TM)) System]]></category>
		<category><![CDATA[Percutaneous Hepatic Perfusion (PHP) System]]></category>
		<category><![CDATA[PHP]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[Queensbury]]></category>
		<category><![CDATA[Special General]]></category>
		<category><![CDATA[trimble]]></category>
		<category><![CDATA[Trimble VRS Now]]></category>
		<category><![CDATA[Trimble(R) VRS Now(TM) service]]></category>
		<category><![CDATA[urge incontinence]]></category>
		<category><![CDATA[Urgent PC System]]></category>
		<category><![CDATA[Uroplasty Inc;]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vical Incorporated]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3185</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Thursday September 3, 2009




**************************************************************

Akamai Technologies,  Inc. (NASDAQ: AKAM), the leader in powering video, dynamic transactions  and enterprise applications online, announced today that it will participate in  Citi&#8217;s 16th Annual Global Technology Conference in New York, New York. President  and CEO, Paul Sagan, will present an update on Akamai&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90309-akam-vicl-dcth-upi-trmb-cyd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MGM Delays Debt Repayment &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/mgm-delays-debt-repayment-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/mgm-delays-debt-repayment-analyst-blog/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 18:40:41 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[diversified model]]></category>
		<category><![CDATA[Kirk Kerkorian]]></category>
		<category><![CDATA[mgm mirage]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24336/MGM+Delays+Debt+Repayment+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>MGM Mirage </strong>(<a href="http://www.zacks.com/stock/quote/mgm">MGM</a>) has offered to exchange a part of its $782 million 8.5% senior notes due next year for up to $500 million of 10.00% Senior Notes due 2016. This swapping would harness liquidity and also allow the company to extend the time to repay its debt at the cost of a somewhat increased debt level and interest expenses.<br />
<br />
The exchange offer will expire September 24, 2009, unless extended by MGM. For each $1,000 in principal amount of existing notes tendered and accepted, the holder will receive $1,175 principal amount of new notes, of which $50 in principal amount of New Notes represents early participation payment only to those who tender notes before the close of business on September 10, 2009.<br />
<br />
Casino operator MGM Mirage has been severely impacted by the recession. The company reported a loss of $212 million in the second quarter as it incurred significant impairment charges.<br />
<br />
However, the company has a strong pipeline of projects and has implemented several cost-control initiatives, which are expected to lead to its earning growth going forward. The company is now trying to expand in Asia and Middle East without investing in land and development, but as a franchisor.<br />
<br />
MGM Mirage owns and operates 16 casinos in Nevada, Mississippi and Michigan and has a 50.0% interest in four other casino resorts. The company also operates luxury hotels in the Middle East and Asia.<br />
<br />
MGM which is partly controlled by billionaire investor Kirk Kerkorian, has a diversified model which allows it to withstand weaker economic times relatively well. The company has international exposure coupled with its diversification within the U.S., which bodes well going forward. Also this swapping of senior notes provides the much needed short-term liquidity to the company though the debt level increases a bit.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MGM">Read the full analyst report on "MGM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/mgm-delays-debt-repayment-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Best Buy to Open 22 Stores &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/best-buy-to-open-22-stores-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/best-buy-to-open-22-stores-analyst-blog/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 15:45:38 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Best Buy Co Inc]]></category>
		<category><![CDATA[Best Buy Europe]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Entertainment Products]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[tough retail environment]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[Wisconsin]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24321/Best+Buy+to+Open+22+Stores+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Best Buy Co. Inc.</strong> (<a href="http://www.zacks.com/stock/quote/BBY">BBY</a>) recently announced its plan to open 22 new U.S. stores in its fiscal third quarter. The stores will be opened in Virginia, Texas, Florida, Pennsylvania, Mississippi, New York, Ohio, California, Wisconsin, Puerto Rico, Arkansas, New Jersey, Massachusetts and Louisiana.<br />
 <br />
Currently, Best Buy operates 1,044 U.S. stores in 50 states and Puerto Rico. The company added 21 stores in the first six months of the fiscal year 2010. It opened 9 stores in the first quarter and another 12 stores in the second quarter.<br />
 <br />
Best Buy&#8217;s pace of opening new stores in the current fiscal year is substantially low compared to prior year quarters. Amid the challenging global economy and tough retail environment, we believe that the company has taken prudent steps to move steadily, rather than aggressively.<br />
 <br />
In fiscal year 2009, Best Buy opened 26 stores in the first quarter, 24 in the second quarter, and 37 stores in the third quarter.<br />
 <br />
The company will report its fiscal second quarter results on Sept 15.<br />
 <br />
During the first quarter, the company&#8217;s revenues jumped 12% year over year to $10,095 million primarily due to the addition of Best Buy Europe&#8217;s revenues and net addition of 185 new stores in the past 12 months, partially offset by a 6.2% decline in comparable store sales. Earnings per share fell 2.3% to 42 cents per share.<br />
 <br />
Best Buy is a global retailer of technology and entertainment products with operations in the United States, Canada, Europe, China and Mexico.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BBY">Read the full analyst report on "BBY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/best-buy-to-open-22-stores-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 8/31/09, DCTH, TSEM, VSEC, KMP, XTEX, RBA</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-83109-dcth-tsem-vsec-kmp-xtex-rba/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-83109-dcth-tsem-vsec-kmp-xtex-rba/#comments</comments>
		<pubDate>Mon, 31 Aug 2009 11:34:16 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Air Force]]></category>
		<category><![CDATA[Air Force’s Hill  AFB]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Auctioneers]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Crosstex Energy Inc;]]></category>
		<category><![CDATA[Crosstex Energy L.P.]]></category>
		<category><![CDATA[Delcath Systems Inc.]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Hepatocellular carcinoma;]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indian Head]]></category>
		<category><![CDATA[industrial auctioneer]]></category>
		<category><![CDATA[International Group’s Fleet  Maintenance Division]]></category>
		<category><![CDATA[Joint Program Office for Cartridge  Actuated Devices and Propellant Actuated Devices]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Kinder Morgan Energy Partners L.P.]]></category>
		<category><![CDATA[Liver Cancer]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[natural gas treating]]></category>
		<category><![CDATA[Naval Surface Weapons Center]]></category>
		<category><![CDATA[Navy’s  Naval Surface Weapons Center]]></category>
		<category><![CDATA[Ogden;]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[online  bidders]]></category>
		<category><![CDATA[Ritchie Bros]]></category>
		<category><![CDATA[TAEJIN Technology Co. Ltd.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Tower Semiconductor Ltd.]]></category>
		<category><![CDATA[U.S. Food & Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VSE Corporation]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3110</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Monday August 31, 2009




**************************************************************

Delcath Systems, Inc.  (Nasdaq: DCTH), a medical technology company testing its proprietary  treatment method for primary and metastatic cancers to the liver, announced that  the U.S. Food &#38; Drug Administration granted Delcath&#8217;s request for orphan  drug designation for doxorubicin for the treatment of hepatocellular carcinoma [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-83109-dcth-tsem-vsec-kmp-xtex-rba/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mainland Resources, Inc. (MNLU.OB) Expands Haynesville Shale Acreage</title>
		<link>http://www.straightstocks.com/market-commentary/mainland-resources-inc-mnlu-ob-expands-haynesville-shale-acreage/</link>
		<comments>http://www.straightstocks.com/market-commentary/mainland-resources-inc-mnlu-ob-expands-haynesville-shale-acreage/#comments</comments>
		<pubDate>Fri, 28 Aug 2009 20:26:10 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Guggenheim Corporate Funding LLC]]></category>
		<category><![CDATA[Mainland Resources Inc.]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=17509</guid>
		<description><![CDATA[Mainland Resources, Inc. is leasing additional acreage in the Haynesville Shale in Mississippi and now controls 8,500 acres in this emerging shale gas play in the southeastern United States. 
Today’s announcement expands the acreage specified in the original agreement, which was signed in June 2009, by 500 additional acres.  Mainland Resources must pay $300,000 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/mainland-resources-inc-mnlu-ob-expands-haynesville-shale-acreage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Toyota to Shutter NUMMI &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/toyota-to-shutter-nummi-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/toyota-to-shutter-nummi-analyst-blog/#comments</comments>
		<pubDate>Fri, 28 Aug 2009 17:56:55 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Cambridge]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Corolla]]></category>
		<category><![CDATA[East Bay Economic Development Alliance]]></category>
		<category><![CDATA[Fremont]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New United Motor Manufacturing Inc.]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Pontiac Vibe]]></category>
		<category><![CDATA[San Antonio]]></category>
		<category><![CDATA[Tacoma;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Toyota]]></category>
		<category><![CDATA[Toyota Motors;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24208/Toyota+to+Shutter+NUMMI+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Toyota Motors</strong> (<a href="http://www.zacks.com/stock/quote/tm">TM</a>) has revealed that it will close down the New United Motor Manufacturing, Inc. (NUMMI) plant in Fremont, California, which had been operated with General Motors since 1984. The move is a part of the company&#8217;s plan to reduce worldwide capacity by 700,000 to 1 million vehicles.<br />
<br />
NUMMI, opened by General Motors in 1962, was shut down in 1982 on the back of operational inefficiency. However, the plant was reopened two years later when it became a 50/50 joint venture between General Motors and Toyota.<br />
<br />
NUMMI was a remarkable joint venture in America&#8217;s as well as Toyota&#8217;s history. The joint venture taught Americans about the famous Japanese "lean manufacturing system" (focused on just-in-time delivery) through NUMMI, and Toyota took its first step in the U.S. using GM&#8217;s supply lines. NUMMI has produced Corolla and Tacoma for Toyota and Pontiac Vibe for GM. However, GM had decided to pull out of NUMMI after completing its bankruptcy filing in June, as it will discontinue the Pontiac brand.<br />
<br />
Toyota will stop production at NUMMI in March 2010 and will shift production to its other plants in the U.S., Canada and Japan. Production of the Corolla subcompact will be moved to Cambridge, Ontario, as well as Japan, and Tacoma pickups will be produced in San Antonio, TX.<br />
<br />
Toyota has been buffeted financially by the economic crisis. The company posted its first annual loss (¥437 billion or $4.4 billion) since 1950 for the fiscal year ended March 2009. Further, management has recently projected its net loss to worsen to ¥550 billion ($5.5 billion) for the fiscal year ending March 2010.<br />
<br />
According to the East Bay Economic Development Alliance, the NUMMI closure would cost 5,400 direct jobs and 30,000 indirect jobs. Toyota has 12 manufacturing facilities in the U.S. Presently, six of them are operating under capacity and one has been idled in Mississippi.<br />
 <br />
We continue to recommend the shares of Toyota as Neutral.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TM">Read the full analyst report on "TM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/toyota-to-shutter-nummi-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Winn-Dixie Turnaround Continues &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/winn-dixie-turnaround-continues-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/winn-dixie-turnaround-continues-analyst-blog/#comments</comments>
		<pubDate>Wed, 26 Aug 2009 19:12:57 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Easter]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Food Retailers]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Jacksonville]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Whole Foods Market Inc]]></category>
		<category><![CDATA[Winn-Dixie Stores Inc.]]></category>
		<category><![CDATA[Winn-Dixie;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24073/Winn-Dixie+Turnaround+Continues+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Winn-Dixie Stores Inc.</strong> (<a href="http://www.zacks.com/stock/quote/winn">WINN</a>) reported fiscal fourth-quarter results earlier this week. The company swung to a net profit of $9.4 million from a net loss of $5.5 million in the year-ago quarter. Earnings per share came in at 17 cents, which missed the Zacks Consensus Estimate by a penny.<br />
<br />
Winn-Dixie is one of the leading food retailers in the U.S. and currently operates 515 grocery locations, including more than 400 in-store pharmacies, across Florida, Alabama, Louisiana, Georgia and Mississippi. The Jacksonville, FL-based company&#8217;s sales posted a slight growth of 1.4% year over year to $1.72 billion. This was driven by a 1.6% rise in identical-store sales, mainly due to a favorable shift in the timing of Easter holidays, partially offset by higher sales of generic drugs compared to branded ones.<br />
<br />
The company, which emerged from bankruptcy protection in November 2006, is remodeling its stores in the midst of its turnaround strategy, an effort which seems to be paying off. By July 15, the company had completed remodeling all 51 stores in Jacksonville, taking the total number of stores remodeled to 170 at the end of fiscal 2009. The company intends to remodel about half of its stores by the end of fiscal 2010 and almost the entire chain by fiscal 2013.<br />
<br />
Winn-Dixie&#8217;s gross profit grew 10% year over year to $500.4 million, while margin expanded 230 basis points (bps) to 29.2%, primarily due to favorable product mix and reduced promotional activities. However, operating and administrative expenses, as a percentage of sales, rose 60 bps year over year to 27.9% mainly on account of higher payroll, advertising expenses and utility rates.<br />
<br />
Nevertheless, driven by improved gross margins, operating income came in at $18.9 million, compared to an operating loss of $6.4 million in the same period last year, while operating margin improved to 1.1% from negative 0.4%. Earnings before interest, taxes, depreciation and amortization (EBITDA) more than doubled to $44.5 million from $17.2 million in the year-ago quarter.<br />
<br />
Cash and equivalents at the end of the quarter was $182.8 million, compared to $201.3 million in the year-ago period. The company generated $199.6 million of cash from operations during fiscal 2009 and deployed about $216.9 million towards capital expenditure.<br />
<br />
Earlier this month, rival <strong>Whole Foods Market Inc</strong>. (<a href="http://www.zacks.com/stock/quote/wfmi">WFMI</a>) posted fiscal third-quarter earnings of 24 cents per share, beating the Zacks Consensus Estimate by 26.3%, or 5 cents. The company recorded a 2% year-over-year growth in sales to $1.9 billion despite a 3.8% decline in identical-store sales.<br />
<br />
Meanwhile, Winn-Dixie continues to expect identical-store sales for the year ending June 2010 to grow by 1% to 2%, and EBITDA to range between $150 million and $160 million. The Zacks Consensus Estimate (derived from 4 covering analysts) on the company&#8217;s earnings for this fiscal year is currently pegged at 44 cents per share, which has climbed 5 cents over the past 2 months.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WINN">Read the full analyst report on "WINN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFMI">Read the full analyst report on "WFMI"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/winn-dixie-turnaround-continues-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wells Fargo Going Slow on Wachovia  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/wells-fargo-going-slow-on-wachovia-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/wells-fargo-going-slow-on-wachovia-analyst-blog/#comments</comments>
		<pubDate>Tue, 25 Aug 2009 15:15:40 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Carolinas;]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[East Coast]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[residential lender]]></category>
		<category><![CDATA[South Carolina]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[Wachovia Bank]]></category>
		<category><![CDATA[Wachovia Corp]]></category>
		<category><![CDATA[Wachovia Mortgage]]></category>
		<category><![CDATA[Wachovia Securities]]></category>
		<category><![CDATA[Washington D C]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23976/Wells+Fargo+Going+Slow+on+Wachovia++-+Analyst+Blog</guid>
		<description><![CDATA[<p>Six months after acquiring Wachovia Corp., the <strong>Wells Fargo</strong> (<a href="http://www.zacks.com/stock/quote/WFC">WFC</a>) name and stagecoach logo have yet to be seen in the Kansas City area. Indeed it will not be visible till the next year. San Francisco-based Wells Fargo has been moving slowly to consolidate Wachovia Bank into its system.<br />
 <br />
During December last year, the brokerage firm Wachovia Securities became part of Wells Fargo. All 4,800 branches of the residential lender Wachovia Mortgage have been folded into Wells Fargo Home Mortgage.<br />
 <br />
Wachovia Corp. was purchased by Wells Fargo on Dec 31, 2008, when it ceased to be an independent corporation. The company had been battered by heavy losses &#8211; especially in its portfolio of flexible, interest-only home loans &#8211; and was suffering a run on its deposits.<br />
 <br />
The consolidation of Wachovia bank branches into Wells Fargo's network is scheduled to begin this November. The integration will begin in Colorado, one of a half-dozen states where both the institutions have overlapping branches.<br />
 <br />
After Colorado, the branch-conversion process will move to five other states &#8211; California, Arizona, Illinois, Nevada and Texas &#8211; where Wells Fargo and Wachovia offices also overlap. Conversion in these states is expected to begin in 2010, though the conversion dates haven&#8217;t been announced for the Wachovia-only markets in the Carolinas and along the East Coast.<br />
 <br />
Wells Fargo&#8217;s growth plans have included a large number of acquisitions, Wachovia being the latest in December 2008. The company has demonstrated its ability to assimilate local franchises offering a wider range of products than the acquired company could have had.<br />
 <br />
The Wachovia merger is expected to generate an internal rate of return (IRR) of about 20% and be accretive to earnings starting from the third year without any adjustments. Further, as a result of the merger, Wells Fargo substantially expanded its distribution network and has a Community Banking presence for the first time in 16 states &#8211; Alabama, Connecticut, Delaware, Florida, Georgia, Kansas, Maryland, Mississippi, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Virginia and Washington D.C.<br />
 <br />
Last month, Wells Fargo reported net income of 57 cents per share. The company reported that the Wachovia merger is on track and expects to realize $5 billion of annual merger-related savings upon completion of the integration process. During the latest reported quarter, 39% of the combined revenue came from Wachovia. With the combined resources, Wells Fargo will be in an even better position to satisfy its customers&#8217; financial needs.</p>
<p>We maintain a Neutral recommendation on the shares of Wells Fargo.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFC">Read the full analyst report on "WFC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/wells-fargo-going-slow-on-wachovia-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PennyOmega.com Stock Report! 8/25/09, ANAD, TOOT, DTVI, RVBD, NSPH, IFSL</title>
		<link>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-82509-anad-toot-dtvi-rvbd-nsph-ifsl/</link>
		<comments>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-82509-anad-toot-dtvi-rvbd-nsph-ifsl/#comments</comments>
		<pubDate>Tue, 25 Aug 2009 13:17:11 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Anadigics Inc.;]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[CN50]]></category>
		<category><![CDATA[Dot VN Inc.]]></category>
		<category><![CDATA[eKnowledge]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Flexible Network Radio]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Ideal Financial Solutions Inc.]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Intermec CN50]]></category>
		<category><![CDATA[Intermec Technologies Corporation for the Wireless Wide]]></category>
		<category><![CDATA[Jackson]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Longview;]]></category>
		<category><![CDATA[Louis]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Missouri]]></category>
		<category><![CDATA[molecular diagnostics systems]]></category>
		<category><![CDATA[Nanosphere Inc.;]]></category>
		<category><![CDATA[online global domain name registration]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[Riverbed Technology]]></category>
		<category><![CDATA[San Antonio]]></category>
		<category><![CDATA[Staging Connections Group Limited]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Sysco]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Tootie Pie Company Inc.]]></category>
		<category><![CDATA[Vietnam]]></category>
		<category><![CDATA[WAN]]></category>
		<category><![CDATA[wireless wide-area network capability]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=785</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-82509-anad-toot-dtvi-rvbd-nsph-ifsl/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MultiCell Technologies, Inc. (MCET.OB) is “One to Watch”</title>
		<link>http://www.straightstocks.com/market-commentary/multicell-technologies-inc-mcet-ob-is-%e2%80%9cone-to-watch%e2%80%9d/</link>
		<comments>http://www.straightstocks.com/market-commentary/multicell-technologies-inc-mcet-ob-is-%e2%80%9cone-to-watch%e2%80%9d/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 20:33:39 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[cell immortalization]]></category>
		<category><![CDATA[cell immortalization technologies]]></category>
		<category><![CDATA[cell-based assay systems]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[drug development technologies]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[fatigue]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[integrated biopharmaceutical;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MultiCell Technologies Inc.;]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[producer]]></category>
		<category><![CDATA[Rhode Island]]></category>
		<category><![CDATA[targets disease]]></category>
		<category><![CDATA[Woonsocket]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=17331</guid>
		<description><![CDATA[Headquartered in Woonsocket, Rhode Island, MultiCell Technologies, Inc. is an integrated biopharmaceutical company. Trading on the OTCBB, their commitment is to the development of breakthrough therapeutics based on a portfolio of therapeutic candidates and patented drug development technologies. The company plans to pursue strategic alliances to better penetrate the various markets for their therapeutics.
The company&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/multicell-technologies-inc-mcet-ob-is-%e2%80%9cone-to-watch%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prime Mortgages Going Sour &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/prime-mortgages-going-sour-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/prime-mortgages-going-sour-analyst-blog/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 19:53:20 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[chief economist]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[good head]]></category>
		<category><![CDATA[head of steam]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mortgage Bankers Association]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[North Dakota]]></category>
		<category><![CDATA[printing money]]></category>
		<category><![CDATA[Regionally]]></category>
		<category><![CDATA[sheriff]]></category>
		<category><![CDATA[Thanksgiving]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Wyoming]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23827/Prime+Mortgages+Going+Sour+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
At the end of the second quarter, 4.3% of all residential mortgages were in some part of the foreclosure process, up from 3.85% at the end of the first quarter and 2.75% a year ago. In addition, on a seasonally adjusted basis, 9.24% of all mortgages were delinquent (behind by at least one payment), up from 9.12% at the end of March, and just 6.41% at the end of June 2008.<br />
<br />
Both were records since the Mortgage Bankers Association (MBA) started keeping track back in 1972. On a non-seasonally-adjusted basis, the delinquency rate was not quite as bad at 8.86%, but still a record.<br />
<br />
That means that 13.16% of all residential mortgages (NSA basis) are in trouble. With about 51 million houses with mortgages in the country, that means 6.71 million bad mortgages out there. With the number of people out of work still rising, the problem is likely to continue to get worse for quite a while.<br />
<br />
The chief economist for the MBA expects that foreclosures will not peak until the end of 2010. I suspect he might be a little bit on the optimistic side, but that projection is reasonable. If someone is also in a house where the value of the house is less than the amount of the mortgage, the probability that they will continue to pay the mortgage falls rapidly.<br />
<br />
If they are also out of work while they are underwater, then continuing to pay their mortgage is simply not an economically rational thing to do.  Far better to simply live rent- and mortgage-free until the sheriff shows up at the door. Given the overwhelming case-load, that can often be well over a year (though it varies greatly by location).<br />
<br />
Once upon a time, people liked to think that the mortgage problems were contained to the subprime market. It was just a problem of irresponsible people on the wrong side of the tracks. That is clearly no longer the case.<br />
<br />
While as a percentage, subprime mortgages are still much more likely to be delinquent or in foreclosure than are prime mortgages, there are far fewer subprime mortgages than prime mortgages.  In absolute numbers, there are far more bad prime mortgages than bad subprime mortgages.<br />
<br />
The graph below (from <a href="http://www.calculatedriskblog.com">http://www.calculatedriskblog.com</a>/) shows just how bad the loans are going sour on the people who had good credit when they took out the mortgages.  <br />
<br />
The percentage of prime loans in foreclosure jumped to 3.00% at the end of the second quarter vs. 2.49% at the end of March. The percentage delinquent rose to 6.41% from 6.06% at the end of March.<br />
<br />
On a percentage basis, subprime loans continue to be an absolute horror show. At the end of the quarter more than one in four (25.35%) subprime loans were delinquent (up from 24.95% at the end of the first quarter) and 15.05% were somewhere in the foreclosure process, up from 14.34% the quarter before.<br />
<br />
Thus, the combined troubled mortgage rate is now over 40% on subprime loans. This is of course bad news for the banks with big mortgage operations like<strong> Bank of America</strong> (<a href="http://www.zacks.com/stock/quote/bac">BAC</a>), <strong>Wells Fargo </strong>(<a href="http://www.zacks.com/stock/quote/wfc">WFC</a>) and<strong> PNC Financial </strong>(<a href="http://www.zacks.com/stock/quote/pnc">PNC</a>).<br />
 <br />
<img src="http://www.zacks.com/images/upload_dir/1250793984.jpg" alt="" /><br />
 <br />
Regionally, California, Florida, Arizona and Nevada are still being hit the hardest, but other states are starting to catch up. Those four states had 44 percent of all of the nation&#8217;s new foreclosures during the second quarter of this year, down from 46 percent in the first quarter.<br />
<br />
Foreclosures are less of a problem in the relatively unpopulated states. Very few people (relatively) are falling behind in North Dakota, Wyoming or Alaska as shown in the second graph (also from <a href="http://www.calculatedriskblog.com/">http://www.calculatedriskblog.com/</a>).<br />
<br />
Florida still has the worst mortgage performance, closely followed only by Nevada.  In Florida, 12 percent of mortgages were somewhere in the process of foreclosure -- the highest in the nation -- and another 5 percent were at least 90 days past due as of the end of June. A total of 22.8 percent were delinquent at least one payment or in the process of foreclosure, which is almost twice the national percentage (excluding Florida).<br />
<br />
In contrast, the next highest states are Nevada at 21.3 percent, Arizona at 16.3 percent and Michigan at 15.3 percent. California is still a problem by virtue of its sheer size, but on a percentage basis, and combining both levels of the problem, Mississippi and Indiana are now in marginally worse shape than is California.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1250793997.jpg" alt="" /><br />
<br />
Some of the delinquencies will get cured, but far from all of them. The farther the house is underwater, the less likely it is to get cured. Many more houses are going to end up in the hands of the banks, which will then dump them onto the market and further depress prices.<br />
<br />
Housing is normally the locomotive that pulls the U.S. economy out of recessions. It is hard to see how that locomotive will work up a good head of steam with so many foreclosures blocking the tracks.<br />
<br />
The first-time homebuyer credit has helped to clear out some of the existing bank owned properties, but that program will end just after Thanksgiving. Unless the program is renewed, that source of buying is likely to dry up significantly. This could lead to another sharp down-leg for the housing market.<br />
<br />
Shifting my metaphor, the economy&#8217;s vital signs have stabilized, but that is due to the powerful drugs that the "doctors" (Bernanke and Obama) have been giving it. Those drugs (printing money, super-low short-term interest rates and massive budget deficits) are known to have very serious long-term side effects -- ones that have been known to be fatal (Weimar style hyperinflation) if given in to big doses and for too long.<br />
<br />
The doctors had no choice but to give them to the patent, since doing nothing would have also been fatal (we narrowly avoided a second Great Depression), but it is a huge question if the patient will be able to get up and about after he is taken off the meds.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFC">Read the full analyst report on "WFC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PNC">Read the full analyst report on "PNC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/prime-mortgages-going-sour-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>L-3 Bags Air Force Contract &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/l-3-bags-air-force-contract-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/l-3-bags-air-force-contract-analyst-blog/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 19:37:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aerospace]]></category>
		<category><![CDATA[Columbus Air Force Base]]></category>
		<category><![CDATA[Department of Defense]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Government Services]]></category>
		<category><![CDATA[high technology products;]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[L-3 Communications]]></category>
		<category><![CDATA[Laughlin Air]]></category>
		<category><![CDATA[Madison]]></category>
		<category><![CDATA[merchant supplier]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[Pensacola Naval Air Station]]></category>
		<category><![CDATA[program management;]]></category>
		<category><![CDATA[repair overhaul services]]></category>
		<category><![CDATA[secure communications systems]]></category>
		<category><![CDATA[T-1A]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vance Air]]></category>
		<category><![CDATA[Wireless Customers]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23806/L-3+Bags+Air+Force+Contract+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
L-3 Communications Holdings Inc.</strong> (<a href="http://www.zacks.com/stock/quote/LLL">LLL</a>) yesterday bagged a $680 million contract from the US Air Force to serve as prime contractor on the T-1A Contractor Logistics Support (CLS) program. This will boost the dwindling order backlog of the company, which fell 20% year-over-year in the second quarter of fiscal 2009 to $3.3 billion.
<p>The 60-day base contract, with eight option years, would be serviced by L-3's Systems Field Support operating unit, based in Madison, Mississippi. The company would provide program management of logistics, material supply support and repair overhaul services for 179 T-1A aircraft based at Vance Air Force Base, Oklahoma; Columbus Air Force Base, Mississippi; Pensacola Naval Air Station, Florida; and the Randolph and Laughlin Air Force Bases, Texas.</p>
<p>Headquartered in New York, L-3 Communications is a leading provider of Intelligence, Surveillance and Reconnaissance (ISR) systems and products; secure communications systems; aircraft modernization, training and government services; and is a merchant supplier of a broad array of high technology products. Its major customers are the Department of Defense (DoD), U.S. government intelligence agencies, major aerospace and defense prime contractors, foreign governments, and commercial telecommunication and wireless customers.</p>
<p>L-3's product mix is approximately 88% defense and 12% commercial. The company functions through four primary business segments: Specialized Products; Government Services; Aircraft Modernization and Maintenance (AM&#38;M); and Command, Control, Communications and Intelligence, Surveillance, and Reconnaissance (C3ISR).</p>
<p>The company trades at a discount to its industry peers in terms of price-to-book, price-to-sales, and price-to-future cash flow. We maintain our market Outperform recommendation on the shares.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLL">Read the full analyst report on "LLL"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/l-3-bags-air-force-contract-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Novartis MS Drug &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/fda-approves-novartis-ms-drug-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-approves-novartis-ms-drug-analyst-blog/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 17:53:42 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active inflammatory]]></category>
		<category><![CDATA[Analyst Blog Earlier]]></category>
		<category><![CDATA[autoimmune disease]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[leading player]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mri]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[National Multiple Sclerosis Society]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Novartis MS Drug]]></category>
		<category><![CDATA[Novartis Pharma]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Teva Pharmaceuticals]]></category>
		<category><![CDATA[treatment of multiple sclerosis;]]></category>
		<category><![CDATA[Tysabri]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23798/FDA+Approves+Novartis+MS+Drug+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Earlier this week, the US Food and Drug Administration (FDA) approved <strong>Novartis Pharma&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/nvs">NVS</a>) Extavia, a branded version of interferon beta-1b, which is used for the treatment of multiple sclerosis (MS). Novartis obtained the rights to seek approval for its own branded version of interferon beta-1b through agreements signed with Bayer Schering, which markets Betaseron. <br />
<br />
MS is a chronic autoimmune disease in which the body's immune system attacks the myelin sheath, or protective tissue surrounding the nerve fibers that carry electrical signals in the brain. As a result, persons afflicted with the disease experience problems with muscle control and strength, vision, balance, sensation and mental function.<br />
<br />
Extavia has been approved for the treatment of relapsing forms of MS to reduce the frequency of clinical exacerbations. It is also indicated for patients who have experienced a first clinical episode of MS and have features consistent with the disease as shown by magnetic resonance imaging (MRI).<br />
<br />
Extavia is already available in 12 countries in the European Union where it is approved for relapsing-remitting MS as well as early MS (defined as a single demyelinating event with an active inflammatory process) and a steadily worsening form of the disease known as secondary progressive MS with relapses.<br />
<br />
According to the National Multiple Sclerosis Society, there are approximately 400,000 MS patients in the US. Worldwide, MS is estimated to affect more than 2.5 million people.<br />
<br />
Novartis will be launching Extavia this fall. Once launched, the product will be competing with <strong>Biogen Idec&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>) Avonex and Tysabri, <strong>Teva Pharmaceuticals&#8217; </strong>(<a href="http://www.zacks.com/stock/quote/teva">TEVA</a>) Copaxone and <strong>Pfizer</strong>/Serono&#8217;s (<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>) Rebif. Biogen is a leading player in the MS market with its Avonex posting sales of $2,203 million in 2008.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NVS">Read the full analyst report on "NVS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEVA">Read the full analyst report on "TEVA"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-approves-novartis-ms-drug-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report!  8/20/09, ETAK, DRJ, PWOIF, HI, AEXP, BCO</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82009-etak-drj-pwoif-hi-aexp-bco/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82009-etak-drj-pwoif-hi-aexp-bco/#comments</comments>
		<pubDate>Thu, 20 Aug 2009 14:00:43 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alberta]]></category>
		<category><![CDATA[American Exploration Corp.]]></category>
		<category><![CDATA[Brink’s Company]]></category>
		<category><![CDATA[carrier grade;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Dreams Inc.]]></category>
		<category><![CDATA[Elephant Talk Communications Inc.]]></category>
		<category><![CDATA[expanded  offering]]></category>
		<category><![CDATA[Gas Formation]]></category>
		<category><![CDATA[Hillenbrand Inc;]]></category>
		<category><![CDATA[Jcpenney]]></category>
		<category><![CDATA[Jefferson County]]></category>
		<category><![CDATA[licensed sports]]></category>
		<category><![CDATA[licensed sports memorabilia]]></category>
		<category><![CDATA[licensed sports products  industry]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[multimedia content distributor]]></category>
		<category><![CDATA[natural gas rights;]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[online sports]]></category>
		<category><![CDATA[Power Oil & Gas]]></category>
		<category><![CDATA[PWOIF]]></category>
		<category><![CDATA[security-related services]]></category>
		<category><![CDATA[sports fan shop]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vertically integrated leader]]></category>
		<category><![CDATA[www.jcp.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2848</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Thursday August 20, 2009




**************************************************************

Elephant Talk  Communications, Inc. (OTC Bulletin Board: ETAK), an international  telecom and multimedia content distributor specializing in carrier grade mobile  enabling platforms, announced second quarter 2009 financial results and is  providing a shareholder update.

Dreams, Inc. (NYSE Amex:  DRJ) the vertically integrated leader in the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82009-etak-drj-pwoif-hi-aexp-bco/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Geospatial Holdings, Inc. (GSPH.OB) Team Awarded Multi-Year Contract to Map Underground Utilities in the Port of Gulfport, Mississippi</title>
		<link>http://www.straightstocks.com/market-commentary/geospatial-holdings-inc-gsph-ob-team-awarded-multi-year-contract-to-map-underground-utilities-in-the-port-of-gulfport-mississippi/</link>
		<comments>http://www.straightstocks.com/market-commentary/geospatial-holdings-inc-gsph-ob-team-awarded-multi-year-contract-to-map-underground-utilities-in-the-port-of-gulfport-mississippi/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 13:59:01 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[3D sensing]]></category>
		<category><![CDATA[3D sensing technologies]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[craft harbor fender systems]]></category>
		<category><![CDATA[Geospatial Holdings Inc.]]></category>
		<category><![CDATA[Geospatial Mapping Gulf Coast LLC]]></category>
		<category><![CDATA[Geospatial Smart Probe Mapping Technologies]]></category>
		<category><![CDATA[Gulfport]]></category>
		<category><![CDATA[location]]></category>
		<category><![CDATA[Mapping Gulf Coast]]></category>
		<category><![CDATA[Mark Smith]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi Engineering Group Inc.]]></category>
		<category><![CDATA[Mississippi Gulf Coast]]></category>
		<category><![CDATA[Mississippi State Port Authority]]></category>
		<category><![CDATA[naturaldisaster]]></category>
		<category><![CDATA[Port of Gulfport]]></category>
		<category><![CDATA[security systems]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=17281</guid>
		<description><![CDATA[Geospatial Holdings, Inc., a high-technology company that utilizes proprietary 3D sensing technologies to locate, map, perform condition assessment and detect leaks of underground pipelines, recently announced it was selected to provide underground pipeline utility location and mapping services to the Mississippi State Port Authority at Gulfport, Mississippi over a three-year period. 
In 2005, when Hurricane [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/geospatial-holdings-inc-gsph-ob-team-awarded-multi-year-contract-to-map-underground-utilities-in-the-port-of-gulfport-mississippi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Working Out What’s Behind the Price</title>
		<link>http://www.straightstocks.com/market-commentary/working-out-what%e2%80%99s-behind-the-price/</link>
		<comments>http://www.straightstocks.com/market-commentary/working-out-what%e2%80%99s-behind-the-price/#comments</comments>
		<pubDate>Mon, 17 Aug 2009 17:37:20 +0000</pubDate>
		<dc:creator>Bill Bonner</dc:creator>
				<category><![CDATA[Economics]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Baltimore]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[Elizabeth]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[fever]]></category>
		<category><![CDATA[Ford]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Jack Lessinger]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[May;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[Mount Washington;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Oil Crisis]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[real estate trends]]></category>
		<category><![CDATA[shanghai]]></category>
		<category><![CDATA[socio economist]]></category>
		<category><![CDATA[swimming]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[writer]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=19941</guid>
		<description><![CDATA[pYou could look at market cycles narrowly – just by keeping your eye on price movements. Or you can look at the Big Picture#8230; all the connections between markets and the rest of the world#8230; in the hopes of understanding what is BEHIND the price movements and where it might take them. /p
pFriday, the Dow dropped 76 points. It’s probably going down soon#8230; but maybe not yet. The Dow would have to rise to about 10,350 to equal the ’29 bounce. And heck, it’s not September yet. September is traditionally the worst month for investors#8230; followed by October, November, December, January, February, March, April, May, June, July and August./p
pBut what’s this? The morning news: Chinese stocks suffered their worst day#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/working-out-what%e2%80%99s-behind-the-price/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Some Entergy Rates Lowering &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/some-entergy-rates-lowering-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/some-entergy-rates-lowering-analyst-blog/#comments</comments>
		<pubDate>Fri, 14 Aug 2009 17:22:54 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Arkansas Public Service Commission]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electricity generating capacity]]></category>
		<category><![CDATA[Entergy Arkansas]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas Prices]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[retail distribution operations;]]></category>
		<category><![CDATA[retail electricity rates]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[utility subsidiary]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23581/Some+Entergy+Rates+Lowering+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Entergy Corporation&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/etr">ETR</a>) utility subsidiary Entergy Arkansas announced yesterday that it will reduce its retail electricity rates from September 1, 2009.<br />
<br />
New Orleans-based Entergy is primarily engaged in electric power production and retail distribution operations. The company owns and operates power plants with approximately 30,000MW of electricity generating capacity. Entergy delivers electricity to 2.7 million utility customers in Arkansas, Louisiana, Mississippi and Texas. With a cumulative capacity of 8,000MW, the company is the second largest nuclear power generator in the U.S.<br />
<br />
The curtailment in rates is for passing on the benefits of recent fall in natural gas prices to its customers. The company filed with the Arkansas Public Service Commission notifying the reduction of 0.346 cents per kilowatt-hour usage in the fuel-cost portion of electric bills to 1.206 cents.    <br />
<br />
As per company estimates this will reduce the average monthly bill of a typical residential customer with monthly consumption of 1,000 kilowatt-hours from $110.17 to $106.71, a decrease of $3.46 per month.<br />
<br />
Natural Gas Spot Prices have witnessed a steep fall from $5.41 per Million British Thermal Units (mmBtu) at the inception of the fiscal to only $3.61 per mmBtu as on August 5, 2009, at the Henry Hub market center in Southern Louisiana. Natural gas prices are expected to slide further in the remainder of the year.<br />
<br />
We currently rate Entergy shares as Neutral, expecting the stock to perform in-line with the broader market.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/some-entergy-rates-lowering-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CCTR, XTEX, SPNG Stock-PR Stock Highlights August 7, 2009</title>
		<link>http://www.straightstocks.com/market-commentary/cctr-xtex-spng-stock-pr-stock-highlights-august-7-2009/</link>
		<comments>http://www.straightstocks.com/market-commentary/cctr-xtex-spng-stock-pr-stock-highlights-august-7-2009/#comments</comments>
		<pubDate>Fri, 07 Aug 2009 14:01:21 +0000</pubDate>
		<dc:creator>Stock-PR</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Alabama midstream natural gas assets]]></category>
		<category><![CDATA[Charlesbank Capital Partners]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Crescent Enterprises Inc.]]></category>
		<category><![CDATA[Crosstex Energy;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CRWENewswire.com]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[electronic informative online financial news publication]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[National Football League]]></category>
		<category><![CDATA[natural gas transportation]]></category>
		<category><![CDATA[New York Jets]]></category>
		<category><![CDATA[registered investment advisor]]></category>
		<category><![CDATA[shanghai]]></category>
		<category><![CDATA[Southcross]]></category>
		<category><![CDATA[Southcross Energy]]></category>
		<category><![CDATA[SpongeTech Delivery Systems Inc]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock-PR]]></category>
		<category><![CDATA[team advertising rights]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wells Fargo Securities]]></category>

		<guid isPermaLink="false">http://stock-pr.com/?p=887</guid>
		<description><![CDATA[Las Vegas CRWENewswire.com is pleased to announce a stock highlight on China Crescent Enterprises, Inc. (OTCBB: CCTR), Crosstex Energy (NASDAQ: XTEX), SpongeTech(R) Delivery Systems, Inc. (&#8221;SpongeTech&#8221;) &#8220;The Smarter Sponge(TM)&#8221;, (OTCBB: SPNG) Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/?p=2546

China Crescent Enterprises, Inc. (OTCBB: CCTR) today announced the launch of a $30 million [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/cctr-xtex-spng-stock-pr-stock-highlights-august-7-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Entergy Misses by a Sliver &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/entergy-misses-by-a-sliver-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/entergy-misses-by-a-sliver-analyst-blog/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 20:15:27 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Allegheny Energy]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Duke Energy Company]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electricity generating capacity]]></category>
		<category><![CDATA[Electricity revenue]]></category>
		<category><![CDATA[Enexus Energy Corporation]]></category>
		<category><![CDATA[Entergy Arkansas]]></category>
		<category><![CDATA[Entergy Corporation]]></category>
		<category><![CDATA[Entergy Gulf States]]></category>
		<category><![CDATA[Entergy Louisiana]]></category>
		<category><![CDATA[Entergy Mississippi]]></category>
		<category><![CDATA[Entergy New Orleans]]></category>
		<category><![CDATA[Eps]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[planned spin-off]]></category>
		<category><![CDATA[retail distribution operations;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23251/Entergy+Misses+by+a+Sliver+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Entergy Corporation</strong> (<a href="http://www.zacks.com/stock/quote/ETR">ETR</a>) announced fiscal second-quarter EPS of $1.23 that was just a cent short of the Zacks Consensus Estimate of $1.24. However year-over-year EPS fell 23 cents, the pain came from higher refueling and outages (both planned and unplanned) at its nuclear power plants.<br />
 <br />
New Orleans-based Entergy is primarily engaged in electric power production and retail distribution operations. The company owns and operates power plants with approximately 30,000MW of electricity generating capacity. Entergy delivers electricity to 2.7 million utility customers in Arkansas, Louisiana, Mississippi and Texas.</p>
<p>The company with a cumulative capacity of 8,000MW is the second largest nuclear power generator in the U.S. Entergy operates through five subsidiaries: Entergy Arkansas, Entergy Gulf States, Entergy Louisiana, Entergy Mississippi and Entergy New Orleans.<br />
 <br />
Entergy&#8217;s revenues fell 22.8% year over year to $2.5 billion in the quarter with Electricity (down 24%), Natural Gas (down 46.6%), and Competitive businesses (down 16.4%). Electricity revenue of Entergy in-line with the industry trend was affected most with the industrial customers. Entergy&#8217;s volume sales to industrial customers fell 9.7%, while overall volume loss was 5.9% in the quarter.</p>
<p>However, the company was able to improve upon the overall headcount of customers year over year by 0.7%, barring the industrial customers, which shrunk by 3.4%. With the economy in doldrums, Entergy&#8217;s industry peers reporting on Tuesday &#8211; <strong>Allegheny Energy</strong> (<a href="http://www.zacks.com/stock/quote/AYE">AYE</a>) and <strong>Duke Energy Company</strong> (<a href="http://www.zacks.com/stock/quote/DUK">DUK</a>) also shared the industrial customer downslide.<br />
 <br />
Entergy revised its fiscal 2009 EPS guidance on account of an expected slide in power prices and charges related to the planned spin-off of its non-utility nuclear business into a separate company, Enexus Energy Corporation. GAAP EPS estimate for the fiscal now stands at $6.00 &#8211; $6.60 and operational EPS estimate at $6.20 &#8211; $6.80. This is in-line with the Zacks Consensus Estimate of $6.57 for the fiscal year.<br />
 <br />
We currently rate Entergy shares as Neutral, expecting the stock to perform in-line with the broader market.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AYE">Read the full analyst report on "AYE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DUK">Read the full analyst report on "DUK"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/entergy-misses-by-a-sliver-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Weyerhaeuser Narrows Quarterly Loss &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/weyerhaeuser-narrows-quarterly-loss-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/weyerhaeuser-narrows-quarterly-loss-analyst-blog/#comments</comments>
		<pubDate>Mon, 03 Aug 2009 20:43:36 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Cellulose Fibers]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Columbus]]></category>
		<category><![CDATA[Federal Way]]></category>
		<category><![CDATA[forward]]></category>
		<category><![CDATA[management ;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Weyerhaeuser]]></category>
		<category><![CDATA[Weyerhaeuser Real Estate Co.]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23156/Weyerhaeuser+Narrows+Quarterly+Loss+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Weyerhaeuser Co.</strong> (<a href="http://www.zacks.com/stock/quote/WY">WY</a>) announced second-quarter results on Friday. The company posted a GAAP net loss of $106 million, compared to a loss of $96 million in the same period last year. Excluding certain special items, net loss came in at $125 million, or 59 cents per share, beating the Zacks Consensus Estimate by 12 cents, or nearly 17%.
<p align="left">Weyerhaeuser, one of the largest forest-products companies in the world with operations across 10 countries, reported its fourth straight quarterly loss as it continues to reel from the effect of sluggish demand from the housing industry. However, the company feels that the sector is witnessing signs of stabilization after negotiating the worst of headwinds. The Federal Way, Washington-based company&#8217;s sales slumped 36% year over year to $1.39 billion.</p>
<p align="left">Revenue from the Timberlands segment fell 7.1% year over year to $208 million, primarily on a slump in log prices and lower harvest levels driven by the collapse of the California housing market. The Wood Products segment slid 44.5% year over year to $594 million as the company slashed capacity amid weak demand for softwood lumber and depressed prices for engineered products.</p>
<p align="left">Sales from Cellulose Fibers dropped 24.1% year over year to $349 million mainly on account of an extensive boiler repair at a facility in Columbus, Mississippi coupled with annual maintenance outages at two other facilities. The Real Estate segment, which operates under Weyerhaeuser Real Estate Co., reported an almost 44% year-over-year decline to $199 million as traffic decreased 33% and home closings dropped by 47%.</p>
<p align="left">Weyerhaeuser reported gross margin of 24.5%, a decline of 570 basis points over the same quarter last year on lower price realizations and sluggish volumes. Meanwhile, the company&#8217;s operating loss came in at $62 million, compared to the loss of $404 million in the year-ago quarter. The narrower loss was caused by cost-restructuring initiatives, including job cuts, which led to a 37.8% year-over-year fall in SG&#38;A expenses to $153 million and a substantial 81% drop in impairment of long-lived assets to $53 million.</p>
<p align="left">Weyerhaeuser&#8217;s cash and cash equivalents at the end of the quarter was $1.75 billion, an improvement of $92 million over the previous quarter on higher cash from operations and a gain of $29 million from the sale of non-strategic lands in southwest Washington. The cash was primarily utilized for the payment of dividends ($53 million), capital expenditure ($32 million) and repayment of debt ($18 million).</p>
<p align="left">Moving forward, management continues to expect a difficult third quarter despite signs of stabilization. Weyerhaeuser anticipates the Timberlands unit&#8217;s performance to deteriorate further on additional deferrals in timber harvest and lower price realizations.</p>
<p align="left">Continued weakness in demand for Wood Products is expected to be partially offset by slight improvement in prices of certain products. Real Estate is also likely to decline further due to a temporary shift to mid-to-lower priced Arizona properties from higher-priced California homes. Cellulose Fibers is the only division that the company sees benefiting from stabilization in pulp prices and lower downtime.</p>
<p align="left">The full-year Zacks Consensus Estimate, derived from 14 covering analysts, is currently pegged at a loss of $2.46 per share, which has worsened by 4 cents in the past month. The most accurate estimate, however, is slightly better at a loss of $2.35 per share.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WY">Read the full analyst report on "WY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/weyerhaeuser-narrows-quarterly-loss-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A.M. Best Remarks on FPIC Deal  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/a-m-best-remarks-on-fpic-deal-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-m-best-remarks-on-fpic-deal-analyst-blog/#comments</comments>
		<pubDate>Mon, 03 Aug 2009 19:45:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[A.M. Best]]></category>
		<category><![CDATA[Advocate]]></category>
		<category><![CDATA[American Physicians Capital]]></category>
		<category><![CDATA[American Physicians Service Group]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[First Professionals Insurance Company Inc.]]></category>
		<category><![CDATA[Fitch]]></category>
		<category><![CDATA[Following FPIC Insurance Group Inc]]></category>
		<category><![CDATA[FPIC]]></category>
		<category><![CDATA[MD Financial Group]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[ProAssurance Corporation]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23150/A.M.+Best+Remarks+on+FPIC+Deal++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Following <strong>FPIC Insurance Group, Inc</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/FPIC">FPIC</a>) agreement to acquire Advocate, MD and its subsidiaries on July 30, A.M. Best has commented that all the ratings on FPIC and its subsidiaries remain unchanged.  We think that this is primarily to support the company&#8217;s acquisition decision.   <br />
 <br />
The all cash deal was signed between FPIC&#8217;s subsidiary, First Professionals Insurance Company, Inc., and Advocate, MD Financial Group. Inc. The total deal value includes $33.6 million at closing of the transaction and up to $12.0 million related to the performance of Advocate, MD over the couple of years following the closing of the deal.<br />
 <br />
As the nature of the business of Advocate, MD is almost similar with FPIC and the deal is consistent with FPIC&#8217;s long-term business strategy, we think that FPIC will gain significant scale in its operations by this acquisition. The company will also get advantages of the Texas and Mississippi markets where Advocate MD has established itself as an innovative company.<br />
 <br />
According to the rating agency, the financial strength rating of A- (Excellent) and issuer credit ratings (ICR) of &#8220;a-" of FPIC and its members remained unchanged. The agency also said that the ICR of FPIC also remained unchanged at &#8220;bbb-".<br />
 <br />
We anticipate FPIC&#8217;s results for the coming quarters to continue to benefit over its peers [<strong>American Physicians Capital</strong> (<a href="http://www.zacks.com/stock/quote/ACAP">ACAP</a>), <strong>American Physicians Service Group</strong> (<a href="http://www.zacks.com/stock/quote/AMPH">AMPH</a>), and <strong>ProAssurance Corporation</strong> (<a href="http://www.zacks.com/stock/quote/PRA">PRA</a>)] from its sound capital position and strong financial strength rating by A.M. Best and Fitch. However, the price softening will continue to moderate top-line growth.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FPIC">Read the full analyst report on "FPIC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACAP">Read the full analyst report on "ACAP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMPH">Read the full analyst report on "AMPH"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PRA">Read the full analyst report on "PRA"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-m-best-remarks-on-fpic-deal-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GRMN, WRI,  DrStockPick Watch List! for Friday July 31, 2009, Garmin Ltd. and Weingarten Realty Investors</title>
		<link>http://www.straightstocks.com/stock-watch/grmn-wri-drstockpick-watch-list-for-friday-july-31-2009-garmin-ltd-and-weingarten-realty-investors/</link>
		<comments>http://www.straightstocks.com/stock-watch/grmn-wri-drstockpick-watch-list-for-friday-july-31-2009-garmin-ltd-and-weingarten-realty-investors/#comments</comments>
		<pubDate>Fri, 31 Jul 2009 00:55:53 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Cayman Islands]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Federal Aviation Administration]]></category>
		<category><![CDATA[First Call]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[G500]]></category>
		<category><![CDATA[Garmin International Inc.]]></category>
		<category><![CDATA[Garmin Ltd]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[GPS technology;]]></category>
		<category><![CDATA[grmn]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Kentucky]]></category>
		<category><![CDATA[Konica Minolta DiMAGE G500 Digital Camera]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Maine]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Missouri]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[OshKosh;]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[real estate investment trust]]></category>
		<category><![CDATA[satellite navigation;]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[www.garmin.com]]></category>
		<category><![CDATA[www.weingarten.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2377</guid>
		<description><![CDATA[GRMN, Garmin Ltd.
WRI, Weingarten Realty Investors
DrStockPick Watch List! 
&#160;
DrStockPick Watch List! for Friday July 31, 2009



&#160;
My Picks for Friday July 31, 2009 are:
**************************************************************
GRMN, Garmin Ltd.
Garmin International Inc. is a subsidiary of GRMN, the global leader in satellite navigation. Since 1989, this group of companies has designed, manufactured, marketed and sold navigation, communication and information devices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/grmn-wri-drstockpick-watch-list-for-friday-july-31-2009-garmin-ltd-and-weingarten-realty-investors/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>A Breather for Entergy  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/a-breather-for-entergy-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-breather-for-entergy-analyst-blog/#comments</comments>
		<pubDate>Tue, 28 Jul 2009 20:34:07 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Covert]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electricity generating capacity]]></category>
		<category><![CDATA[Enexus Energy Corp.]]></category>
		<category><![CDATA[Entergy]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Oswego County]]></category>
		<category><![CDATA[Palisades plant]]></category>
		<category><![CDATA[Plymouth]]></category>
		<category><![CDATA[regulated utilities;]]></category>
		<category><![CDATA[retail distribution operations;]]></category>
		<category><![CDATA[spin-off]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Vernon]]></category>
		<category><![CDATA[Westchester County]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22899/A+Breather+for+Entergy++-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Entergy Corp.</strong> (<a href="http://www.zacks.com/stock/quote/ETR">ETR</a>) recently got a breather as the Nuclear Regulatory Commission approved a pending half-yearly extension on its spin-off effort. The Nuclear Regulatory Commission has given Entergy an additional six months to get the pending regulatory approvals in New York and Vermont and procure the required financing to spin off five nuclear plants. Earlier in May, Entergy had requested a six-month extension to tide over the hurdles.
<p align="left">Entergy wants to spin off the nuclear plants as a new company &#8211; Enexus Energy Corp. The nuclear plants are Pilgrim in Plymouth, Massachusetts; Vermont Yankee in Vernon, Vermont; Indian Point in Westchester County, New York; Fitzpatrick in Oswego County, New York and the Palisades plant in Covert, Michigan.</p>
<p align="left">Entergy plans to finish the spin-off of its non-utility nuclear power business by end of 2009. The spin-off will leave the company with five regulated utilities and other assets in the Gulf States region.</p>
<p align="left">This news could not have come at a better time for Entergy. The company recently lowered its guidance for both the second quarter and the full year. It will release earnings for the quarter on August 4, 2009.</p>
<p align="left">New Orleans-based Entergy is primarily engaged in electric power production and retail distribution operations. The company owns and operates power plants with approximately 30,000MW of electricity generating capacity. It delivers electricity to 2.7 million utility customers in Arkansas, Louisiana, Mississippi and Texas. Entergy Nuclear is the second-largest nuclear generator in the U.S., with interests in six nuclear plants. We maintain our speculative BUY recommendation on ETR.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-breather-for-entergy-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract (DrStockPick Stock Report)</title>
		<link>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report-2/#comments</comments>
		<pubDate>Tue, 28 Jul 2009 11:02:45 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[203-466-0600]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[951-657-8840]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[energy efficient heating]]></category>
		<category><![CDATA[energy supply]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[general contractor]]></category>
		<category><![CDATA[Green Group Inc.]]></category>
		<category><![CDATA[house diagnostic equipment]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Project Manager]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[radiation emitting diagnostic equipment]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Sip]]></category>
		<category><![CDATA[SIP panel system]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[water systems;]]></category>
		<category><![CDATA[West Coast]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2279</guid>
		<description><![CDATA[STDF, Steadfast Holdings Group Inc, STDF.PK
DrStockPick Stock Report!  










DrStockPick News Report!
STDF, Steadfast Holdings Group Inc, STDF.PK
&#8220;Steadfast Holdings Group, Inc. Subsidiary
Lands $28.6 Million Building Contract&#8220;



&#160;
DrStockPick Stock Report! Tuesday July 28, 2009
Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract
Steadfast Holdings Group, Inc. (OTC PINK SHEETS: STDF) through its Banx and Green Group, Inc. subsidiary [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract (DrStockPick Stock Report)</title>
		<link>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 14:12:54 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[203-466-0600]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[951-657-8840]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[energy efficient heating]]></category>
		<category><![CDATA[energy supply]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[general contractor]]></category>
		<category><![CDATA[Green Group Inc.]]></category>
		<category><![CDATA[house diagnostic equipment]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Project Manager]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[radiation emitting diagnostic equipment]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Sip]]></category>
		<category><![CDATA[SIP panel system]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[water systems;]]></category>
		<category><![CDATA[West Coast]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2263</guid>
		<description><![CDATA[STDF, Steadfast Holdings Group Inc, STDF.PK
DrStockPick Stock Report!  









DrStockPick News Report!
STDF, Steadfast Holdings Group Inc, STDF.PK
&#8220;Steadfast Holdings Group, Inc. Subsidiary
Lands $28.6 Million Building Contract&#8220;



&#160;
DrStockPick Stock Report! Monday July 27, 2009
***********************************************
Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract
Steadfast Holdings Group, Inc. (OTC PINK SHEETS: STDF) through its Banx and Green Group, Inc. subsidiary [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: ITT Educational Services, Toyota Motor, Ford, General Motors and Schlumberger Limited &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-itt-educational-services-toyota-motor-ford-general-motors-and-schlumberger-limited-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-itt-educational-services-toyota-motor-ford-general-motors-and-schlumberger-limited-press-releases/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 13:30:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Akio Toyoda]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[auto giant]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[Corolla]]></category>
		<category><![CDATA[Ford]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Fremont]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Itt Educational Services]]></category>
		<category><![CDATA[Kiichiro Toyoda]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New United Motor Manufacturing Inc.]]></category>
		<category><![CDATA[Pontiac Vibe]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Schlumberger Limited]]></category>
		<category><![CDATA[Tacoma;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Toyota Motor]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Yoshimi Inaba]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22789/Zacks+Analyst+Blog+Highlights%3A+ITT+Educational+Services%2C+Toyota+Motor%2C+Ford%2C+General+Motors+and+Schlumberger+Limited+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; July 27, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>ITT Educational Services </strong>(<a href="void(0)">ESI</a>), <strong>Toyota Motor </strong>(<a href="void(0)">TM</a>), <strong>Ford </strong>(<a href="void(0)">F</a>), <strong>General Motors </strong>(<a href="void(0)">MTLQQ</a>) and <strong>Schlumberger Limited </strong>(<a href="void(0)">SLB</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left">Here are highlights from Friday&#8217;s <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><strong>ITT Educational Tops; Lifts Guidance </strong></p>
<p align="left"><strong>ITT Educational Services </strong>(<a href="void(0)">ESI</a>) reported strong second quarter results, and beat expectations by $0.15 per share. Quarterly earnings were $1.87 per diluted share, representing a 55.8% increase over $1.20 reported in the corresponding prior-year period.</p>
<p align="left">Quarterly revenue increased 28.7% year-over-year to $317 million driven by a 33.5% increase in new student enrollment and an increase in tuition. The quarter student persistence rate increased 140 basis points (bps) to 75.3% primarily due to strong increases in student retention rates. Total student enrollment (excluding international enrollments) increased 26.2% to 69,127 versus 54,793 students in the comparable prior-year period.</p>
<p align="left"><strong>Toyota Expecting Profits in 2010</strong></p>
<p align="left">Recently, North American chief of Japanese auto giant <strong>Toyota Motor </strong>(<a href="void(0)">TM</a>), Yoshimi Inaba, revealed that the company&#8217;s North American operations would possible become profitable in 2010. The forecast assumed U.S. vehicle sales to reach 10 million units this year and 12 million next. However, Inaba is dubious about returning to the 2007 level vehicle sales of 16 million units soon.</p>
<p align="left">Last month, Akio Toyoda &#8211; the newly joined President and grandson of Toyota&#8217;s founder Kiichiro Toyoda &#8211; expressed views about making the company profitable. He anticipated the annual global vehicle production capacity to increase from 10 million units to 13 million units.</p>
<p align="left">Toyota has been struggling hard amidst weak U.S. sales. In the first six months of the year, the company&#8217;s U.S. sales plunged 38%, higher than the overall market decline of 35%. In June, <strong>Ford </strong>(<a href="void(0)">F</a>) toppled the automaker by occupying the second position in terms of absolute sales figures.</p>
<p align="left">Currently, Toyota is seeking to review its U.S. manufacturing strategy. The company has 12 manufacturing facilities in the U.S. Half of these are operating under capacity and one has been idled in Mississippi. It also looks forward to close down the New United Motor Manufacturing, Inc. (NUMMI) plant in Fremont, California. NUMMI is a 50/50 joint venture between Toyota and <strong>General Motors </strong>(<a href="void(0)">MTLQQ</a>) that produces Corolla and Tacoma for the former and Pontiac Vibe for the latter.</p>
<p align="left"><strong>Schlumberger: Competitive results, positive outlook</strong></p>
<p align="left">Houston, Texas-based <strong>Schlumberger Limited </strong>(<a href="void(0)">SLB</a>), the world&#8217;s largest oilfield services company, reported its second quarter results before today&#8217;s market opened. Diluted earnings per share from continuing operations were $0.68, compared to our estimate of $0.62 per share and market expectations of $0.63.</p>
<p align="left">However, the operating earnings were lower than the first quarter earnings of $0.78 per share and year-ago quarter earnings of $1.16 per share. The negative comparisons were primarily due to a steep decline in North American drilling activity.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-itt-educational-services-toyota-motor-ford-general-motors-and-schlumberger-limited-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Toyota Expecting Profits in 2010 &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/toyota-expecting-profits-in-2010-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/toyota-expecting-profits-in-2010-analyst-blog/#comments</comments>
		<pubDate>Fri, 24 Jul 2009 16:09:58 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Akio Toyoda]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[auto giant]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[Corolla]]></category>
		<category><![CDATA[Ford]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Fremont]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Kiichiro Toyoda]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New United Motor Manufacturing Inc.]]></category>
		<category><![CDATA[Pontiac Vibe]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Tacoma;]]></category>
		<category><![CDATA[Toyota]]></category>
		<category><![CDATA[Toyota Motor]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Yoshimi Inaba]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22753/Toyota+Expecting+Profits+in+2010+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, North American chief of Japanese auto giant Toyota Motor (<a href="http://www.zacks.com/stock/quote/TM">TM</a>), Yoshimi Inaba, revealed that the company&#8217;s North American operations would possible become profitable in 2010. The forecast assumed U.S. vehicle sales to reach 10 million units this year and 12 million next. However, Inaba is dubious about returning to the 2007 level vehicle sales of 16 million units soon. <br />
<br />
Last month, Akio Toyoda &#8211; the newly joined President and grandson of Toyota&#8217;s founder Kiichiro Toyoda &#8211; expressed views about making the company profitable. He anticipated the annual global vehicle production capacity to increase from 10 million units to 13 million units. <br />
<br />
Toyota has been struggling hard amidst weak U.S. sales. In the first six months of the year, the company&#8217;s U.S. sales plunged 38%, higher than the overall market decline of 35%. In June, Ford (<a href="http://www.zacks.com/stock/quote/F">F</a>) toppled the automaker by occupying the second position in terms of absolute sales figures. <br />
<br />
Toyota posted its first annual loss (437 billion yen or $4.4 billion) since 1950 for the fiscal year ended March 2009. Further, management has recently projected net loss to worsen to 550 billion yen ($5.5 billion) for the fiscal year ending March 2010. <br />
<br />
Currently, Toyota is seeking to review its U.S. manufacturing strategy. The company has 12 manufacturing facilities in the U.S. Half of these are operating under capacity and one has been idled in Mississippi. It also looks forward to close down the New United Motor Manufacturing, Inc. (NUMMI) plant in Fremont, California. NUMMI is a 50/50 joint venture between Toyota and General Motors (<a href="http://www.zacks.com/stock/quote/MTLQQ">MTLQQ</a>) that produces Corolla and Tacoma for the former and Pontiac Vibe for the latter. <br />
<br />
We continue to recommend TM as Hold with a six-month target price of $75.00.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TM">Read the full analyst report on "TM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=F">Read the full analyst report on "F"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MTLQQ">Read the full analyst report on "MTLQQ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/toyota-expecting-profits-in-2010-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mental Aspects of Trading</title>
		<link>http://www.straightstocks.com/investing-lessons/mental-aspects-of-trading/</link>
		<comments>http://www.straightstocks.com/investing-lessons/mental-aspects-of-trading/#comments</comments>
		<pubDate>Fri, 24 Jul 2009 14:05:53 +0000</pubDate>
		<dc:creator>Trading School</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Trading Lessons]]></category>
		<category><![CDATA[Baseball]]></category>
		<category><![CDATA[Bill McCready]]></category>
		<category><![CDATA[doctor or lawyer]]></category>
		<category><![CDATA[engineer]]></category>
		<category><![CDATA[heart surgery]]></category>
		<category><![CDATA[Market Club;]]></category>
		<category><![CDATA[Microsoft Vista]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[operating system]]></category>
		<category><![CDATA[Peter Bernstein]]></category>
		<category><![CDATA[Robert Fritz]]></category>
		<category><![CDATA[Ryan Jones]]></category>
		<category><![CDATA[Scientific American]]></category>
		<category><![CDATA[surgeon]]></category>
		<category><![CDATA[terrible trader]]></category>
		<category><![CDATA[TRADER]]></category>
		<category><![CDATA[trading school]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Van K. Tharp;]]></category>
		<category><![CDATA[venture capital]]></category>
		<category><![CDATA[Windows XP]]></category>
		<category><![CDATA[Your Computer]]></category>

		<guid isPermaLink="false">http://club.ino.com:80/trading/?p=1558</guid>
		<description><![CDATA[As an added Guest Blogger bonus, Bill McCready from Futures Trading Secrets, has a very informative article on the mental aspects of trading, that I think we ALL can learn a little something from. Bill&#8217;s been trading for a long time, and a long time successfully, and his knowledge and wisdom is widely appreciated. Bill [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/mental-aspects-of-trading/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract  (PennyOmega.com Stock Report!)</title>
		<link>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-pennyomega-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-pennyomega-com-stock-report/#comments</comments>
		<pubDate>Wed, 22 Jul 2009 18:05:53 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[203-466-0600]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[951-657-8840]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[energy efficient heating]]></category>
		<category><![CDATA[energy supply]]></category>
		<category><![CDATA[general contractor]]></category>
		<category><![CDATA[Green Group Inc.]]></category>
		<category><![CDATA[house diagnostic equipment]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Project Manager]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[radiation emitting diagnostic equipment]]></category>
		<category><![CDATA[Sip]]></category>
		<category><![CDATA[SIP panel system]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[water systems;]]></category>
		<category><![CDATA[West Coast]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=498</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-pennyomega-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract (DrStockPick News Report)</title>
		<link>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-news-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-news-report/#comments</comments>
		<pubDate>Wed, 22 Jul 2009 17:04:13 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[203-466-0600]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[951-657-8840]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[energy efficient heating]]></category>
		<category><![CDATA[energy supply]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[general contractor]]></category>
		<category><![CDATA[Green Group Inc.]]></category>
		<category><![CDATA[house diagnostic equipment]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Project Manager]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[radiation emitting diagnostic equipment]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Sip]]></category>
		<category><![CDATA[SIP panel system]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[water systems;]]></category>
		<category><![CDATA[West Coast]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2170</guid>
		<description><![CDATA[STDF, Steadfast Holdings Group Inc, STDF.PK
DrStockPick Stock Report!  






DrStockPick News Report!
STDF, Steadfast Holdings Group Inc, STDF.PK
&#8220;Steadfast Holdings Group, Inc. Subsidiary
Lands $28.6 Million Building Contract&#8220;



&#160;
DrStockPick Stock Report! Wednesday July 22, 2009
Steadfast Holdings Group, Inc. Subsidiary Lands $28.6 Million Building Contract
East Haven, CT - (WORLD STOCK WIRE) - July 22, 2009 &#8212; Steadfast Holdings Group, Inc. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-subsidiary-lands-28-6-million-building-contract-drstockpick-news-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF Steadfast Holdings Group, Inc. Hires Builder and Contracts for First Nine Residential Units (DrStockPick News Report!)</title>
		<link>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-hires-builder-and-contracts-for-first-nine-residential-units-drstockpick-news-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-hires-builder-and-contracts-for-first-nine-residential-units-drstockpick-news-report/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 12:04:23 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[203-466-0600]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Baton Rouge]]></category>
		<category><![CDATA[Biloxi]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Green Group Inc.]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[licensed contractor]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mr. Waxman]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[Peter Waxman]]></category>
		<category><![CDATA[PeterBuilt Homes LLC]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2130</guid>
		<description><![CDATA[STDF, Steadfast Holdings Group Inc, STDF.PK
DrStockPick Stock Report!  





DrStockPick News Report!
STDF, Steadfast Holdings Group Inc, STDF.PK
&#8220;Steadfast Holdings Group, Inc. Hires Builder and Contracts
for First Nine Residential Units&#8220;



DrStockPick Stock Report! Tuesday July 21, 2009
&#8220;Steadfast Holdings Group, Inc. Hires Builder and Contracts for First Nine Residential Units&#8220;
East Haven, CT - (WORLD STOCK WIRE) - July 20, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/stdf-steadfast-holdings-group-inc-hires-builder-and-contracts-for-first-nine-residential-units-drstockpick-news-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DuPont Raises TiO2 Prices &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/dupont-raises-tio2-prices-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/dupont-raises-tio2-prices-analyst-blog/#comments</comments>
		<pubDate>Mon, 20 Jul 2009 20:13:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Altamira]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[Dupont]]></category>
		<category><![CDATA[DuPont Titanium Technologies]]></category>
		<category><![CDATA[Eastern Europe]]></category>
		<category><![CDATA[Edge Moor]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Kuan Yin]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New Johnsonville]]></category>
		<category><![CDATA[Plastics]]></category>
		<category><![CDATA[plastics industries]]></category>
		<category><![CDATA[skin care products]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[whiteness and opacity to products]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22463/DuPont+Raises+TiO2+Prices+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, Delaware-based chemical giant <strong>DuPont</strong> (<a href="http://www.zacks.com/stock/quote/dd">DD</a>) increased prices for all its Ti-Pure® titanium dioxide (TiO2) products sold in Eastern Europe, Middle East and Africa regions. Effective August 1, 2009, or as permitted by the contract, prices in these markets were increased by $150 per ton. This is on top of a $100 per ton price increase announced on May 15, 2009, in Europe and Middle East.<br />
<br />
Titanium dioxide is noteworthy for its wide range of applications. When used as a pigment, it is called titanium white. The pigment is widely used to provide whiteness and opacity to products such as paints, plastics, paper, ink, food and toothpastes. It is also used in cosmetic and skin care products, and it is present in almost every sunblock, where it helps protect the skin from ultraviolet light. Titanium dioxide accounts for 70% of the total production volume of pigments worldwide.<br />
<br />
DuPont has witnessed stable production rates and inventories for titanium dioxide. Further, the company foresees gradually improving global market conditions in the second half of 2009. These seem to be the driving factors behind the recent price increases.<br />
<br />
DuPont Titanium Technologies is the world's largest manufacturer of titanium dioxide, serving worldwide customers in the coatings, paper and plastics industries. Currently, DuPont has 17 products registered under the Ti-Pure® brand.<br />
<br />
Crude titanium dioxide is purified through conversion to titanium tetrachloride in the chloride process. DuPont&#8217;s chloride manufacturing processes are located in DeLisle, Mississippi; New Johnsonville, Tennessee; Edge Moor, Delaware; Altamira, Mexico; and Kuan Yin, Taiwan.<br />
<br />
We continue to recommend DD as Hold with a six-month target price of $25.00.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DD">Read the full analyst report on "DD"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dupont-raises-tio2-prices-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STDF.PK Stock-PR Press Release for Steadfast Holdings Group, Inc.</title>
		<link>http://www.straightstocks.com/market-commentary/stdf-pk-stock-pr-press-release-for-steadfast-holdings-group-inc/</link>
		<comments>http://www.straightstocks.com/market-commentary/stdf-pk-stock-pr-press-release-for-steadfast-holdings-group-inc/#comments</comments>
		<pubDate>Mon, 20 Jul 2009 18:29:36 +0000</pubDate>
		<dc:creator>Stock-PR</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[407-641-0705]]></category>
		<category><![CDATA[Baton Rouge]]></category>
		<category><![CDATA[Biloxi]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[East Haven]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[John Calash]]></category>
		<category><![CDATA[licensed contractor]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mr. Waxman]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[PeterBuilt Homes LLC]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Steadfast Holdings Group Inc.;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock-PR]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://stock-pr.com/?p=739</guid>
		<description><![CDATA[CRWENewswire - Steadfast Holdings Group, Inc. (OTC Pink Sheets: STDF) through its Banx and Green Group, Inc. subsidiary has completed an agreement with Peter Waxman to build homes using environmentally, energy efficient structurally insulated panels (SIPS).
The Company has been offered an option to purchase PeterBuilt Homes LLC. Mr. Waxman is a licensed contractor active in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/stdf-pk-stock-pr-press-release-for-steadfast-holdings-group-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Long and the Short of it All</title>
		<link>http://www.straightstocks.com/financial/the-long-and-the-short-of-it-all/</link>
		<comments>http://www.straightstocks.com/financial/the-long-and-the-short-of-it-all/#comments</comments>
		<pubDate>Wed, 15 Jul 2009 17:34:12 +0000</pubDate>
		<dc:creator>Bullish Bankers</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[accessory products]]></category>
		<category><![CDATA[active trader;]]></category>
		<category><![CDATA[active traders]]></category>
		<category><![CDATA[Advance Auto Parts Inc.]]></category>
		<category><![CDATA[agricultural equipment]]></category>
		<category><![CDATA[Airborne Systems]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[alcoholic beverage brands]]></category>
		<category><![CDATA[American Eagle Outfitters Inc]]></category>
		<category><![CDATA[anxiety disorder;]]></category>
		<category><![CDATA[Athena Technologies Inc.]]></category>
		<category><![CDATA[attendance solutions]]></category>
		<category><![CDATA[automotive chemicals]]></category>
		<category><![CDATA[Autopart International]]></category>
		<category><![CDATA[aviation applications;]]></category>
		<category><![CDATA[Aviation Electronics]]></category>
		<category><![CDATA[Baseball]]></category>
		<category><![CDATA[basketball]]></category>
		<category><![CDATA[Bed Bath & Beyond Inc.;]]></category>
		<category><![CDATA[Bel Arbor Wines]]></category>
		<category><![CDATA[beverage brands;]]></category>
		<category><![CDATA[BioProcess H2O LLC]]></category>
		<category><![CDATA[Bollab]]></category>
		<category><![CDATA[Brown-Forman Corporation]]></category>
		<category><![CDATA[bullish bankers]]></category>
		<category><![CDATA[Bystolic;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Campral]]></category>
		<category><![CDATA[Canadian Mist]]></category>
		<category><![CDATA[Cardiac Surgery Systems]]></category>
		<category><![CDATA[cardiovascular disease]]></category>
		<category><![CDATA[care technologies]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Christmas Tree Shops]]></category>
		<category><![CDATA[CLARCOR Inc.]]></category>
		<category><![CDATA[communications markets;]]></category>
		<category><![CDATA[compensation insurance services]]></category>
		<category><![CDATA[Cree Inc.]]></category>
		<category><![CDATA[CSG Systems International Inc;]]></category>
		<category><![CDATA[customer interaction management]]></category>
		<category><![CDATA[D. C.]]></category>
		<category><![CDATA[data leakage prevention systems]]></category>
		<category><![CDATA[DataProse Inc.]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Don Eduardo Tequila]]></category>
		<category><![CDATA[Durham]]></category>
		<category><![CDATA[Education Loan Processing Inc.]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[Electronics Technology;]]></category>
		<category><![CDATA[employee benefits outsourcing solutions]]></category>
		<category><![CDATA[employee payment services]]></category>
		<category><![CDATA[Engine/Mobile Filtration Segment]]></category>
		<category><![CDATA[ethical drug products]]></category>
		<category><![CDATA[Fetzer]]></category>
		<category><![CDATA[filtration products]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[Financial Data Service S.r.l.]]></category>
		<category><![CDATA[first ITT Technical Institute]]></category>
		<category><![CDATA[Flight Options LLC]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[football]]></category>
		<category><![CDATA[Forest Laboratories Inc.;]]></category>
		<category><![CDATA[Forest Pharmaceuticals]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[global player]]></category>
		<category><![CDATA[Goleta]]></category>
		<category><![CDATA[golf]]></category>
		<category><![CDATA[H2O]]></category>
		<category><![CDATA[Harmon Face Values]]></category>
		<category><![CDATA[heart valve disease;]]></category>
		<category><![CDATA[Home & More S.A. de C.V.]]></category>
		<category><![CDATA[home products retailer;]]></category>
		<category><![CDATA[household products]]></category>
		<category><![CDATA[Huizhou]]></category>
		<category><![CDATA[human resource outsourcing services]]></category>
		<category><![CDATA[human resource services]]></category>
		<category><![CDATA[hypertension]]></category>
		<category><![CDATA[I.R.I.S. s.a. TG3Z3510AFCS Headset]]></category>
		<category><![CDATA[information ;]]></category>
		<category><![CDATA[information services]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[information technology professionals]]></category>
		<category><![CDATA[Integrated Defense Systems]]></category>
		<category><![CDATA[Interactive Data Corp.;]]></category>
		<category><![CDATA[Internet sales]]></category>
		<category><![CDATA[Island-based]]></category>
		<category><![CDATA[ITT Educational Services Inc.]]></category>
		<category><![CDATA[J.L. Clark Inc.]]></category>
		<category><![CDATA[Jack Daniel]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Keddeg Company]]></category>
		<category><![CDATA[Kentucky]]></category>
		<category><![CDATA[Kler]]></category>
		<category><![CDATA[Korbel]]></category>
		<category><![CDATA[law firms]]></category>
		<category><![CDATA[LED Lighting Fixtures Inc.]]></category>
		<category><![CDATA[Lexapro;]]></category>
		<category><![CDATA[Lopez Tequilas]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[Makita Corporation]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[mobile equipment applications]]></category>
		<category><![CDATA[Network Centric Systems]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[NIKE Incorporated]]></category>
		<category><![CDATA[non-prescription pharmaceutical products]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[NTT DATA Financial Corporation]]></category>
		<category><![CDATA[Oakley Networks Inc.]]></category>
		<category><![CDATA[order processing]]></category>
		<category><![CDATA[Organization]]></category>
		<category><![CDATA[outsourced solutions]]></category>
		<category><![CDATA[Paychex Inc]]></category>
		<category><![CDATA[Paychex Premier Human Resources]]></category>
		<category><![CDATA[payroll processing;]]></category>
		<category><![CDATA[payroll tax administration services]]></category>
		<category><![CDATA[payroll-related services]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[peripheral vascular disease;]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[portable woodworking tools]]></category>
		<category><![CDATA[power tools]]></category>
		<category><![CDATA[Professional Employer Organization]]></category>
		<category><![CDATA[project staffing]]></category>
		<category><![CDATA[Protiviti]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[Raytheon]]></category>
		<category><![CDATA[Raytheon Aircraft Company]]></category>
		<category><![CDATA[Raytheon Company;]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Rhode Island]]></category>
		<category><![CDATA[Robert Half International Inc.;]]></category>
		<category><![CDATA[Robert Half Legal]]></category>
		<category><![CDATA[Robert Half Management Resources]]></category>
		<category><![CDATA[Robert Half Technology]]></category>
		<category><![CDATA[Rockwell Collins Inc.]]></category>
		<category><![CDATA[Salt Lake City]]></category>
		<category><![CDATA[semiconductor materials and devices]]></category>
		<category><![CDATA[SEOS Group Limited]]></category>
		<category><![CDATA[shipboard applications]]></category>
		<category><![CDATA[SI Government Solutions]]></category>
		<category><![CDATA[skateboarding]]></category>
		<category><![CDATA[soccer]]></category>
		<category><![CDATA[South Carolina]]></category>
		<category><![CDATA[Southern Comfort]]></category>
		<category><![CDATA[staffing and risk consulting services]]></category>
		<category><![CDATA[Strayer Education Inc.]]></category>
		<category><![CDATA[Strayer University Inc.]]></category>
		<category><![CDATA[Technical Services]]></category>
		<category><![CDATA[technologically advanced]]></category>
		<category><![CDATA[technologically advanced products]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[Telemus Solutions Inc]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[tennis]]></category>
		<category><![CDATA[The Creative Group]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[to its customers through its network]]></category>
		<category><![CDATA[treatment of hypertension]]></category>
		<category><![CDATA[treatment of major depression and generalized anxiety disorder]]></category>
		<category><![CDATA[Umbro Ltd.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Department of Education]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[Virgin Islands;]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[volleyball]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[water reuse filtration systems]]></category>
		<category><![CDATA[Web design fields]]></category>
		<category><![CDATA[wrestling]]></category>
		<category><![CDATA[Xcitax LLC]]></category>
		<category><![CDATA[Xcitek LLC]]></category>

		<guid isPermaLink="false">http://www.bullishbankers.com/?p=15019</guid>
		<description><![CDATA[We are presenting a list of companies which we believe are currently mispriced, based on our estimate of fair value, by the market. We develop our fair value ranges by projected free cash flow out one year and estimating an appropriate FCF multiple based on our assessment of risk and the strength of the balance sheet. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/financial/the-long-and-the-short-of-it-all/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSX -What Does This Tell Us?</title>
		<link>http://www.straightstocks.com/investing-in-energy-markets/csx-what-does-this-tell-us/</link>
		<comments>http://www.straightstocks.com/investing-in-energy-markets/csx-what-does-this-tell-us/#comments</comments>
		<pubDate>Tue, 14 Jul 2009 13:35:00 +0000</pubDate>
		<dc:creator>Michael E. Brisky</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Csx]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[FULL]]></category>
		<category><![CDATA[Jacksonville]]></category>
		<category><![CDATA[michael brisky]]></category>
		<category><![CDATA[Michael Ward]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi River]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-819581243324579563.post-3368852224888943276</guid>
		<description><![CDATA[The first of the major railroads, a href="http://finance.yahoo.com/q?s=csx"CSX/a, a href="http://finance.yahoo.com/news/CSX-2Q-profit-falls-20-apf-3069938868.html?x=0amp;.v=8"reported last night/a.  I like to look to railroads for a accurate representation of the broad economy, and CSX  beat expectations. br /br /span style="font-weight: bold;"-Railroad operator CSX said Monday that second-quarter earnings fell 20 percent as it collected fewer fuel surcharges and shipments continued to drop./spanbr /br /span style="font-weight: bold;"-The results still topped Wall Street's expectations, as the company slashed expenses by 27 percent./spanbr /br /span style="font-weight: bold;"-The Jacksonville, Fla.-based company, which runs its signature blue and yellow locomotives from Canada to Florida and west to the Mississippi River, said Monday it earned $308 million, or 78 cents per share, compared with $385 million, or 93 cents a share, last year./spanbr /br /span style="font-weight: bold;"-Revenue fell 25 percent to $2.19 billion./spanbr /br /span style="font-weight: bold;"-CSX's shipping volume fell 21 percent in the period, compared with 22 percent industrywide. Railroad shipping volumes are viewed as a key economic indicator because so many consumer and manufactured goods are moved on the tracks./spanbr /br /span style="font-weight: bold;"-"While the economy continues to significantly impact our business, there are some signs that we may be seeing the bottom in many markets," CEO Michael Ward said. "Even in this difficult business environment, we are still strengthening our operations, optimizing our resources and making the right investments to prepare our network for the future."/spanbr /br /My take:br /br /Although their are a lot of headwinds, they also had significantly lower fuel prices, which had to help.  Obviously lower auto-related shipments hurt (specifically Eastern carriers like CSX and NSC).  Metals were down, as well as coal, which is just broad weakness in the economy.  The CEO's comment was what I expect to hear from about 90% of industrial companies this quarter.  They'll say there are some signs of a bottom, and although their numbers don't necessarily reflect it, they think things are improving. br /br /For whatever its worth, CSX shares are up 5.5% this morning.  It was a fairly significant beat on the bottom line, but revenue's were pretty weak.  Clearly expectations are still low and this could bode well for stocks as we get further into earnings' season.  I'll continue to track these companies as a sort of barometer of the real economy.div class="blogger-post-footer"img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/819581243324579563-3368852224888943276?l=briskycapital.blogspot.com'//div]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-energy-markets/csx-what-does-this-tell-us/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Toyota Shuttering NUMMI Plant?  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/toyota-shuttering-nummi-plant-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/toyota-shuttering-nummi-plant-analyst-blog/#comments</comments>
		<pubDate>Mon, 13 Jul 2009 17:18:58 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Corolla]]></category>
		<category><![CDATA[East Bay Economic Development Alliance]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi Plant;]]></category>
		<category><![CDATA[NUMMI]]></category>
		<category><![CDATA[Pontiac Vibe]]></category>
		<category><![CDATA[Tacoma;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[Toyota]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vibe;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22128/Toyota+Shuttering+NUMMI+Plant%3F++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, Japanese auto major <strong>Toyota Motor</strong> (<a href="http://www.zacks.com/stock/quote/tm">TM</a>) said it would possibly close its New United Motor Manufacturing Inc. (NUMMI) plant in Fremont, California. Higher manufacturing cost in California, shortage of parts suppliers in the area (only 11% of NUMMI&#8217;s parts suppliers are within 400 miles of the plant) and unionization (the only plant of Toyota organized by UAW in the U.S.) led the company to seek a possible closure.
<p align="left">The NUMMI was started as a <strong>General Motors</strong> (<a href="http://www.zacks.com/stock/quote/gmgmq">GMGMQ</a>) plant in 1962 but closed down in 1982 due to operational inefficiency. However, it was reopened two years later as a 50/50 joint venture between General Motors and Toyota. It was a remarkable joint venture in America&#8217;s as well as Toyota&#8217;s history.</p>
<p align="left">Americans learnt of the famous Japanese &#8216;lean manufacturing system&#8217; (focused on just-in-time delivery) through NUMMI and Toyota took its first step in the U.S. using GM&#8217;s supply lines. NUMMI produces Corolla and Tacoma for Toyota and Pontiac Vibe (Toyota&#8217;s version of the Vibe) for GM.</p>
<p align="left">GM decided to pull out of NUMMI after declaring bankruptcy last month as it will discontinue the Pontiac brand. Last week, the &#8216;New GM&#8217; emerged after the company completed its bankruptcy filing. The company will dump its NUMMI assets in &#8216;Old GM&#8217; for liquidation. However, it will continue producing its Pontiac Vibe until August as the current UAW contract with NUMMI expires on August 31.</p>
<p align="left">According to the East Bay Economic Development Alliance, the NUMMI closure would cost 5,400 direct jobs and 30,000 indirect jobs.</p>
<p align="left">With the slump in industry sales, NUMMI has seen severe production cuts over the past six months. The assembly line manufacturing the Vibe and the Corolla has witnessed a 25% decline in production to 76,000 vehicles, while the Tacoma has seen an 83% fall in production.</p>
<p align="left">Toyota has also been affected financially by the economic crisis. The company posted its first annual loss (437 billion yen or $4.4 billion) since 1950 for the fiscal year ended March 2009. Further, management has recently projected net loss to worsen to 550 billion yen ($5.5 billion) for the fiscal year ending March 2010.</p>
<p align="left">Toyota has 12 manufacturing facilities in the U.S. Presently, six of them are operating under capacity and one Mississippi plant has been idled. The NUMMI closure seems likely as wages are higher at the plant (due to unionization) compared to others including plants in Canada and Mexico, which producing Corolla and Tacoma, respectively.</p>
<p align="left">We reserve our opinion on Toyota as a Hold with a target price of $75.00.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TM">Read the full analyst report on "TM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GMGMQ">Read the full analyst report on "GMGMQ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/toyota-shuttering-nummi-plant-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ESP Resources Inc. (ESPI.OB) is “One to Watch”</title>
		<link>http://www.straightstocks.com/market-commentary/esp-resources-inc-espi-ob-is-%e2%80%9cone-to-watch%e2%80%9d/</link>
		<comments>http://www.straightstocks.com/market-commentary/esp-resources-inc-espi-ob-is-%e2%80%9cone-to-watch%e2%80%9d/#comments</comments>
		<pubDate>Tue, 30 Jun 2009 17:35:09 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[ESP Petrochemicals Inc.]]></category>
		<category><![CDATA[ESP Resources Inc.]]></category>
		<category><![CDATA[ESP Resources supplies]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[oil and gas industry]]></category>
		<category><![CDATA[oil field applications]]></category>
		<category><![CDATA[oil field petrochemical expertise]]></category>
		<category><![CDATA[oil production assets]]></category>
		<category><![CDATA[paraffin chemicals]]></category>
		<category><![CDATA[Pecos County]]></category>
		<category><![CDATA[petrochemical subsidiary]]></category>
		<category><![CDATA[production chemicals]]></category>
		<category><![CDATA[retail and wholesale specialty chemicals]]></category>
		<category><![CDATA[Scott]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[waste remediation chemicals]]></category>
		<category><![CDATA[waste treatment chemicals]]></category>
		<category><![CDATA[west africa]]></category>
		<category><![CDATA[work-over chemicals]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=15644</guid>
		<description><![CDATA[ESP Resources, Inc. is an oil and gas company headquartered in Austin, Texas. Founded in 2006, the company, through their wholly owned subsidiary, ESP Petrochemicals, Inc., is a manufacturer, blender, distributor, and marketer of specialty chemicals to the oil and gas industry. Trading on NASDAQ&#8217;s OTCBB, they have operations in Scott, Louisiana, and Pecos County, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/esp-resources-inc-espi-ob-is-%e2%80%9cone-to-watch%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>State Budgets Are Anti-Stimulus &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/state-budgets-are-anti-stimulus-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/state-budgets-are-anti-stimulus-analyst-blog/#comments</comments>
		<pubDate>Tue, 30 Jun 2009 15:54:00 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[District Of Columbia]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Hawaii]]></category>
		<category><![CDATA[Idaho]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[Iowa]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Kentucky]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Maine]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Missouri]]></category>
		<category><![CDATA[Nebraska]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New Hampshire]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Oklahoma]]></category>
		<category><![CDATA[Oregon]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Rhode Island]]></category>
		<category><![CDATA[South Carolina]]></category>
		<category><![CDATA[South Dakota]]></category>
		<category><![CDATA[Tennessee]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[West Virginia]]></category>
		<category><![CDATA[Wisconsin]]></category>
		<category><![CDATA[Wyoming]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21644/State+Budgets+Are+Anti-Stimulus+-+Analyst+Blog</guid>
		<description><![CDATA[<p>Today is the end of the 2009 fiscal year, and many states are still scrambling to get budgets in place for the 2010 fiscal year.  <br />
<br />
It is not easy since when the economy turns south, so do tax revenues, and states are not allowed to run deficits or borrow for operating needs. Some states have managed to cut costs or raise taxes enough to close their deficits for the upcoming year. The only two states without a budget problem are Montana and North Dakota.  <br />
<br />
As shown in the table below (from http://www.cbpp.org/cms/index.cfm?fa=view&#38;id=711), the total spending cuts or revenue increase needs to be $166 billion or 24% of the projected budget. To some extent states have used "rainy day funds" and the money from the Federal Stimulus bill to close some of the gap. Still the problem is very severe with 5 states (CA, AZ, NV, IL, NY) facing shortfalls of greater than 30%. California is in the worst shape with a gap of 58.2%.</p>
<p align="center">
<table cellspacing="1" cellpadding="3" bgcolor="#ffffff" width="80%">
    <tbody>
        <tr>
            <th colspan="8"><strong>STATES WITH PROJECTED FY2010 BUDGET GAPS</strong></th>
        </tr>
        <tr bgcolor="#a2d39c">
            <td align="left"><strong><u>	State	</u></strong></td>
            <td align="center"><strong><u>	FY2010<br />
            pre-budget	</u></strong></td>
            <td align="center"><strong><u>	FY2010<br />
            mid-year gap	</u></strong></td>
            <td align="center"><strong><u>	FY2010<br />
            Total	</u></strong></td>
            <td align="center"><strong><u>	FY2010 Total<br />
            % of Budget	</u></strong></td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Alabama</td>
            <td align="center"><strong><u>	$1.2 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.2 billion</td>
            <td align="center">16.70%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Alaska</td>
            <td align="center"><strong><u>	$1.3 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.3 billion</td>
            <td align="center">30.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Arizona</td>
            <td align="center"><strong><u>	$4.0 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$4.0 billion</td>
            <td align="center">41.10%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Arkansas</td>
            <td align="center"><strong><u>	$146 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$146 million</td>
            <td align="center">3.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">California*</td>
            <td align="center"><strong><u>	$34.2 billion	</u></strong></td>
            <td align="center">$19.5 billion</td>
            <td align="center">$53.7 billion</td>
            <td align="center">58.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Colorado</td>
            <td align="center"><strong><u>	$1.0 billion	</u></strong></td>
            <td align="center">$384 million</td>
            <td align="center">$1.4 billion</td>
            <td align="center">18.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Connecticut</td>
            <td align="center"><strong><u>	$4.1 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$4.1 billion</td>
            <td align="center">23.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Delaware</td>
            <td align="center"><strong><u>	$557 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$557 million</td>
            <td align="center">17.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">District of Columbia</td>
            <td align="center"><strong><u>	$650 million	</u></strong></td>
            <td align="center">$150 million</td>
            <td align="center">$800 million</td>
            <td align="center">12.70%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Florida</td>
            <td align="center"><strong><u>	$5.9 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$5.9 billion</td>
            <td align="center">22.80%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Georgia</td>
            <td align="center"><strong><u>	$3.1 billion	</u></strong></td>
            <td align="center">$750 million</td>
            <td align="center">$3.9 billion</td>
            <td align="center">22.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Hawaii</td>
            <td align="center"><strong><u>	$682 million	</u></strong></td>
            <td align="center">$297 million</td>
            <td align="center">$978 million</td>
            <td align="center">19.10%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Idaho</td>
            <td align="center"><strong><u>	$411 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$411 million</td>
            <td align="center">16.40%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Illinois</td>
            <td align="center"><strong><u>	$9.2 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$9.2 billion</td>
            <td align="center">33.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Indiana</td>
            <td align="center"><strong><u>	$1.1 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.1 billion</td>
            <td align="center">7.50%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Iowa</td>
            <td align="center"><strong><u>	$779 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$779 million</td>
            <td align="center">13.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Kansas</td>
            <td align="center"><strong><u>	$1.4 billion	</u></strong></td>
            <td align="center">Yes, DK size</td>
            <td align="center">$1.4 billion</td>
            <td align="center">22.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Kentucky</td>
            <td align="center"><strong><u>	0	</u></strong></td>
            <td align="center">$1.1 billion</td>
            <td align="center">$1.1 billion</td>
            <td align="center">11.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Louisiana</td>
            <td align="center"><strong><u>	$1.8 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.8 billion</td>
            <td align="center">21.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Maine</td>
            <td align="center"><strong><u>	$640 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$640 million</td>
            <td align="center">21.40%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Maryland</td>
            <td align="center"><strong><u>	$1.9 billion	</u></strong></td>
            <td align="center">Yes, DK size</td>
            <td align="center">$1.9 billion</td>
            <td align="center">13.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Massachusetts</td>
            <td align="center"><strong><u>	$5.0 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$5.0 billion</td>
            <td align="center">17.90%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Michigan</td>
            <td align="center"><strong><u>	$2.4 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$2.4 billion</td>
            <td align="center">12.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Minnesota</td>
            <td align="center"><strong><u>	$3.2 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$3.2 billion</td>
            <td align="center">21.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Mississippi</td>
            <td align="center"><strong><u>	$480 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$480 million</td>
            <td align="center">9.60%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Missouri</td>
            <td align="center"><strong><u>	$923 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$923 million</td>
            <td align="center">10.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Nebraska</td>
            <td align="center"><strong><u>	$150 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$150 million</td>
            <td align="center">4.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Nevada</td>
            <td align="center"><strong><u>	$1.2 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.2 billion</td>
            <td align="center">37.80%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">New Hampshire</td>
            <td align="center"><strong><u>	$250 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$250 million</td>
            <td align="center">16.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">New Jersey</td>
            <td align="center"><strong><u>	$8.8 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$8.8 billion</td>
            <td align="center">29.90%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">New Mexico</td>
            <td align="center"><strong><u>	$345 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$345 million</td>
            <td align="center">6.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">New York</td>
            <td align="center"><strong><u>	$17.9 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$17.9 billion</td>
            <td align="center">32.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">North Carolina</td>
            <td align="center"><strong><u>	$4.6 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$4.6 billion</td>
            <td align="center">21.90%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Ohio</td>
            <td align="center"><strong><u>	$3.3 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$3.3 billion</td>
            <td align="center">12.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Oklahoma</td>
            <td align="center"><strong><u>	$600 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$600 million</td>
            <td align="center">10.50%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Oregon*</td>
            <td align="center"><strong><u>	0	</u></strong></td>
            <td align="center">0</td>
            <td align="center">0</td>
            <td align="center">0.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Pennsylvania</td>
            <td align="center"><strong><u>	$4.8 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$4.8 billion</td>
            <td align="center">18.00%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Rhode Island</td>
            <td align="center"><strong><u>	$590 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$590 million</td>
            <td align="center">19.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">South Carolina</td>
            <td align="center"><strong><u>	$725 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$725 million</td>
            <td align="center">12.50%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">South Dakota</td>
            <td align="center"><strong><u>	$32 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$32 million</td>
            <td align="center">2.90%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Tennessee</td>
            <td align="center"><strong><u>	$1.0 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$1.0 billion</td>
            <td align="center">9.70%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Texas</td>
            <td align="center"><strong><u>	$3.5 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$3.5 billion</td>
            <td align="center">9.50%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Utah</td>
            <td align="center"><strong><u>	$721 million	</u></strong></td>
            <td align="center">$279 million</td>
            <td align="center">$1.0 billion</td>
            <td align="center">19.80%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Vermont</td>
            <td align="center"><strong><u>	$278 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$278 million</td>
            <td align="center">24.80%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Virginia</td>
            <td align="center"><strong><u>	$1.8 billion	</u></strong></td>
            <td align="center">Yes, DK size</td>
            <td align="center">$1.8 billion</td>
            <td align="center">10.90%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Washington</td>
            <td align="center"><strong><u>	$3.4 billion	</u></strong></td>
            <td align="center">$195 million</td>
            <td align="center">$3.6 billion</td>
            <td align="center">23.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">West Virginia</td>
            <td align="center"><strong><u>	$200 million	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$200 million</td>
            <td align="center">5.30%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Wisconsin</td>
            <td align="center"><strong><u>	$3.2 billion	</u></strong></td>
            <td align="center">0</td>
            <td align="center">$3.2 billion</td>
            <td align="center">23.20%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Wyoming</td>
            <td align="center"><strong><u>	0	</u></strong></td>
            <td align="center">$32 million</td>
            <td align="center">$32 million</td>
            <td align="center">1.70%</td>
        </tr>
        <tr bgcolor="#e6f3e7">
            <td align="left">Total</td>
            <td align="center"><strong><u>	$143.2 billion	</u></strong></td>
            <td align="center">$22.7 billion</td>
            <td align="center">$165.9 billion</td>
            <td align="center">24.40%</td>
        </tr>
    </tbody>
</table>
</p>
<p align="left">This will lead to very drastic cuts in state budgets. Access to medical care by the poor will likely be one of the first things to be cut.  <br />
<br />
Education budgets will also probably be pared. This could be decreased spending on new textbooks, which would not be good news for publishers like <strong>McGraw-Hill</strong> (<a href="http://www.zacks.com/stock/quote/MHP">MHP</a>) and <strong>Scholastic</strong> (<a href="http://www.zacks.com/stock/quote/SCHL">SCHL</a>).  <br />
<br />
Another area that is likely to be hit is new equipment at the municipal level. For example, I would not expect <strong>Oshkosh</strong> (<a href="http://www.zacks.com/stock/quote/OSK">OSK</a>) to have a very good year selling new fire engines and snow removal equipment to municipalities.  <br />
<br />
Layoffs of state and municipal workers will simply add to the already high and rising unemployment rate. In short, a big part of the federal stimulus spending is being offset by (legally mandated) anti-stimulus actions at the state level.  <br />
<br />
As the graph shows, state fiscal problems tend to persist well after the recession is officially over. Indeed the problem is usually worse in the second or third year since by then the "rainy day funds" have already been used up.  <br />
<br />
Following the last recession, states collectively had their worst year in 2004 with a shortfall of $80 billion (or less than half what they face for fiscal 2010), which was well after the recession officially ended. Thus 2011, and possibly even 2012, will be a very lean year at the state level as well.</p>
<p align="center"><img height="295" width="400" src="http://www.zacks.com/images/upload_dir/1246373430.jpg" alt="" /></p>
<p align="left"> </p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MHP">Read the full analyst report on "MHP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SCHL">Read the full analyst report on "SCHL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=OSK">Read the full analyst report on "OSK"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/state-budgets-are-anti-stimulus-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Paccar Scales Back on Ambitious Project &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/paccar-scales-back-on-ambitious-project-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/paccar-scales-back-on-ambitious-project-analyst-blog/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 19:59:42 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[DAF]]></category>
		<category><![CDATA[Daimler AG]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi Plant;]]></category>
		<category><![CDATA[Navistar International;]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Paccar;]]></category>
		<category><![CDATA[Retail Sales]]></category>
		<category><![CDATA[truck retail sales]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Volvo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21601/Paccar+Scales+Back+on+Ambitious+Project+-+Analyst+Blog</guid>
		<description><![CDATA[<p></p>
<p>Headquartered in Bellevue, Washington, Paccar Inc. (<a href="http://www.zacks.com/stock/quote/pcar">PCAR</a>) announced the delay in the commissioning of its diesel engine plant near Columbus, Mississippi. Paccar attributed the delay to adverse economic conditions that have impacted truck demand. The plant, which was scheduled to begin operations by the end of 2009, will now start production in late 2010. </p>
<p align="left">Paccar is engaged in the design, manufacture and distribution of light, medium, and heavy-duty trucks. The company markets heavy-duty diesel trucks under the Kenworth, Peterbilt and DAF brands. The company's trucks are used for over the road and off the highway to haul freight, petroleum, wood products, construction and other materials. Paccar's upcoming plant in Mississippi will manufacture 12.9-liter and 9.2-liter diesel engines for Kenworth, Peterbilt and DAF vehicles. </p>
<p align="left">Back in 2007, Paccar had signed a contract with the state to provide 500 jobs at the Mississippi plant by 2013. According to the management, construction at the facility is nearly completed and workers are installing and checking equipment. This is a matter of concern, as the company has incurred capital expenditure for the plant but has decided to keep the plant idle, as the economic outlook is bleak. </p>
<p align="left">A downturn in the U.S. has affected Paccar's freight shipments and truck purchases worldwide. Paccar expects European sales to decline by as much as 10% in 2009. Truck retail sales have dampened due to the increase in diesel prices along with the depressed housing market and lower auto production. Global truck retail sales in 2008 were below the five-year average of 235,000 units because of the current recession. </p>
<p align="left">The weak truck markets will continue to affect PACCAR's business in North America and Europe in 2009. The company has lowered its 2009 outlook in the U.S. and Canada. PACCAR is now looking at truck sales in the range of 100,000 to 130,000 units for the industry in 2009, down from the previous estimate of 130,000 to 170,000 units. Furthermore, PACCAR faces strong competition from its three principal competitors Navistar International (<a href="http://www.zacks.com/stock/quote/nav">NAV</a>) (headquartered in the U.S.), and Daimler Ag (<a href="http://www.zacks.com/stock/quote/dai">DAI</a>) and Volvo (both headquartered in Europe) in the U.S. and Canada truck market. </p>
<p align="left">We rate the stock a Hold and set a six-month target of $30.00. </p>
<p align="left"></p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCAR">Read the full analyst report on "PCAR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NAV">Read the full analyst report on "NAV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DAI">Read the full analyst report on "DAI"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/paccar-scales-back-on-ambitious-project-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>We&#8217;re Positive on Acorda &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/were-positive-on-acorda-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/were-positive-on-acorda-analyst-blog/#comments</comments>
		<pubDate>Mon, 22 Jun 2009 19:20:25 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acorda Pharmaceuticals]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[late-stage biotechnology products;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21327/We%27re+Positive+on+Acorda+-+Analyst+Blog</guid>
		<description><![CDATA[<br />Over the past few months, we have become increasingly confident <span style="font-weight: bold;">Acorda Pharmaceuticals'</span> (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>) application for Fampridine-SR looks strong -- from a clinical data standpoint. The application contains data from a comprehensive development program assessing the safety and efficacy of Fampridine-SR, including two phase III trials that involved 540 people with MS, and were conducted under Special Protocol Assessments (SPAs) from the FDA.<br /><br />The safety and efficacy profile of Fampridine-SR was consistent across phase II and phase III trials. In total, the NDA filing included more that 50 clinical studies and over 1,200 patient-years. Additionally, more than 450 people are currently enrolled in Fampridine-SR extension trials, with treatment duration ranging from seven months to almost five year. We believe the odds favor approval in October 2009.<br /><br />In the meantime, Acorda is preparing for the launch in the U.S. by doubling the sales force currently promoting Zanaflex, to 120 - 130 representatives by the end of the year. Approval in October 2009 is only a month or two ahead of management's original thinking prior to the RFT delay, so we believe that timelines at Acorda for ramping the commercial infrastructure are well with reasonable expectations.<br /><br />Management also remains in active discussions with potential European partners for Fampridine-SR. We just recently learned that the product is eligible to be filed under the EU's centralized procedure, and will have 10 years of exclusivity post-approval. A European partnership has the potential to bring in significant upfront cash and backend milestones and royalties to Acorda. This is a major catalyst for the shares potentially later this summer or fall ahead of U.S. approval.<br /><br />Fampridine-SR remains one of the more interesting late-stage biotechnology products and has multi-hundred million dollar potential, in our view. We have been waiting for an opportunity to recommend the shares. We encourage investors to pick up Acorda at today's price based on our belief that the future looks very bright for the firm, despite the minor setback on the filing.<br /><br />One wildcard event that could send Acorda's shares soaring would be an acquisition by a larger player in the MS space. The three names that come to mind are <span style="font-weight: bold;">Biogen</span> (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), <span style="font-weight: bold;">Novartis</span> (<a href="http://www.zacks.com/stock/quote/nvs">NVS</a>) and <span style="font-weight: bold;">Sanofi-Aventis</span> (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>). In the meantime, we see $30 as a near-term fair-value.  
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACOR">Read the full analyst report on "ACOR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NVS">Read the full analyst report on "NVS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/were-positive-on-acorda-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Worst Credit Risk in the World</title>
		<link>http://www.straightstocks.com/market-commentary/the-worst-credit-risk-in-the-world/</link>
		<comments>http://www.straightstocks.com/market-commentary/the-worst-credit-risk-in-the-world/#comments</comments>
		<pubDate>Wed, 27 May 2009 20:06:28 +0000</pubDate>
		<dc:creator>Bill Bonner</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[Capitol building;]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[obama]]></category>
		<category><![CDATA[oil remains;]]></category>
		<category><![CDATA[Peron;]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Government]]></category>
		<category><![CDATA[Us Treasury]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Warren Buffett]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=17182</guid>
		<description><![CDATA[pWe#8217;re now in an extended bounce which could last until mid-summer. Stocks were up yesterday#8230; the Dow rose 196 points.  What were investors thinking? /p
p#8220;a style="font-weight: bold; color: #006b99;" href="http://www.bloomberg.com/apps/news?pid=20603037#38;sid=aJjnVOs7SUW8#38;refer=home" target="_blank"Home prices fell more than forecast,/a#8221; reports Bloomberg. They’re still going down at a 19% rate. Unemployment is still rising too./p
pThe state with the biggest economy in the nation is going broke. So is the nation’s biggest manufacturer. Profits are falling. And the government is racing to put in place a form of state-sponsored socio-capitalism much like Mussolini’s Italy#8230; or Peron’s Argentina./p
pThese do not sound to us like ideal conditions for a bull market./p
pDid we say thinking? There’s not much thinking going on. People don’t often think#8230; not if they can avoid it. And it’s probably#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/the-worst-credit-risk-in-the-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Maybe, Just Maybe A Break In The Link?</title>
		<link>http://www.straightstocks.com/market-commentary/maybe-just-maybe-a-break-in-the-link/</link>
		<comments>http://www.straightstocks.com/market-commentary/maybe-just-maybe-a-break-in-the-link/#comments</comments>
		<pubDate>Wed, 27 May 2009 12:45:11 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Alan Greenspan]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[BRL]]></category>
		<category><![CDATA[Case-Shiller U.S.;]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[DKK]]></category>
		<category><![CDATA[email server;]]></category>
		<category><![CDATA[EUR]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[HKD]]></category>
		<category><![CDATA[HUF]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[INR]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Koruna]]></category>
		<category><![CDATA[Marc Faber]]></category>
		<category><![CDATA[Marc Faber speaks;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[N. Korea;]]></category>
		<category><![CDATA[Peso]]></category>
		<category><![CDATA[PLN;]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[SEK]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[Treasury ranch;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[ZAR]]></category>
		<category><![CDATA[Zimbabwe]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=17138</guid>
		<description><![CDATA[pCurrencies consolidate#8230;  Brazil posts a surplus!  Dr. Marc Faber speaks#8230;  High yielders rule!                                                   And Now#8230; Today#8217;s Pfennig!br /
Good day#8230; And a Wonderful Wednesday to you! A very tight trading range day was in place yesterday for the currencies#8230; In yet another sign that maybe, just maybe, because you never know, the currencies could be breaking their link to stocks#8230; U.S. stocks jumped 196 points yesterday, and the currencies range traded#8230; Hmmm#8230;./p
pNot that this will become a #8220;stock jockey journal#8221;#8230; Stocks jumped on the news that Consumer Confidence surged this month#8230; Talk about looking at things through rose colored glasses! Any way, Consumer Confidence surged#8230; Better to have blips in Confidence than to be all negative all the time I guess! I#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/maybe-just-maybe-a-break-in-the-link/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Energtek, Inc. (EGTK.PK) Success Partially Based On High-Powered International Board</title>
		<link>http://www.straightstocks.com/market-commentary/energtek-inc-egtkpk-success-partially-based-on-high-powered-international-board/</link>
		<comments>http://www.straightstocks.com/market-commentary/energtek-inc-egtkpk-success-partially-based-on-high-powered-international-board/#comments</comments>
		<pubDate>Tue, 19 May 2009 17:01:25 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Adam Law Firm;]]></category>
		<category><![CDATA[Angstore Technologies;]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Bar-Ilan University;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[College of Management Law School;]]></category>
		<category><![CDATA[costly compressed natural gas transportation;]]></category>
		<category><![CDATA[Council of Europe]]></category>
		<category><![CDATA[economical and clean natural gas;]]></category>
		<category><![CDATA[Eliezer (Moodi) Sandberg;]]></category>
		<category><![CDATA[Energtek Inc.]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[gas network using bulk transportation solutions;]]></category>
		<category><![CDATA[High-Powered International Board;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[israel]]></category>
		<category><![CDATA[Israel-Africa Friendship Union;]]></category>
		<category><![CDATA[Israel-Brazil Friendship Union;]]></category>
		<category><![CDATA[Israel-Vietnam Friendship Union;]]></category>
		<category><![CDATA[Israeli Air Force;]]></category>
		<category><![CDATA[Israeli Computer Society;]]></category>
		<category><![CDATA[Israeli Parliament Subcommittee on Hi-Tech;]]></category>
		<category><![CDATA[Justice Haim Cohen Center for the Legal Protection of Human Rights;]]></category>
		<category><![CDATA[Kazakhstan]]></category>
		<category><![CDATA[legal and strategic business consultation;]]></category>
		<category><![CDATA[Lev Zaidenberg]]></category>
		<category><![CDATA[Mahwah;]]></category>
		<category><![CDATA[Manheimer Inc.;]]></category>
		<category><![CDATA[Message Board]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[National Science and Technology Council of Kazakhstan;]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Ramapo College;]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Science and Technology Committee;]]></category>
		<category><![CDATA[St. Petersburg State University in Russia;]]></category>
		<category><![CDATA[State Bar of California;]]></category>
		<category><![CDATA[supply natural gas]]></category>
		<category><![CDATA[Symrise Inc;]]></category>
		<category><![CDATA[Technion Israel Institute of Technology;]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Tel-Aviv University;]]></category>
		<category><![CDATA[The Philippines]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Yishai Aizik;]]></category>
		<category><![CDATA[Zhenia Fleisher;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=15351</guid>
		<description><![CDATA[
Energtek, Inc., a leader in alternative technologies for the storage and movement of natural gas, leverages the strengths of its Board of Directors as it seeks to grow internationally. The company uses ANG (Adsorbed Natural Gas) and other technologies to supply natural gas for industrial and commercial consumers not connected to a gas network using [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/energtek-inc-egtkpk-success-partially-based-on-high-powered-international-board/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advanced Growing Systems, Inc. (AGWS.OB) Subsidiary Completes Initial Reengineering of Production at Mississippi Plant</title>
		<link>http://www.straightstocks.com/market-commentary/advanced-growing-systems-inc-agwsob-subsidiary-completes-initial-reengineering-of-production-at-mississippi-plant/</link>
		<comments>http://www.straightstocks.com/market-commentary/advanced-growing-systems-inc-agwsob-subsidiary-completes-initial-reengineering-of-production-at-mississippi-plant/#comments</comments>
		<pubDate>Mon, 18 May 2009 14:01:40 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Advanced Growing Systems Inc.;]]></category>
		<category><![CDATA[enVentive Solutions Inc.;]]></category>
		<category><![CDATA[Kilchrist;]]></category>
		<category><![CDATA[Mark D. Nichols;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi Plant;]]></category>
		<category><![CDATA[Organic Growing Systems Inc.;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=15333</guid>
		<description><![CDATA[Organic Growing Systems, Inc. (OGSI), a subsidiary of Advanced Growing Systems, Inc., announced that enVentive Solutions, Inc., working together with OGSI personnel, has completed the initial phase of plant reengineering to bring daily fertilizer production to 250+ tons per day. 
&#8220;The first phase of the re-engineering process focusing on raw material handling, debris and moisture [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/advanced-growing-systems-inc-agwsob-subsidiary-completes-initial-reengineering-of-production-at-mississippi-plant/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Entergy Results Disappoint &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/entergy-results-disappoint-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/entergy-results-disappoint-analyst-blog/#comments</comments>
		<pubDate>Wed, 13 May 2009 17:30:23 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Date]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[energy utility industry;]]></category>
		<category><![CDATA[Entergy Corp.]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[retail distribution operations;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vermont]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/20137/Entergy+Results+Disappoint+-+Analyst+Blog</guid>
		<description><![CDATA[<br /><span style="font-weight: bold; text-decoration: underline;">Entergy Generates Disappointing Q1'09 Results</span><br /><br /><span style="font-weight: bold;">Entergy Corp.</span> (<a href="http://www.zacks.com/stock/quote/etr">ETR</a>) released financial results for the 1st quarter of 2009 in which the company reported a 23.8% decrease in earnings of $235.3 million, or $1.20 per diluted share ($1.22 basic), compared to $308.7 million, or $1.56 per diluted share ($1.60 basic), in the year-ago quarter.<br /><br />Ongoing operating earnings were reported at $252.6 million, or $1.29 per share, compared with $308.7 million, or $1.56 per share, in the comparable prior-year quarter.<br /><br />Operating revenues in the reported quarter decreased 2.6% to $2.79 billion from $2.86 billion in the prior-year quarter.<br /><br />Cash flow provided by operating activities decreased in the 1st quarter of 2009 as compared to the year-ago period due to lower net income, and changes in other regulatory assets.<br /><br />Outlook: Entergy reaffirmed its fiscal 2009 outlook and expects EPS in the range of $6.70 - $7.30. As-reported guidance ranges from $6.56 to $7.16 and reflects $0.14 per share of projected dis-synergies associated with the expected spin-off of Entergy's non-utility nuclear business and plan to enter into a nuclear services joint venture.<br /><br />Entergy is focusing on its traditional electric utility business with the imminent separation of its nuclear business.<br /><br />However, destruction from Hurricanes Gustav and Ike in September 2008 affected the performance of the company. According to company estimates, total restoration costs are estimated to be within the range of $1.295 billion to $1.360 billion. Previously, the company showed strong resilience during two back-to-back destructive hurricanes in 2005.<br /><br />Going forward, improving credit markets, a reasonable valuation, and steady recovery from hurricane damage, should continue to deliver strong earnings and cash-flow growth.<br /><br />However, pending regulatory approvals in New York and Vermont for the proposed spin-off of its nuclear business is likely to further delay the spin-off transaction.<br /><br />Looking ahead, the company's ability to achieve management's targeted earnings growth will depend primarily upon intrinsic growth, the recovery of hurricane-related restoration costs, and the return of customers. In addition, the implementation of a formula rate plan, and significant free cash flow generation available for capital deployment for share repurchases, dividend hikes and/or debt retirement should collectively support management's focus on creating shareholder value.<br /><br />Over the past year, ETR traded within a P/E range of 9.2x to 18.7x then current-year EPS estimates. ETR shares currently trade at 11.2x and 10.6x, respectively, our 2009 and 2010 earnings per share estimates, or at a discount to the median and mean multiples for the diversified energy utility industry. Meanwhile, ETR trades at the upper-end of the range of its industry peers based upon relative multiples of book value yet in-line with its utility industry peers based on relative multiples of sales cash flow.<br /><br />Therefore, with above industry average earnings growth expectations and a bullish outlook, we reiterate our BUY recommendation on ETR with a six-month target price of $78.00, or 11.9x our 2009 EPS forecast and 11.3x our forward 2010 EPS estimate. Price appreciation to our near-term valuation target, coupled with the $0.75 per share quarterly cash dividend - which appears sustainable and secure based on reasonable projected earnings payouts of 45.7% and 43.5%, respectively, of our 2009 and 2010 EPS estimates - represents annualized total return potential of 17.2%.<br /><br />New Orleans-based Entergy Corporation is primarily engaged in electric power production and retail distribution operations. With 30,000 MW of generating capacity, it distributes electricity to 2.6 million customers in Arkansas, Louisiana, Mississippi, and Texas. The company also distributes natural gas to 240,000 customers in Louisiana.
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ETR">Read the full analyst report on "ETR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/entergy-results-disappoint-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Casino Stocks: The One Sin Stock You Should Be Betting On</title>
		<link>http://www.straightstocks.com/market-commentary/casino-stocks-the-one-sin-stock-you-should-be-betting-on/</link>
		<comments>http://www.straightstocks.com/market-commentary/casino-stocks-the-one-sin-stock-you-should-be-betting-on/#comments</comments>
		<pubDate>Thu, 07 May 2009 13:02:51 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Airline Tickets]]></category>
		<category><![CDATA[Alexander Green]]></category>
		<category><![CDATA[Ameristar Casinos Inc;]]></category>
		<category><![CDATA[Bluffs;]]></category>
		<category><![CDATA[casino hotel;]]></category>
		<category><![CDATA[casino operator;]]></category>
		<category><![CDATA[Colorado]]></category>
		<category><![CDATA[David Fessler]]></category>
		<category><![CDATA[East Chicago;]]></category>
		<category><![CDATA[facility sports;]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Chain]]></category>
		<category><![CDATA[Golden]]></category>
		<category><![CDATA[Gordon Kanofsky;]]></category>
		<category><![CDATA[Hotel Vicksburg;]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[Iowa]]></category>
		<category><![CDATA[Jackpot;]]></category>
		<category><![CDATA[Kansas City]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[mgm mirage]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Missouri]]></category>
		<category><![CDATA[Molson]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New York Times]]></category>
		<category><![CDATA[Oxford Club]]></category>
		<category><![CDATA[Platte River;]]></category>
		<category><![CDATA[Quest childcare facility;]]></category>
		<category><![CDATA[Resort Spa;]]></category>
		<category><![CDATA[Riviera Holdings;]]></category>
		<category><![CDATA[St. Charles;]]></category>
		<category><![CDATA[St. Louis]]></category>
		<category><![CDATA[Station Casinos;]]></category>
		<category><![CDATA[Steve McDonald]]></category>
		<category><![CDATA[travel destinations;]]></category>
		<category><![CDATA[travel industry]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/May/casino-stocks.html</guid>
		<description><![CDATA[Casino Stocks: The One Sin Stock You Should Be Betting On 
by David Fessler, Advisory Panelist
Casino stocks have been more than down on their luck lately. In fact, they&#8217;ve been on the ropes more than one of their prizefighting boxers. And it&#8217;s no wonder.
The recession has hit consumers hard. And many have cut their spending, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/casino-stocks-the-one-sin-stock-you-should-be-betting-on/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acorda Pops On Good News &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/acorda-pops-on-good-news-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/acorda-pops-on-good-news-analyst-blog/#comments</comments>
		<pubDate>Wed, 06 May 2009 17:12:33 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acorda Therapeutics Inc.;]]></category>
		<category><![CDATA[Biogen Idec Inc.]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Blog We]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[late-stage biotechnology products;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Sanofi-Aventis S.A.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/19895/Acorda+Pops+On+Good+News+-+Analyst+Blog</guid>
		<description><![CDATA[<span style="font-style: italic;">We highlight Acorda Therapeutics, Inc. (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>), Biogen Idec, Inc. (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), Pfizer, Inc. (<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>), Sanofi-Aventis SA (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>) and Wyeth</span> (<a href="http://www.zacks.com/stock/quote/wye">WYE</a>).<br /><br />We upgraded shares of <span style="font-weight: bold;">Acorda Therapeutics, Inc.</span> (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>) the day after the FDA issued the RTF ("refuse to file") letter on April 1, 2009. At that time the shares were hit hard -- down to the $18 level -- and we noted that we "Finally got our buying opportunity." We previously had a Hold rating on the name, waiting for a pullback before we recommended clients get in.<br /><br />Over the past few months we have become increasingly confident that the application for Fampridine-SR looks strong -- from a clinical data standpoint. The application contains data from a comprehensive development program assessing the safety and efficacy of Fampridine-SR, including two phase III trials that involved 540 people with MS and were conducted under Special Protocol Assessments (SPAs) from the FDA.<br /><br />The safety and efficacy profile of Fampridine-SR was consistent across phase II and phase III trials. In total, the NDA filing included more that 50 clinical studies and over 1,200 patient-years. Additionally, more than 450 people are currently enrolled in Fampridine-SR extension trials, with treatment duration ranging from seven months to almost five year. We believe the odds favor approval in October 2009.<br /><br />In the meantime, Acorda is preparing for the launch in the U.S. by doubling the sales force currently promoting Zanaflex, to 120 - 130 representatives by the end of the year. Approval in October 2009 is only a month or two ahead of management's original thinking prior to the RFT letter, so we believe that timelines at Acorda for ramping the commercial infrastructure are well with reasonable expectations.<br /><br />Management also remains in active discussions with potential European partners for Fampridine-SR. A European partnership has the potential to bring in significant upfront cash and backend milestones and royalties to Acorda. This is a major catalyst for the shares potentially later this summer or fall ahead of U.S. approval.<br /><br />Fampridine-SR remains one of the more interesting late-stage biotechnology products and has multi-hundred million dollar potential in our view. We have been waiting for an opportunity to recommend the shares. We encourage investors to pick up Acorda at today's price based on our belief that the future looks very bright for the firm, despite the minor setback on the filing.<br /><br />One wildcard event that could send Acorda's shares soaring would be an acquisition by a larger player in the MS space. The three names that come to mind are <span style="font-weight: bold;">Biogen</span> (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), <span style="font-weight: bold;">Pfizer</span> (<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>) and <span style="font-weight: bold;">Sanofi-Aventis</span> (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>). Pfizer seems unlikely given its recent $68 billion engulfing of <span style="font-weight: bold;">Wyeth</span> (<a href="http://www.zacks.com/stock/quote/wye">WYE</a>). Biogen-Idec would be an excellent fit. In the meantime, we see $30 as a near-term fair-value.
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACOR">Read the full analyst report on "ACOR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WYE">Read the full analyst report on "WYE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/acorda-pops-on-good-news-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Friday’s Market Recap (04/17/09)</title>
		<link>http://www.straightstocks.com/financial/friday%e2%80%99s-market-recap-041709/</link>
		<comments>http://www.straightstocks.com/financial/friday%e2%80%99s-market-recap-041709/#comments</comments>
		<pubDate>Sat, 18 Apr 2009 01:44:24 +0000</pubDate>
		<dc:creator>Bullish Bankers</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[Beau Rivage;]]></category>
		<category><![CDATA[bullish bankers]]></category>
		<category><![CDATA[Carl Ichan;]]></category>
		<category><![CDATA[casino hotel;]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[GE Capital]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[Kirk Kerkorian]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Matt Shannon;]]></category>
		<category><![CDATA[MGM Grand;]]></category>
		<category><![CDATA[mgm mirage]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[Nasdaq 100]]></category>
		<category><![CDATA[S&P]]></category>
		<category><![CDATA[straight large bank;]]></category>
		<category><![CDATA[Treasure Island casino hotel;]]></category>
		<category><![CDATA[Treasure Island;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.bullishbankers.com/?p=12397</guid>
		<description><![CDATA[The markets were up today, with the S&#38;P closing 869.90.  The NASDAQ was up 0.16% closing at 1673.07, while the Dow Jones was up 0.07% closing at 8131.33.  Crude contracts were up settling at $50.33, while gold futures were down in trading, settling at $867.90.  The 10-year price was down, as the yield closed up [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/financial/friday%e2%80%99s-market-recap-041709/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brinx Resources Ltd. (BNXR.OB) Well Producing Oil and Natural Gas</title>
		<link>http://www.straightstocks.com/market-commentary/brinx-resources-ltd-bnxrob-well-producing-oil-and-natural-gas/</link>
		<comments>http://www.straightstocks.com/market-commentary/brinx-resources-ltd-bnxrob-well-producing-oil-and-natural-gas/#comments</comments>
		<pubDate>Fri, 17 Apr 2009 17:43:31 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Brinx Resources Ltd.;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas reserves]]></category>
		<category><![CDATA[Noble County;]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil and gas prices]]></category>
		<category><![CDATA[oil and gas sector]]></category>
		<category><![CDATA[oil-producing areas;]]></category>
		<category><![CDATA[Oklahoma]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=15112</guid>
		<description><![CDATA[Brinx Resources Ltd. (OTCBB: BNXR) is an expanding exploration company focused on developing North American oil and natural gas reserves. The company&#8217;s current focus is on the continued exploration and development of its working interests in three oil-producing areas. 
Brink Resources&#8217; land portfolio consists of the following: a 40% interest in the Three Sand Project [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/brinx-resources-ltd-bnxrob-well-producing-oil-and-natural-gas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are Corporate Profits &#8220;Depressed&#8221;? &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/are-corporate-profits-depressed-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/are-corporate-profits-depressed-analyst-blog/#comments</comments>
		<pubDate>Wed, 08 Apr 2009 18:03:28 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American International Group Inc.]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Carter Administration]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Ford Motor Co]]></category>
		<category><![CDATA[Gdp]]></category>
		<category><![CDATA[General Motors Corp]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Reagan Administration]]></category>
		<category><![CDATA[Sp 500]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/18958/Are+Corporate+Profits+%22Depressed%22%3F+-+Analyst+Blog</guid>
		<description><![CDATA[<br /><span style="font-style: italic;">Highlights include American International Group, Inc. (<a href="http://www.zacks.com/stock/quote/aig">AIG</a>), Citigroup, Inc. (<a href="http://www.zacks.com/stock/quote/c">C</a>), General Motors Corp. (<a href="http://www.zacks.com/stock/quote/gm">GM</a>) and Ford Motor Co. (<a href="http://www.zacks.com/stock/quote/f">F</a>).</span><br /><br />As we head into earnings season, it seems clear that we are in for another quarter of rough sledding. As things stand now, the total net income for the S&#38;P 500 is expected to be 27.5% lower than in the first quarter of 2008. This is after a very large increase in the expected profitability of the mega-banks for the quarter -- one that appears tied to the change in mark-to-market rules, which improves accounting profits, but does nothing to help economic profits.<br /><br />Still, this will mark a major improvement over the fourth quarter, when the total net income for the 500 firms fell by 62% excluding extraordinary items. Much of that was due to exceptionally large losses in firms like <span style="font-weight: bold;">American International Group </span>(<a href="http://www.zacks.com/stock/quote/aig">AIG</a>) and <span style="font-weight: bold;">Citigroup </span>(<a href="http://www.zacks.com/stock/quote/c">C</a>).<br /><br />Let us pray that AIG does not deliver another $61 billion dollar loss ($35 billion excluding extraordinary items). On the other hand, we could be looking at some very large losses at firms like <span style="font-weight: bold;">General Motors</span> (<a href="http://www.zacks.com/stock/quote/gm">GM</a>) and <span style="font-weight: bold;">Ford</span> (<a href="http://www.zacks.com/stock/quote/f">F</a>) this quarter.<br /><br />Those sorts of numbers however, give support to the idea that corporate profits are severely depressed and that investors need to "look across the valley." However, the data really do not support that view. It's not that current profits are abnormally low -- but they were coming off of abnormally high levels.<br /><br />The graph below looks at the government's measure of corporate profits after tax. It's not the same thing as the S&#38;P 500 earnings, but it's a pretty good proxy. Since the first quarter of 1951, corporate profits never exceeded 8% of GDP until the first quarter of 2005. Profits eventually peaked out at 10.89% in the third quarter of 2006. They were above 10% of GDP for nine straight quarters.<br /><br />Prior to the first quarter of 2004, profits had only exceeded 7% of GDP in seven quarters, almost all of them during the Carter Administration. The average over the whole period shown is 5.87% and the median is 5.80%, and that includes the abnormally high levels of a few years ago. In the fourth quarter of 2008, they fell all the way back to the "extremely depressed level" of 6.56%, which is higher than 78% of the historical quarters.<br /><br />I see no particular reason why corporate profits share of GDP is likely to go back to the extreme levels that we saw between 2004 and 2007. It seems more likely that they will fall to more historically normal levels. In short, this valley could be a very wide one, sort of like the Mississippi watershed.<br /><br />How deep a valley is still unknown, and let's hope that we do not see profits as a share of GDP fall to the levels seen during the Reagan Administration, when they averaged only 4.2% of GDP. If that were to occur, P/E ratios at current market levels would be extraordinarily high.<br /><br />"Depressed"? It all depends on your perspective and what you are comparing it too. Yes, relative to the past few years, profits are depressed, but don't mistake the last few years for being normal.<br /><br /><img src="http://www.zacks.com/images/upload_dir/1239208795bmp" alt="" /><br />
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GM">Read the full analyst report on "GM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=F">Read the full analyst report on "F"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/are-corporate-profits-depressed-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Corrections Corp Up Today &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/corrections-corp-up-today-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/corrections-corp-up-today-analyst-blog/#comments</comments>
		<pubDate>Thu, 02 Apr 2009 18:39:18 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adams County Correctional Facility;]]></category>
		<category><![CDATA[Adams County facility;]]></category>
		<category><![CDATA[Adams County;]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Bureau of Prisons;]]></category>
		<category><![CDATA[Cornell Companies Inc.]]></category>
		<category><![CDATA[Corrections Corp.;]]></category>
		<category><![CDATA[Cxw]]></category>
		<category><![CDATA[Federal Bureau of Prisons;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[The GEO Group Inc.;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/18779/Corrections+Corp+Up+Today+-+Analyst+Blog</guid>
		<description><![CDATA[<br /><span style="font-style: italic;">Highlights include Corrections Corporation of America (<a href="http://www.zacks.com/stock/quote/cxw">CXW</a>), Cornell Companies, Inc. (<a href="http://www.zacks.com/stock/quote/crn">CRN</a>) and The Geo Group, Inc. (<a href="http://www.zacks.com/stock/quote/geo">GEO</a>).</span><br /><br />Shares of <span style="font-weight: bold;">Corrections Corporation of America</span> (<a href="http://www.zacks.com/stock/quote/cxw">CXW</a>) are up 10% today after the company announced that it has been awarded a contract with the Federal Bureau of Prisons to house up to 2,567 federal inmates at one of the company's facilities.<br /><br />The contract calls for the inmates to be housed at the recently-completed Adams County Correctional Facility in Mississippi. CXW owns this facility, and completed its construction in the fourth quarter of 2008. The facility currently houses 2,232 beds, and the company has the capacity to add additional beds to meet the potential 2,567 bed demand from the Bureau of Prisons.<br /><br />The company has signed a four-year contract, which also provides for up to three two-year renewal options. The contract includes a 50% guarantee of occupancy during the activation period, and a 90% occupancy guarantee thereafter. The company expects to begin to receive inmates under the contract in the third quarter of 2009.<br /><br />We feel that this contract award provides a good example of the company's growth potential. CXW constructed the Adams County facility without a contract for the housing of inmates, in anticipation of future demand. Shares of CXW had lagged since the completion of the facility in fourth quarter of 2008, as the company was in line to incur approximately $2 million in annual carrying costs while the facility remained vacant.<br /><br />Now, however, the facility has a contract in place that appears likely to keep the facility filled to near capacity for the foreseeable future.<br /><br />Private prison operators only manage approximately 7.9% of prison populations nationwide, but we expect this percentage to continue to grow over time. CXW manages approximately 46% of all private prison and jail beds in the country, significantly more than competitors such as <span style="font-weight: bold;">Cornell Companies, Inc.</span> (<a href="http://www.zacks.com/stock/quote/crn">CRN</a>) and <span style="font-weight: bold;">The Geo Group, Inc. </span>(<a href="http://www.zacks.com/stock/quote/geo">GEO</a>).<br /><br />As the market leader, we anticipate that CXW stands to win additional business going forward, and as such, we maintain our Buy rating on the shares.
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CXW">Read the full analyst report on "CXW"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/corrections-corp-up-today-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genzyme Signs New Pact with Bayer &#8211; Zacks Tale of the Tape</title>
		<link>http://www.straightstocks.com/stock-watch/genzyme-signs-new-pact-with-bayer-zacks-tale-of-the-tape/</link>
		<comments>http://www.straightstocks.com/stock-watch/genzyme-signs-new-pact-with-bayer-zacks-tale-of-the-tape/#comments</comments>
		<pubDate>Tue, 31 Mar 2009 20:25:01 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Cambridge]]></category>
		<category><![CDATA[Campath;]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[EUR]]></category>
		<category><![CDATA[Genzyme Corp]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[Leukemia Treatment]]></category>
		<category><![CDATA[Leukine;]]></category>
		<category><![CDATA[Liver Cancer]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Nasdaq 100]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[transplantation]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/18706/Genzyme+Signs+New+Pact+with+Bayer+-+Zacks+Tale+of+the+Tape</guid>
		<description><![CDATA[<p><b></b></p>
<p><b>Genzyme Corp.</b> (<a href="void(0)">GENZ</a>) said it acquired the worldwide rights of marketing leukemia treatment Campath and two other hematological-cancer drugs from its German partner Bayer for up to $650 million in royalties. </p>
<p align="left">As part of the agreement, Genzyme will be responsible for developing Campath to treat multiple sclerosis (MS). However, Bayer will retain an option to co-promote the drug if it gets approval for MS and the right to commercialize Campath for use in organ transplantation. </p>
<p align="left">After selling the rights of Campath, and blood cancer drugs Flurdara and Leukine to Genzyme, Bayer said it will focus on kidney and liver cancer drug Nexavar. </p>
<p align="left">A Bayer spokesperson said the deal "significantly improves the profitability for two of our key franchises - oncology and MS". The company has generated about 220 million euros ($293.2 million) annually from the three drugs. </p>
<p align="left">On the other hand, the deal will generate $185 million in sales for Genzyme's oncology segment in 2009 and up to $700 million over the next three years. The Cambridge, Massachusetts-based company also expects the transaction to add to its earnings per share. </p>
<p align="left">Genzyme shares climbed more than 2% to $60.35 at noon on the NASDAQ. </p>
<p align="left"></p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZRANK&#38;t=GENZ">"GENZ" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genzyme-signs-new-pact-with-bayer-zacks-tale-of-the-tape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How to Spend $95 in Biotech &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/how-to-spend-95-in-biotech-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/how-to-spend-95-in-biotech-analyst-blog/#comments</comments>
		<pubDate>Tue, 17 Mar 2009 20:42:59 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adult stem cell product;]]></category>
		<category><![CDATA[antisense ;]]></category>
		<category><![CDATA[antisense technology;]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology investors;]]></category>
		<category><![CDATA[biotechnology stocks;]]></category>
		<category><![CDATA[Blog 
Sometime;]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chronic obstructive pulmonary disease;]]></category>
		<category><![CDATA[coronary artery disease]]></category>
		<category><![CDATA[Crohn's disease]]></category>
		<category><![CDATA[Cypress Biosciences]]></category>
		<category><![CDATA[Cystic Fibrosis]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fibromyalgia]]></category>
		<category><![CDATA[Genzyme]]></category>
		<category><![CDATA[Glaxosmithkline]]></category>
		<category><![CDATA[graft-vs-host disease;]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[Isis Pharmaceuticals;]]></category>
		<category><![CDATA[Isis;]]></category>
		<category><![CDATA[Johnson]]></category>
		<category><![CDATA[leap-forward product;]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[migraine headaches;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[monoclonal antibody technology breakthroughs;]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myocardial Infarction]]></category>
		<category><![CDATA[one drug;]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[recombinant DNA;]]></category>
		<category><![CDATA[respective product;]]></category>
		<category><![CDATA[Spinal Cord Injury]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[ulcerative colitis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/18283/How+to+Spend+%2495+in+Biotech+-+Analyst+Blog</guid>
		<description><![CDATA[<br />Sometime during the middle of the year, <span style="font-weight: bold;">Genentech</span> (<a href="http://www.zacks.com/stock/quote/dna">DNA</a>) shareholders are going to get $95 in cash for each share of Genentech stock they own. In total, nearly $47 billion in funds are expected to be returned to biotechnology investors.<br /><br />We've come up with an effective "basket approach" to re-deploy those funds back into the biotech sector -- in search of the next Genentech.<br /><br /><span style="font-weight: bold; text-decoration: underline;">Antisense Makes a Lot of Sense</span><br /><br />For a little over $13, investors can pick up one share of<span style="font-weight: bold;"> Isis Pharmaceuticals </span>(<a href="http://www.zacks.com/stock/quote/isis">ISIS</a>). Isis is the market leader in antisense technology.<br /><br />We've made it no secret in the past -- we are big fans of antisense. We view the drug discovery engine fueled by Isis' antisense technology very similar to the power of Genentech's recombinant DNA and monoclonal antibody technology breakthroughs of the 1980's. Antisense drugs are still in their infancy, but no company is better positioned to benefit from this exciting new approach to drug discovery than Isis Pharmaceuticals.<br /><br />Isis boasts over a dozen clinical stage candidates in just about every major disease class. The leading candidate, mipomersen, a cholesterol-lowering agent, is currently in phase III trials, partnered with <span style="font-weight: bold;">Genzyme</span> (<a href="http://www.zacks.com/stock/quote/genz">GENZ</a>). Mipomersen has blockbuster potential in our view given key differentiating factors that could make the drug a superior option for high risk or statin intolerant patients with high cholesterol.<br /><br />Other drugs at Isis or Isis partners include ISIS-113715 for diabetes, OGX-011 and LY2181308 for cancer, alicaforsen for Crohn's disease and ulcerative colitis, TV-1102 for multiple sclerosis, and ISIS-353512 for coronary artery disease. Besides the best pipeline in small-to-mid-cap biotech, Isis also has over $500 million in cash on hand. If there ever was a "Baby Genentech," Isis surely fits the bill.<br /><br /><span style="font-weight: bold; text-decoration: underline;">Here Come the Stem Cells</span><br /><br />Finding the next big thing is certainly something biotech investors are always in searching for. Above we discussed our enthusiasm for antisense technology as powerful drug discovery engine. Perhaps the only other discovery platform that provides as much enthusiasm as antisense is stem cells. The leading stem cell company is <span style="font-weight: bold;">Osiris Therapeutics</span> (<a href="http://www.zacks.com/stock/quote/osir">OSIR</a>).<br /><br />Osiris is developing Prochymal, an adult stem cell product currently in 3 phase III trials for steroid refractory graft-vs-host disease (GvHD), acute GvHD and Crohn's disease. Prochymal is also in a slew of earlier-stage clinical programs for diabetes, myocardial infarction, chronic obstructive pulmonary disease and acute radiation syndrome. It's a potential wonder-drug built on a the premise that viable adult mesenchymal stem cells (MSCs) can engraft and selectively differentiate, based on the tissue environment, to such lineages as muscle, bone, cartilage, marrow stroma, tendon and fat.<br /><br />Research shows that MSCs offer anti-inflammatory, anti-fibrotic and regenerative properties that make this platform an exciting disease modulator treatment engine for discovering new drugs. Investors can pick up one share of Osiris for just over $17 per share.<br /><br /><span style="font-weight: bold; text-decoration: underline;">The One-Drug Home Run</span><br /><br />Not every biotechnology company needs to have a potentially revolutionary new drug discovery platform in order to out-perform the market. In the case of <span style="font-weight: bold;">Vertex Pharmaceuticals</span> (<a href="http://www.zacks.com/stock/quote/vrtx">VRTX</a>), all you need is one drug -- one very big drug. Vertex, along with development partner <span style="font-weight: bold;">Johnson &#38; Johnson </span>(<a href="http://www.zacks.com/stock/quote/jnj">JNJ</a>), is developing telaprevir in phase III trials for hepatitis-C (HCV) infection.<br /><br />Telaprevir has shown the best data we've seen so far to combat HCV. It's a leap-forward product, and should be a blockbuster almost immediately after approval in 2011. The drug should help drive Vertex to profitability, as well as help fund the company's research efforts, which include earlier-stage candidate for HCV and cystic fibrosis. And, like the above three, Vertex is well capitalized, with over $800 million in cash on hand. One share of Vertex will cost you $28.<br /><br /><span style="font-weight: bold;">Acorda Therapeutics </span>(<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>) is developing Fampridine-SR, a potassium channel blocker that prevents nerve impulse leakage over demyelinated regions of axons. Acorda is developing the drug as a therapy to improve walking and motor function in patients with multiple sclerosis (MS) or spinal cord injury. It's an area of significant unmet medical need -- and if approved, Fampridine-SR would own the market.<br /><br />Rumors were circulating in February that <span style="font-weight: bold;">Biogen Idec</span> (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), the worldwide leader in MS, was interested in acquiring Acorda. We see several other names, including <span style="font-weight: bold;">Pfizer </span>(<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>) and <span style="font-weight: bold;">Sanofi-Aventis</span> (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>), that would also be excellent potential suitors for Acorda. But in the meantime, assuming the FDA approves Fampridine-SR in 2010, which is something we are confident in, we see Acorda reaching profitability in 2011. As a result, the stock is attractively valued at just over $24 for one share.<br /><br />With the remaining $13 left over, we recommend investors buy 2 smaller biotechnology stocks on the brink of profitability. Both <span style="font-weight: bold;">Pozen </span>(<a href="http://www.zacks.com/stock/quote/pozn">POZN</a>) and<span style="font-weight: bold;"> Cypress Biosciences</span> (<a href="http://www.zacks.com/stock/quote/cypb">CYPB</a>) each have one drug approved that is sold by a commercialization partner.<br /><br />Pozen's Treximet, a new combination NSAID+triptan migraine drug, received approval last year and is being sold by <span style="font-weight: bold;">GlaxoSmithKline </span>(<a href="http://www.zacks.com/stock/quote/gsk">GSK</a>). Cypress's Savella, a new dual-reuptake inhibitor for fibromyalgia syndrome, received approval earlier in the year and will hit the market through partner <span style="font-weight: bold;">Forest Labs</span> (<a href="http://www.zacks.com/stock/quote/frx">FRX</a>) this summer. Both products offer a significantly better treatment option for patients suffering from migraine headaches or fibromyalgia, and both should post sales around $500 million in the U.S. by 2013.<br /><br />Both companies will receive double-digit royalty on sales of their respective product, and that means that both companies will be highly profitable by 2012 as a result.<br /><br />Profitable biotech companies are hard to come by. Investors can pick up one share of Pozen for just over $5 and one share of Cypress Bio for just over $7 to round out their new basket approach to replacing Genentech as the staple biotech representative holding in their portfolio.<br />
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ISIS">Read the full analyst report on "ISIS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=OSIR">Read the full analyst report on "OSIR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VRTX">Read the full analyst report on "VRTX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACOR">Read the full analyst report on "ACOR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=POZN">Read the full analyst report on "POZN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/how-to-spend-95-in-biotech-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beacon Equity Research Featured Company: Universal Bioenergy, Inc. (UBRG.PK)</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/beacon-equity-research-featured-company-universal-bioenergy-inc-ubrgpk/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/beacon-equity-research-featured-company-universal-bioenergy-inc-ubrgpk/#comments</comments>
		<pubDate>Mon, 02 Mar 2009 20:40:20 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Beacon Equity Research Featured Company]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[distribution networks;]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Message Board]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nettleton;]]></category>
		<category><![CDATA[Universal Bioenergy Inc.;]]></category>
		<category><![CDATA[vegetable oil]]></category>
		<category><![CDATA[wholesale distributors;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=14576</guid>
		<description><![CDATA[Universal Bioenergy Inc. is a development stage company engaging in the green technologies revolution. The company has their own unique process for producing biodiesel that requires less time and energy while still producing a high-quality product. The Company has their corporate headquarters in Nettleton, Mississippi.
The company conducts their processes in their state-of-the-art processing plant. It [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/beacon-equity-research-featured-company-universal-bioenergy-inc-ubrgpk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Should You Be Eyeing Acorda? &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/should-you-be-eyeing-acorda-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/should-you-be-eyeing-acorda-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Feb 2009 21:13:12 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>
		<category><![CDATA[Zanaflex;]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/17694/Should+You+Be+Eyeing+Acorda%3F+-+Analyst+Blog</guid>
		<description><![CDATA[<br /><span style="font-style: italic;">Highlighted stocks include Acorda Therapeutics (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>), Biogen-Idec (<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), Pfizer (<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>), Sanofi-Aventis (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>) and Wyeth (<a href="http://www.zacks.com/stock/quote/wye">WYE</a>).</span><br /><br /><span style="font-weight: bold;">Acorda Therapeutics</span> (<a href="http://www.zacks.com/stock/quote/acor">ACOR</a>) released financial results for the 4th quarter 2009 on February 24, 2009. Revenues came in at $12.5 million and were comprised of $14.0 million in Zanaflex product sales, $1.5 million in discounts and product return allowances.<br /><br />Management reported that Zanaflex was cash-flow positive in 2008, and will remain cash-flow positive again in 2009. Net Zanaflex sales of $12.5 million were dead-on with our forecast. Net loss of the quarter totaled $20.2 million, or $0.54 per share.<br /><br />For the full year 2008, Acorda reported total revenues of approximately $47.8 million and a net loss of $74.3 million. Acorda exited the quarter with $246 million in cash and investments -- enough cash in management's view to fund operations through year-end 2010.<br /><br />On January 30, 2009, Acorda Therapeutics filed the new drug application (NDA) for Fampridine-SR. The filing contains data from a comprehensive development program assessing the safety and efficacy of Fampridine-SR, including two phase III trials that involved 540 people with MS and were conducted under Special Protocol Assessments (SPAs) from the FDA.<br /><br />The safety and efficacy profile of Fampridine-SR was consistent across phase II and phase III trials. In total, the NDA filing included more that 50 clinical studies and over 1,200 patient years. Additionally, more than 450 people are currently enrolled in Fampridine-SR extension trials, with treatment duration ranging from seven months to almost 5 years.<br /><br />In our view, the application looks strong. The FDA should accept the filing in March and establish a PDUFA [Prescription Drug User Fee Act] action date in early December 2009. Meeting the actual date may prove to be a challenge given the backlog at the FDA, but we expect that Acorda will be in position to launch Fampridine-SR in early 2010.<br /><br />Approval could be a transformational event for Acorda. The company has spent the last several years preparing for the launch with "gateway" product Zanaflex. Acorda has $500 million or more peak sales potential in the U.S. Additional upside will come from potential EU/RoW partnerships for the drug.<br /><br />The positive fundamentals with the potential for approval of a $500 million product later in the year certainly makes Acorda an attractive acquisition target. Our money would be on one of the following firms: <span style="font-weight: bold;">Biogen-Idec </span>(<a href="http://www.zacks.com/stock/quote/biib">BIIB</a>), <span style="font-weight: bold;">Pfizer</span> (<a href="http://www.zacks.com/stock/quote/pfe">PFE</a>) or <span style="font-weight: bold;">Sanofi-Aventis</span> (<a href="http://www.zacks.com/stock/quote/sny">SNY</a>).<br /><br />Pfizer may be the most unlikely considering its recent attraction to <span style="font-weight: bold;">Wyeth</span> (<a href="http://www.zacks.com/stock/quote/wye">WYE</a>). Sanofi and Biogen both make excellent sense. Either firm could easily pay north of $30 per share. On a stand-alone basis, we see $28 as fair-value.<br /><br />  
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACOR">Read the full analyst report on "ACOR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BIIB">Read the full analyst report on "BIIB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=">Read the full analyst report on ""</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/should-you-be-eyeing-acorda-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sanderson Farms Stays Plucky &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/sanderson-farms-stays-plucky-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/sanderson-farms-stays-plucky-analyst-blog/#comments</comments>
		<pubDate>Mon, 09 Feb 2009 16:16:16 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[chicken products]]></category>
		<category><![CDATA[end-products]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Poultry Processing]]></category>
		<category><![CDATA[Safm]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Waco]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/17293/Sanderson+Farms+Stays+Plucky+-+Analyst+Blog</guid>
		<description><![CDATA[<br /><span style="bold;">Sanderson Farms </span>(<a href="http://www.zacks.com/stock/quote/safm">SAFM</a>) is the 4th largest poultry processing company in the U.S. The improved efficiencies at the company's poultry complexes in Georgia and Mississippi, along with the new facility in Waco, Texas, should improve unit operating costs and increase production levels in fiscal 2009.<br /><br />However, grain costs increased substantially in fiscal 2008 resulting in a loss. Even though grain prices have declined, the Hold rating is maintained.<br /><br />Due to the company's volatile earnings and losses reported in fiscal 2006 and 2008, the stock is best valued on a price-to-sales basis. During the last five years, the stock has traded in the range of 0.26 to 0.94 times sales.<br /><br />There is considerable commodity risk involved with the production of chicken products, both on the pricing of end-products and the costs of feed, processing, and storage. With stock currently trading at 0.44 times sales, the target is a 0.47 price-to-sales ratio or $38.75 per share.<br /><br /><a href="http://www.zacks.com/ZER/zer_comp_reports.php?f_ticker=safm">Read the full analyst report on SAFM</a><br /><br /><br />    
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=YAHOO_content_ZRANK&#38;t=SAFM">"SAFM" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/sanderson-farms-stays-plucky-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wall Street’s Bonus System  Was a Major Financial Crisis Catalyst</title>
		<link>http://www.straightstocks.com/market-commentary/wall-street%e2%80%99s-bonus-system-was-a-major-financial-crisis-catalyst/</link>
		<comments>http://www.straightstocks.com/market-commentary/wall-street%e2%80%99s-bonus-system-was-a-major-financial-crisis-catalyst/#comments</comments>
		<pubDate>Thu, 05 Feb 2009 06:30:04 +0000</pubDate>
		<dc:creator>Shah Gilani</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[American International Group Inc.]]></category>
		<category><![CDATA[Are Wall Street;]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Banking]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Chuck Prince]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Claire McCaskill;]]></category>
		<category><![CDATA[David A. Viniar;]]></category>
		<category><![CDATA[E. Stanley "Stan" O'Neal]]></category>
		<category><![CDATA[Federal Government]]></category>
		<category><![CDATA[Gary D. Cohn;]]></category>
		<category><![CDATA[Goldman Sachs Group Inc]]></category>
		<category><![CDATA[government insurance;]]></category>
		<category><![CDATA[Gross Domestic Product]]></category>
		<category><![CDATA[Insurance Giant]]></category>
		<category><![CDATA[Jon Winkelried;]]></category>
		<category><![CDATA[Lloyd C. Blankfein]]></category>
		<category><![CDATA[Martin Sullivan;]]></category>
		<category><![CDATA[Merrill Lynch]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[New York State Comptroller's office;]]></category>
		<category><![CDATA[Pay Act;]]></category>
		<category><![CDATA[R. Shah Gilani]]></category>
		<category><![CDATA[U.S. Treasury Department]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://www.moneymorning.com/?p=4724</guid>
		<description><![CDATA[By Shah Gilani
    Contributing Editor
Money Morning/The Money Map Report
In a report released last week, New York State Comptroller  Thomas P. DiNapoli estimated that the securities industry granted...

Money Morning is here to help investors profit h...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/wall-street%e2%80%99s-bonus-system-was-a-major-financial-crisis-catalyst/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genesis Energy, L. P. &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/genesis-energy-l-p-value-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/genesis-energy-l-p-value-zacks-rank-buy/#comments</comments>
		<pubDate>Thu, 05 Feb 2009 00:00:00 +0000</pubDate>
		<dc:creator>Tracey Ryniec</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Products]]></category>
		<category><![CDATA[energy transporter;]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Genesis Energy L. P.;]]></category>
		<category><![CDATA[Industrial Gases Division;]]></category>
		<category><![CDATA[integrated oil]]></category>
		<category><![CDATA[Large Portion]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[oil producers]]></category>
		<category><![CDATA[Pipeline Transportation Division;]]></category>
		<category><![CDATA[Refinery Services Division;]]></category>
		<category><![CDATA[sour gas;]]></category>
		<category><![CDATA[Supply and Logistics Division;]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>
		<category><![CDATA[Zacks Rank Buy Genesis Energy L. P.;]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/9947/Genesis+Energy%2C+L.+P.+-+Value+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Genesis Energy, L. P.</b> (<a href="http://www.zacks.com/stock/quote/GEL" alt="GEL")">GEL</a>) just announced its 14th consecutive quarterly dividend increase as the energy transporter continues to see increased profits. The stock is cheap. GEL trades at only 7x forward earnings and has a current dividend yield of 11.80%.<p ALIGN="left">

<b>Company Description</b></p><p ALIGN="left">

Genesis Energy operates as an energy master limited partnership ("MLP") which transports energy and refines products throughout Texas, Louisiana, Arkansas, Mississippi, Alabama and Florida.  Its customers include the integrated oil companies as well as independent oil producers.</p><p ALIGN="left">

<table align="right"><tr><td>< ?DART(15);?></td></tr></table>

The company has 4 business segments: </p><p ALIGN="left">

<ol>
<li>Pipeline Transportation Division which transports crude oil, carbon dioxide and natural gas
</li><li>Refinery Services Division which processes sour gas streams to remove sulfur
</li><li>Supply and Logistics Division which transports, stores and supplies energy products to customers 
</li><li>Industrial Gases Division which produces and supplies industrial gases like carbon dioxide and syngas.
</li></ol></p><p ALIGN="left">

<b>14th Consecutive Quarterly Dividend Increase</b></p><p ALIGN="left">

As a MLP, Genesis Energy distributes a large portion of its income to unit holders. On Jan 8, the company announced a distribution payment for the quarter ended Dec 31, 2008 which rose 16% over the fourth quarter 2007. The 33 cents per common unit distribution is payable on Feb 13 for unitholders of record as of Feb 3. </p><p ALIGN="left">

<b>Surprised on Third-Quarter Estimates by 19.05%</b></p><p ALIGN="left">

On Nov 6, Genesis Energy reported third-quarter 2008 earnings that beat analysts' estimates by 4 cents a share. </p><p ALIGN="left">

Net income jumped 535.29% to $10.8 million, or 25 cents per unit, from $1.7 million, or 7 cents, in the prior year. Analysts expected 21 cents. Third quarter 2007 only saw the impact of the Davison businesses for 2 months of that quarter.</p><p ALIGN="left">

The company saw no lasting effects from the 2 Gulf hurricanes during the quarter.</p><p ALIGN="left">

<b>Solid Cash Position</b></p><p ALIGN="left">

Even with its large distributions, Genesis still has a strong cash position. At the end of the third quarter, the company had $170 million in cash and debt commitments.</p><p ALIGN="left">

<b>Consensus Estimates Rise for 2008</b></p><p ALIGN="left">

Given the company's recent solid track record, covering analysts are fairly optimistic about the fourth-quarter 2008 and full-year 2008. Fourth-quarter estimates are up a penny in the last 30 days to 23 cents. 2008 consensus estimates rose 2 cents to 69 cents in the last 90 days.</p><p ALIGN="left">

For 2009, analysts are projecting 51.44% year-over-year earnings growth, with consensus estimates of $1.05 per unit.</p><p ALIGN="left">

Analysts are also bullish on long term growth, forecasting 20% earnings growth over the next 5 years. </p><p ALIGN="left">

GEL is scheduled to report fourth-quarter and full-year earnings on Feb 25.</p><p ALIGN="left">

<b>Value Fundamentals</b></p><p ALIGN="left">

Genesis Energy is a Zacks #1 Rank (strong buy) stock. It has surprised on estimates 3 out of the last 4 quarters. </p><p ALIGN="left">

GEL is trading at only 7.4x forward earnings. It has a price-to-book of 0.71. Its PEG ratio is only 0.60. As an MLP, Genesis pays a quarterly distribution with a current spectacular yield of 11.80%.</p><p ALIGN="left">


<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=YAHOO_content_ZRANK&#038;t=GEL">"GEL" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com" alt="Investment Research">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genesis-energy-l-p-value-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biogen-Idec (NASDAQ:BIIB): Upgraded to Buy at Goldman Sachs</title>
		<link>http://www.straightstocks.com/market-commentary/biogen-idec-nasdaqbiib-upgraded-to-buy-at-goldman-sachs/</link>
		<comments>http://www.straightstocks.com/market-commentary/biogen-idec-nasdaqbiib-upgraded-to-buy-at-goldman-sachs/#comments</comments>
		<pubDate>Tue, 27 Jan 2009 13:03:00 +0000</pubDate>
		<dc:creator>Notable Calls</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CDP323;]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[hemophilia B;]]></category>
		<category><![CDATA[HSP90;]]></category>
		<category><![CDATA[lupus nephritis;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Parkinson's disease]]></category>
		<category><![CDATA[Rituxan;]]></category>
		<category><![CDATA[Tysabri]]></category>
		<category><![CDATA[Upgraded]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-29297569.post-596078283012220893</guid>
		<description><![CDATA[div style="text-align: justify;"Goldman Sachs is upgrading span style="font-weight: bold;"Biogen-Idec (NASDAQ:BIIB)/span to Buy from Neutral and adding the stock to their Conviction Buy list with a $61 tgt (up from $57).br /br /According to the firm this is based on potential upside revision to earnings and attractive valuation. They believe the threat of generics and competition should be manageable, leading to their 2009/2010 EPS (incl. ESO) of $4.14 amp; $4.55 vs. consensus of $3.97 and $4.23, resp. BIIB’s pipeline is underestimated and should gain visibility in 2009/2010. The product profile and manufacturing capacity might be attractive for potential pharma acquirers. The intrinsic value of $46 implies a pipeline value of $3 which the firm views as attractive.br /br /span style="font-weight: bold;"Catalyst/spanbr /span style="font-weight: bold;"/spanbr /1) Safety data from over 10,000 patients on Tysabri therapy by yearend.br /br /2) In 2009, MLCO expects Phase 3 data on Rituxan in lupus nephritis (1Q, $1bn potential), Phase 2 data on CDP323 for multiple sclerosis (MS), BIIB14 for Parkinson’s disease, and HSP90 inhibitor for cancer, as well as Phase 1/2 results on long acting Avonex for MS and long acting Factor IX for hemophilia B. Combined potential of the Phase 1amp;2 programs exceeds $3 bn.br /br /3) Detailed data on two competing agents in MS in 4/09.br /br /span style="color: rgb(255, 0, 0);"Notablecalls:/span Could do 3-4% to the upside.br //div]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/biogen-idec-nasdaqbiib-upgraded-to-buy-at-goldman-sachs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MARKET COMMENT January 20, 2009 That wasn&#8217;t the type of greeting Obama was expecting from markets I suppose.</title>
		<link>http://www.straightstocks.com/investing-in-exchange-traded-funds/market-comment-january-20-2009-that-wasn8217t-the-type-of-greeting-obama-was-expecting-from-markets-i-suppose/</link>
		<comments>http://www.straightstocks.com/investing-in-exchange-traded-funds/market-comment-january-20-2009-that-wasn8217t-the-type-of-greeting-obama-was-expecting-from-markets-i-suppose/#comments</comments>
		<pubDate>Tue, 20 Jan 2009 23:10:19 +0000</pubDate>
		<dc:creator>David Fry</dc:creator>
				<category><![CDATA[Exchange Traded Funds]]></category>
		<category><![CDATA[Alcoa]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[Conoco]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[Economic Times]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Ibm]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[State Street]]></category>
		<category><![CDATA[Yahoo]]></category>

		<guid isPermaLink="false">http://etfdigest.com/daveDaily.php?id=734</guid>
		<description><![CDATA[ MARKET COMMENT January 20, 2009 That wasn#8217;t the type of greeting Obama was expecting from markets I suppose. (I think markets behaved similarly the day after the election.) Maybe it#8217;s just that most investors were hanging out at the Mall in DC or watching TV. This is one ugly market featuring disappointments atop disappointments.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-exchange-traded-funds/market-comment-january-20-2009-that-wasn8217t-the-type-of-greeting-obama-was-expecting-from-markets-i-suppose/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comstock Buy Rating Maintained &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/comstock-buy-rating-maintained-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/comstock-buy-rating-maintained-analyst-blog/#comments</comments>
		<pubDate>Mon, 08 Dec 2008 11:52:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Blog 
Texas;]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Cotton Valley]]></category>
		<category><![CDATA[gulf of mexico]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[North Louisiana;]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[oil and gas properties]]></category>
		<category><![CDATA[pure-play onshore natural gas producer]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/16268/Comstock+Buy+Rating+Maintained+-+Analyst+Blog</guid>
		<description><![CDATA[<br />Texas-based <span style="bold;">Comstock Resources, Inc.</span> (<a href="http://www.zacks.com/stock/quote/crk">CRK</a>) is an independent oil and gas exploration and production company engaged in the acquisition, exploration, and development of oil and gas properties. The company's operations are concentrated primarily in four regions in the U.S.: the Gulf of Mexico, East Texas/North Louisiana, Mississippi and South Texas.<br /><br />We are maintaining our Buy recommendation on Comstock shares, given the company's growing volumes (for the first nine months of 2008, volumes were up 36%), attractive valuation, and relatively lower risk profile. Additionally, the Bois d'Arc sale to Stone Energy has streamlined Comstock's operations and positioned it to function as a pure-play onshore natural gas producer. <br /><br />The Haynesville Shale play offers significant long-term reserve-add potential going forward. Comstock's drilling success in the Cotton Valley formation is another catalyst for future production growth.<br /><br /><a href="http://www.zacks.com/ZER/zer_comp_reports.php?f_ticker=crk">Read the full analyst report on CRK</a>.<br /><br /><br />
<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=YAHOO_content_ZRANK&#38;t=CRK">"CRK" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/comstock-buy-rating-maintained-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stocks Which Benefit from Low Oil Prices Part 2: Utilities</title>
		<link>http://www.straightstocks.com/current-market-news/stocks-which-benefit-from-low-oil-prices-part-2-utilities/</link>
		<comments>http://www.straightstocks.com/current-market-news/stocks-which-benefit-from-low-oil-prices-part-2-utilities/#comments</comments>
		<pubDate>Sun, 07 Dec 2008 05:18:00 +0000</pubDate>
		<dc:creator>Fred Fuld</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alliant Energy Corp.]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Arkansas]]></category>
		<category><![CDATA[Cleco Corp.]]></category>
		<category><![CDATA[electric energy coming]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy coming]]></category>
		<category><![CDATA[Entergy Corp.]]></category>
		<category><![CDATA[HTML]]></category>
		<category><![CDATA[http]]></category>
		<category><![CDATA[Iowa]]></category>
		<category><![CDATA[Kansas]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas tanking;]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[OGE Energy Corp.]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[Pinnacle West Capital Corp.]]></category>
		<category><![CDATA[Prince Edward Island]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Westar Energy Inc.]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-23020893.post-953157171877037793</guid>
		<description><![CDATA[a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_T9VXVyuEITg/STtlkEBkX0I/AAAAAAAAAmM/1FYndgjniZU/s1600-h/oilderrick.jpg"img style="float:right; margin:0 0 10px 10px;cursor:pointer; cursor:hand;width: 213px; height: 320px;" src="http://2.bp.blogspot.com/_T9VXVyuEITg/STtlkEBkX0I/AAAAAAAAAmM/1FYndgjniZU/s320/oilderrick.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5276923058624683842" //abr /Oil may break through $40 a barrel, since it is skirting very close to that price and has traded as low as $40.81. Recently, I wrote about the trucking and package delivery a href="http://stockerblog.blogspot.com/2008/12/stocks-which-benefit-from-low-oil.html"stocks which could benefit from lower gasoline prices/a.br /br /With the price of oil and natural gas tanking, investors are now looking closely at the utility stocks that use oil and gas as a major fuel source of their electrical generation. Hopefully, the cost savings for these companies will pass through to the bottom line long before the Utilities Commissions implement rate reductions. br /br /Pinnacle West Capital Corp. (PNW) has one of the heaviest exposures, with 24% of their electric energy coming from oil and natural gas. About 35% comes from coal and 21.5% from nuclear. This Phoenix, Arizona based company has a PE of 11, a PEG of 2.62 and a yield of 7.2%.br /br /Westar Energy Inc. (WR) generates about 34% of its energy from natural gas, with 56% from coal and 9% from nuclear. This utility which serves Kansas has a PE of 12, a PEG of 3.11 and a yield of 6.2%.br /br /Entergy Corp. (ETR) has about 18% of its fuel sources coming from oil and natural gas. 12% is from coal and 33% from nuclear, with the rest purchased. Entergy serves Arkansas, Mississippi, Texas, and Louisiana, including the City of New Orleans, where it is based. The stock has a PE of 13, a PEG of 1.17 and a yield of 3.7%.br /br /OGE Energy Corp. (OGE) has 29% of its energy coming from natural gas, with 51% from coal. They serve the south central United States. The stock has a PE of 9, a PEG of 2.32 and a yield of 6%.br /br /Alliant Energy Corp. (LNT) has 28% of its electricity generated from natural gas and 6% from oil. The company serves Iowa and southern Minnesota. The stock has a PE of 8, a PEG of 1.78 and a yield of 4.9%.br /br /Cleco Corp. (CNL), another Louisiana based company, with 14% exposure to natural gas. The stock has a PE of 13, a PEG of 0.99 and a yield of 4.2%.br /br /If you like utility stocks, you should take a look at a href=" http://stockerblog.blogspot.com/2008/07/highest-yielding-electric-utilities-for.html"Highest Yielding Electric Utilities/a and a href=" http://stockerblog.blogspot.com/2008/07/highest-yielding-natural-gas-utilities.html"Highest Yielding Natural Gas Utilities/a. You can also find an Excel database of utility stocks, which you can download, add to and sort, at a href="http://WallStreetNewsNetwork.com"WallStreetNewsNetwork.com/abr /br /emAuthor does not own any of the above./embr /br /By Fred Fuld at a href="http://Stockerblog.com"Stockerblog.com/adiv class="blogger-post-footer"div class='adsense' style='text-align:center; padding: 0px 3px 0.5em 3px;'
script type="text/javascript"!--
google_ad_client="ca-pub-2427831169011625";
google_ad_width=300;
google_ad_height=250;
google_ad_format="300x250_as";
google_ad_type="text";
google_ad_channel ="8681602088";
google_color_border="FFF3DB";
google_color_bg="FFF3DB";
google_color_link="1B0431";
google_color_url="1B0431";
google_color_text="29303B";
//--/script
script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js"
/script
/div]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/stocks-which-benefit-from-low-oil-prices-part-2-utilities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Anatomy of a panic? The collapse of Morgan Stanley</title>
		<link>http://www.straightstocks.com/gold-markets/anatomy-of-a-panic-the-collapse-of-morgan-stanley/</link>
		<comments>http://www.straightstocks.com/gold-markets/anatomy-of-a-panic-the-collapse-of-morgan-stanley/#comments</comments>
		<pubDate>Mon, 01 Dec 2008 22:48:17 +0000</pubDate>
		<dc:creator>Alex Stanczyk</dc:creator>
				<category><![CDATA[Gold Markets]]></category>
		<category><![CDATA[Alex Stanczyk]]></category>
		<category><![CDATA[American International Group Inc.]]></category>
		<category><![CDATA[Andrew Cuomo]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[big insurer;]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Credit Suisse]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[John Mack]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[Julian Robertson Jr.;]]></category>
		<category><![CDATA[Kynikos Associates]]></category>
		<category><![CDATA[Lehman]]></category>
		<category><![CDATA[Merrill Lynch]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[rival banks;]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Short Seller]]></category>
		<category><![CDATA[Ubs Ag]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>

		<guid isPermaLink="false">http://www.rapidtrends.com/blog/2008/12/01/anatomy-of-a-panic-the-collapse-of-morgan-stanley/</guid>
		<description><![CDATA[Anatomy of a panic? The collapse of Morgan Stanley
http://ftalphaville.ft.com/blog/2008/11/25/18667/anatomy-of-a-panic-the-collapse-of-morgan-stanley/
Anatomy of a panic? The collapse of Morgan Stanley
From the WSJ:
It turns out that some of the biggest names on Wall Street — Merrill Lynch &#38; Co., Citigroup Inc., Deutsche Bank and UBS AG — were placing large bets against Morgan Stanley, the records indicate. They did [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/gold-markets/anatomy-of-a-panic-the-collapse-of-morgan-stanley/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Raven Biofuels International Corp. (RVBF.OB) Signs Agreement with Larson Engineering</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/raven-biofuels-international-corp-rvbfob-signs-agreement-with-larson-engineering/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/raven-biofuels-international-corp-rvbfob-signs-agreement-with-larson-engineering/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 13:40:29 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[cellulosic ethanol biorefinery technology;]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[John Sams;]]></category>
		<category><![CDATA[Larson Engineering;]]></category>
		<category><![CDATA[local utilities]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[oil and gas industry]]></category>
		<category><![CDATA[Raven Biofuels International Corp.;]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=13922</guid>
		<description><![CDATA[Raven Biofuels International Corporation (RVBF.OB), a developing global renewable energy company focused on producing ethanol from waste or biomass (cellulosic ethanol), recently announced that the company has entered into an agreement with Larson Engineering to begin engineering for Raven&#8217;s proposed Mississippi biorefinery. The planned 33 million gallon per year biorefinery offers regional benefits, including lower [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/raven-biofuels-international-corp-rvbfob-signs-agreement-with-larson-engineering/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mississippi Stocks</title>
		<link>http://www.straightstocks.com/current-market-news/mississippi-stocks/</link>
		<comments>http://www.straightstocks.com/current-market-news/mississippi-stocks/#comments</comments>
		<pubDate>Tue, 18 Nov 2008 23:26:00 +0000</pubDate>
		<dc:creator>Fred Fuld</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[BacorpSouth Inc.;]]></category>
		<category><![CDATA[Banking]]></category>
		<category><![CDATA[Banking Services]]></category>
		<category><![CDATA[Cal-Maine Foods Inc.;]]></category>
		<category><![CDATA[Callon Petroleum Company;]]></category>
		<category><![CDATA[chemical products]]></category>
		<category><![CDATA[EastGroup Properties Inc.;]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[grain products;]]></category>
		<category><![CDATA[Hancock Holding Company;]]></category>
		<category><![CDATA[important agricultural products;]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Kentucky]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[oil reserves]]></category>
		<category><![CDATA[Parkway Properties Inc.;]]></category>
		<category><![CDATA[Peoples Financial Corporation;]]></category>
		<category><![CDATA[Poultry Processing]]></category>
		<category><![CDATA[Prince Edward Island]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Renasant Corporation;]]></category>
		<category><![CDATA[retail and commercial businesses;]]></category>
		<category><![CDATA[Sanderson Farms Inc]]></category>
		<category><![CDATA[state product;]]></category>
		<category><![CDATA[Trustmark Corporation;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wisconsin]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-23020893.post-7307138018777858962</guid>
		<description><![CDATA[<a href="http://1.bp.blogspot.com/_T9VXVyuEITg/SSNP2lgtDEI/AAAAAAAAAlk/p61jqzCxfLI/s1600-h/Mississippi.jpg"><img style="210px;" src="http://1.bp.blogspot.com/_T9VXVyuEITg/SSNP2lgtDEI/AAAAAAAAAlk/p61jqzCxfLI/s320/Mississippi.jpg" border="0" /></a><br />Until 1990, gambling in Mississippi was not permitted. Now it is a major source of revenue for the state and an attractive tourist attraction. Following are some interesting facts about Mississippi:<br />1. 25% of total employment is generated by the agriculture industry.<br />2. Mississippi most important agricultural products are poultry and eggs, forestry, soybeans and corn.<br />3. The state offers different business incentives to new businesses and businesses relocating to Mississippi. They include tax credits, and tax exemptions.<br />4. The top manufactured products are processed foods, beverages, dairy and grain products.<br />5. Between 2004 and 2005 Mississippi’s export increased by 26% to achieve a record $4 billion.<br />6. Mississippi’s top export are chemical products.<br />7. Manufacturing firms employ 172,000 workers in the state.<br />8. Mississippi’s oil reserves rank it number 13 out of 50 states, with 167 million barrels of oil.<br />9. Mississippi has the lowest cost of living of all states.<br />10. In 2006 the total state product was $84 billion.<br /><br />The following companies are headquartered in Mississippi:<br /><br />BacorpSouth, Inc. (BX) is a financial institution, providing services to individuals and businesses in several states. The stock has a market cap of $2.11 billion, a PE of 15, a PEG of 1.93, and it pays a yield of 3.6%.<br /><br />Hancock Holding Company (HBHC) is a financial institution. It services include banking, and lending. The stock has a market cap of $1.49 billion, a PE of 20, a PEG of 1.78, and it pays a yield of 2.1%.<br /><br />Trustmark Corporation (TRMK) is a financial company. Its services include banking and financial services for individuals, institutions and corporations. The stock has a market cap of $1.19 billion, a PE of 12, a PEG of 1.33, and it pays a yield of 4.4%.<br /><br />EastGroup Properties, Inc. (EGP) is a real estate company. It purchases and develops properties throughout the United States. The stock has a market cap of $905.92 million, a PE of 27, a PEG of 1.17 and it pays a yield of 5.9%.<br /><br />Sanderson Farms, Inc. (SAFM) is a poultry processing company. The stock has a market cap of $672.82 million, a PE of 21, a PEG of 9.13, and it pays a yield of 1.6%.<br /><br />Cal-Maine Foods, Inc. (CALM) is in the business of producing and packaging shell eggs. The stock has a market cap of $668.23 million, a PE of 5, and it pays a yield of 2.5%.<br /><br />Renasant Corporation (RNST) is a financial and insurance company. Its clients are retail and commercial businesses. The stock has a market cap of $416.98 million, a PE of 13, a PEG of 1.56, and it pays a yield of 3.4%.<br /><br />Parkway Properties, Inc. (PKY) is a real estate company, it purchases, manages and rents office space. The stock has a market cap of $312.90 million, a PEG of 1.25, and it pays a yield of 12.4%.<br /><br />Callon Petroleum Company (CPE) is an oil and gas exploration company. The stock has a market cap of $237.19 million, a PE of 12, and a PEG of 0.77.<br /><br />Peoples Financial Corporation (PFBX) is a financial institution providing banking services in the United States. The stock has a market cap of $103.78 million, a PE of 17, and it pays a yield of 2.8%.<br /> <br />Don't forget to check out the stocks from the states of <a href="http://stockerblog.blogspot.com/2008/10/wisconsin-stocks.html">Wisconsin</a>, <a href="http://stockerblog.blogspot.com/2008/10/louisiana-stocks.html">Louisiana</a>, <a href="http://stockerblog.blogspot.com/2008/10/michigan-stocks.html">Michigan</a>, and <a href="http://stockerblog.blogspot.com/2008/10/kentucky-stocks.html">Kentucky</a>. <br /><br /><i>Author does not own any of the above.</i><br /><br />By <a href="http://Stockerblog.com">Stockerblog.com</a><div class="blogger-post-footer"><div class='adsense' style='0px 3px 0.5em 3px;'>



</div></div>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/mississippi-stocks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>N-Viro International Corp. (NVIC.OB) Reports 56% Rise in Third Quarter Revenue </title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/n-viro-international-corp-nvicob-reports-56-rise-in-third-quarter-revenue%e2%80%a8/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/n-viro-international-corp-nvicob-reports-56-rise-in-third-quarter-revenue%e2%80%a8/#comments</comments>
		<pubDate>Tue, 18 Nov 2008 20:06:27 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Daytona Beach;]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Michigan State University]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[N-Viro International Corp.;]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Ohio facility;]]></category>
		<category><![CDATA[Timothy R. Kasmuch;]]></category>
		<category><![CDATA[Tohopekaliga Water Authority;]]></category>
		<category><![CDATA[Toledo]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=13892</guid>
		<description><![CDATA[N-Viro International Corp., which handles biodegradable materials and waste and converts it to biofuel, showed a financially stronger company overall in its third quarter report. Revenues and gross profits are up and operating expenses are down for the company that has facilities in 10 states east of the Mississippi and another in Louisiana. 
Gross profits [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/n-viro-international-corp-nvicob-reports-56-rise-in-third-quarter-revenue%e2%80%a8/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Poll: Are Hedge Funds Doomed or Positioned for Re-Growth</title>
		<link>http://www.straightstocks.com/investing-in-hedge-funds/poll-are-hedge-funds-doomed-or-positioned-for-re-growth/</link>
		<comments>http://www.straightstocks.com/investing-in-hedge-funds/poll-are-hedge-funds-doomed-or-positioned-for-re-growth/#comments</comments>
		<pubDate>Tue, 04 Nov 2008 04:26:28 +0000</pubDate>
		<dc:creator>Richard C. Wilson</dc:creator>
				<category><![CDATA[Hedge Funds]]></category>
		<category><![CDATA[Asx 200]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[corrupted banking world;]]></category>
		<category><![CDATA[Enron]]></category>
		<category><![CDATA[Fannie Mae]]></category>
		<category><![CDATA[Freddie Mac]]></category>
		<category><![CDATA[Hedge Fund]]></category>
		<category><![CDATA[HF domicile;]]></category>
		<category><![CDATA[Investment Services]]></category>
		<category><![CDATA[investments services;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MSCI World]]></category>
		<category><![CDATA[retail banks]]></category>
		<category><![CDATA[Tyco]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-125009547106294711.post-3226862938790302233</guid>
		<description><![CDATA[<h1><b>Poll: Hedge Funds Doomed?<br /></b></h1><h2><b><span style="rgb(102, 0, 0);">Poll: Is the Hedge Fund Industry Doomed?</span></b></h2><br /><a href="http://1.bp.blogspot.com/_wM_OZdOMR_Y/SQ_NZo7VPCI/AAAAAAAACeo/RKaO9snNsCQ/s1600-h/Hedge-Fund-Globe.jpg"><img style="200px;" src="http://1.bp.blogspot.com/_wM_OZdOMR_Y/SQ_NZo7VPCI/AAAAAAAACeo/RKaO9snNsCQ/s200/Hedge-Fund-Globe.jpg" alt="" border="0" /></a>I recently began a poll within a Linkedin.com discussion group on the hedge fund industry and whether it was doomed or will be well positioned for great growth after this crisis passes. Below are the numerous comments from investment professionals on this topic - please feel free to add yours below within the comments sections:<br />___________<br /><br />Hedge funds are the new Investment Banks. Say goodbye to 2 and 20, but I for one believe that they are positioned to evade the coming regulatory maelstrom and over the next four years will outperform the market. Thats just my two cents though.<br />________<br /><br />Falling markets and tighter regs will show if there is actually any alpha at all.<br />If there is then hedge funds will surely recover. If there isn't then they don't really deserve to...<br /><br />__________<br /><br />Ditto!<br />The ones who deliver <a title="alpha" href="http://richard-wilson.blogspot.com/2008/01/alpha.html">alpha</a>, will stay, the others...will crash and burn. No one will cry<br /><br />___________<br /><br />If ever there was a case for hedge funds the current market highlights it<br /><br />___________<br /><br />Firstly, in complex markets, short sellers are akin to investigative journalists, looking for the scoop of finding an overvalued company or industry. Also like journalists, short sellers aren't always popular with corporate management or regulators.<br /><br />Hedge funds managed to operate profitably outside the morass of mortgage-based securities. They are lightly regulated, in contrast with traditional investment and retail banks. This means that the least regulated financial institutions were the ones that identified problems in the most regulated parts of the industry.<br /><br />Forensic accounting experts at hedge funds have performed the hat trick of being the first to signal, through short selling, troubles at Tyco, Enron and now Fannie Mae, Freddie Mac and banks.<br /><br />Hedge funds and their short sellers deserve thanks for delivering information to markets. But alas, it's human nature instead to blame the messengers of bad news, especially when the news turns out to be true.<br /><br />With my Australian focus I can add that while there will no doubt be an industry shake out in Australia similar to that which is happening around the globe, the good news for managers left standing is that there is a strong appetite for alternative investments. <a title="Institutional Investors Hedge Fund Due Diligence" href="http://richard-wilson.blogspot.com/2008/02/institutional-investors-hedge-fund-due.html">Institutional Investors</a> and their advisors are looking for quality alternative investments.<br /><br />In these fear ridden times it is worth looking at the relative performances of hedge funds versus market indices. The HLA Aus Long Short Index was down 5.77% in Sep, which was pretty steep but compares well relative to other indices - HFN Long Short Equity Index (-6.57%), the ASX 200 Accumulation Index (-9.85%) and the MSCI World Index (-11.89%). The longer term performance numbers are very compelling for hedge funds and because they have not lost anywhere as much as long only investors are in a much better position to benefit from any future correction.<br /><br />Therefore I believe that there is a strong case for hedge funds, perhaps a smaller universe in quantity and an increase in quality.<br /><br />____________<br /><br />Well i believe this is the perfect market for hedge fund area....There is tremendous opportunity in market to invest and sleep .By the time you wake up i.e. 2009 end or 2010 you have not even outperformed the market but you have given the new edge to this area.<br />Opportunity in a way you really need an eye for it...look for DIstressed securities, merger arbitrage wave is already there , natural resource is already oversold look for it...big speculation in FX Exchange market...<br />So in short, this is the time to get your investor confidence and act rather than sit.<br />Just my view..<br /><br />__________<br /><br />Hi, All. You are right, this should be perfect conditions for HF to perform. Did they perform? Not all of them, at least the good one will survive.<br /><br />My questions then is about HF domicile. In the current market conditions and looking at the impact of this crisis on the real economy. What will be the reaction of politicians around the world? They are convinced that this is the right time to kill offshore places. Politicians are under pressure to find money for their budget. It could be good to see all that money sitting in offshores places coming back home??<br /><br />What are the domicile of most the HF? offshore places! Will it possible for all of them to find more regulated environment if need be?<br /><br />___________<br />In the past year , it would appear that some of the hedge fund managers seem to have forgotten to hedge some of their  positions.My  sense is that the year 2008 will probably be remembered as the year of the "Hedge Fund Shake-Out" , with only the exceptional fund managers remaining and possibly MS and GS being more active in the hedge fund space as they won't be able to apply that much leverage onto their balance sheets as they are now bank holding companies . To try to answer the question , my opinion is that there will be less participants going forward ,however , exceptional managers (Paulson, Simons etc) will thrive.<br />_____________<br /><br />Doom and recovery are currently equally likely, in my opinion. The next 3-6 months will be show whether there is a future for the hedge fund industry. If there will be cases of fraud surfacing or ugly legal disputes about small print, hedge funds will experience a loss of confidence similar to the investment banks, or "banks" in general. In case of a confidence crisis, hedge funds will become as stigmatized as for example CDOs.<br /><br />The tale of higher volatility increasing alpha opportunities has been marketed many times already. It neglects that high volatility also increases the probability of being wrong from the viewpoint of the investor. As we have seen over tha last 12 months, higher volatility mainly increases dispersion of results. Given the zero sum characteristics of the alpha game, this will mainly lead to deteriorating hedge fund performance on a risk-adjusted basis in investor portfolios.<br /><br />Personally, I believe that we are confronted with a gap between investor expectations and the product characteristics of real-world hedge funds. There are definitely issues with the promised "absolute return" features, <span style="rgb(0, 0, 0);"><a href="http://richard-wilson.blogspot.com/2008/09/hedge-fund-redemption-day-september.html" title="Hedge Fund Redemption Day &#124; September 30th">redemption</a></span> gates, side pockets and similar conjuring tricks are supporting concerns raised by investors in the past on several occasions. A forthcoming "Hedge Fund 2.0 industry" will have to address these issues.<br /><br />The reason the current situation is called a "crisis" is that investors (and also money managers) are experiencing somthing which has been termed "fundamental learning": During this crisis, not only the industry will change, but also the perception of industry participants. This is the difference between a "crisis" and a "drawdown": eventually, recovery takes place, but the "world will look different and will be perceived differently" in the case of a crisis.<br /><br />Another interesting question is what will happen to the "convergence theory": Due to excessive framing on median characteristics, traditional funds / traditional asset management is also experiencing an expectation gap. Wealth management clients in all corners of the world are seeing their capital preservation preferences being trampled under foot. So-called "balanced" accounts are currently experiencing drawdowns of -20% (and the bottom is probably not reached yet).<br /><br />Black swans, the Perfect storm, fat tails (on both sides), correlation breakdowns and reversals, contagion / unexpected transmission mechanisms - all participants are undergoing fundamental learning in risk management topics. Personally, I hope that the current crisis will result in a general realignment of investment services with client preferences. It is badly needed, in the alternative as well as traditional part of the money management industry.<br /><br />Just my two cents, unleveraged and not mortgage-backed ones, that is...<br />___________<br /><br />I agree with Andreas comments on the gap between how <a href="http://richard-wilson.blogspot.com/2008/03/hedge-funds.html">hedge funds</a> are (were) perceived and the reality of their characteristics when market conditions worsen and his hope for a general realignment of investments services with client expectations.<br />I also like his views about the convergence theory .<br /><br />There is no doubt that most Hedge Funds are in trouble and will remain under pressure for a while. There is also no doubt, in my view that there was too many so called <a href="http://richard-wilson.blogspot.com/">hedge funds</a> around these last 3 to 5 years and that not all of them deserved our attention as investors and their 2 and 20.<br /><br />If something good must come out of this crisis, it is most certainly the fact that, at least for a while, investors will focus again on Hubris and Greed, and will pay a lot more attention to the "how" returns are achieved rather than the "how much".<br /><br />One of the paradox (among many others) in the current environment, is that Banks have failed to finance the "real" economy and have left a large share of this role to Hedge Funds (e.g. ABL or other related strategies), and that regulators and governments around the world have forgotten that in a growing risk adverse environment the need for "conscious" risk takers is even more important, hence they try to save whatever they can save in a corrupted banking world and are stigmatizing hedge funds.<br /><br />Now, going back to the initial question, I personally do not think that hedge funds are doomed, but that the industry will shine again, probably as soon as the third quarter of 2009, of course the number of hedge funds will be reduced, and most of the survivors as well as the new ones will become more "institutionalized".<br /><br />I hope that we will see an increase in quality, but it will probably remain as difficult as ever to assess who are the good ones and the bad ones. Expecting an increase in quality is wishful thinking.<br /><br />Another two cents, unleveraged and not "structured"....<br />______<br /><h4>Related to "Poll: Are Hedge Funds Doomed or Positioned for Re-Growth":</h4><ul><li><a href="http://richard-wilson.blogspot.com/2008/05/hedge-fund-performance.html" title="Hedge Fund Performance">Hedge Fund Performance</a></li><li><a href="http://richard-wilson.blogspot.com/2008/01/fund-of-hedge-funds-database.html" title="hedge fund databases">Hedge Fund Databases</a></li><li><a href="http://richard-wilson.blogspot.com/2008/04/investment-book-reviews.html" title="Investment Book Reviews">Investment Book Reviews</a> </li></ul>Tags: Hedge Fund Poll, Hedge Fund Survey, Investment Poll, Investment Survey<div class="feedflare">
<a href="http://feeds.feedburner.com/~f/richard-wilson-blog?a=6OAbn"><img src="http://feeds.feedburner.com/~f/richard-wilson-blog?i=6OAbn" border="0"/></a> <a href="http://feeds.feedburner.com/~f/richard-wilson-blog?a=Qm8nN"><img src="http://feeds.feedburner.com/~f/richard-wilson-blog?i=Qm8nN" border="0"/></a> <a href="http://feeds.feedburner.com/~f/richard-wilson-blog?a=bMdSn"><img src="http://feeds.feedburner.com/~f/richard-wilson-blog?i=bMdSn" border="0"/></a>
</div><img src="http://feeds.feedburner.com/~r/richard-wilson-blog/~4/441702042" height="1"/>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-hedge-funds/poll-are-hedge-funds-doomed-or-positioned-for-re-growth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Winn-Dixie Stores, Inc. (WINN) Reports Strong First Quarter Results; CEO Comments on Strategic Initiatives</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/winn-dixie-stores-inc-winn-reports-strong-first-quarter-results-ceo-comments-on-strategic-initiatives/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/winn-dixie-stores-inc-winn-reports-strong-first-quarter-results-ceo-comments-on-strategic-initiatives/#comments</comments>
		<pubDate>Fri, 31 Oct 2008 00:15:38 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Food Retailers]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Louisiana]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nasd]]></category>
		<category><![CDATA[Peter Lynch]]></category>
		<category><![CDATA[private label products]]></category>
		<category><![CDATA[retail grocery locations]]></category>
		<category><![CDATA[Tropical Storm Fay]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Winn-Dixie Stores Inc.]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=13201</guid>
		<description><![CDATA[Winn-Dixie Stores, Inc. (NASD: WINN), one of the nation&#8217;s largest food retailers that currently operates 521 retail grocery locations, including more than 400 in-store pharmacies in Florida, Alabama, Louisiana, Georgia, and Mississippi, recently announced the companyâ€™s financial results from its first fiscal quarter of 2009 ended September 17, 2008. Net sales in the first quarter [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/winn-dixie-stores-inc-winn-reports-strong-first-quarter-results-ceo-comments-on-strategic-initiatives/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Petrosearch Energy Corp. (PTNL.OB) Expects Full Flood Installation at Texas Site by 2008 Year-End</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/petrosearch-energy-corp-ptnlob-expects-full-flood-installation-at-texas-site-by-2008-year-end/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/petrosearch-energy-corp-ptnlob-expects-full-flood-installation-at-texas-site-by-2008-year-end/#comments</comments>
		<pubDate>Thu, 25 Sep 2008 15:41:27 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[DDJET Limited LLC]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[Expects Full Flood Installation]]></category>
		<category><![CDATA[gas exploration property]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[North Dakota]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil and gas deposits]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[once-developed oil leases]]></category>
		<category><![CDATA[Petrosearch Energy Corp.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=12580</guid>
		<description><![CDATA[In the natural resources exploration and development game, all the testing and exploration in the world is of little use unless the end-product can be extracted at a profitable cost/price ratio. For the most part, achieving this ratio requires excellent planning and execution to maximize yield and minimize cost. From an investment perspective, a management [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/petrosearch-energy-corp-ptnlob-expects-full-flood-installation-at-texas-site-by-2008-year-end/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why an American free trade deal is a ludicrous and dangerous idea</title>
		<link>http://www.straightstocks.com/new-zealand/why-an-american-free-trade-deal-is-a-ludicrous-and-dangerous-idea/</link>
		<comments>http://www.straightstocks.com/new-zealand/why-an-american-free-trade-deal-is-a-ludicrous-and-dangerous-idea/#comments</comments>
		<pubDate>Tue, 23 Sep 2008 04:44:08 +0000</pubDate>
		<dc:creator>Bernard Hickey</dc:creator>
				<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[agribusiness sector]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Aud]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[beef producer]]></category>
		<category><![CDATA[Bill Clinton]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[drug buying agency]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Green camp]]></category>
		<category><![CDATA[Helen Clark]]></category>
		<category><![CDATA[House of Representatives]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[K Street]]></category>
		<category><![CDATA[Marion Berry]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Research and Manufacturers Association]]></category>
		<category><![CDATA[Standard & Poor]]></category>
		<category><![CDATA[Steve Zammarchi]]></category>
		<category><![CDATA[Trent Lott]]></category>
		<category><![CDATA[Tyson Foods]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US Commerce Department]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vietnam]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[World Trade Organisation]]></category>
		<category><![CDATA[Wunderman New York]]></category>

		<guid isPermaLink="false">http://stuff.co.nz/blogs/showmethemoney/2008/09/23/why-an-american-free-trade-deal-is-a-ludicrous-and-dangerous-idea/</guid>
		<description><![CDATA[Free trade is a wonderful thing. I am not in the socialist Green camp of opposing free trade deals because they give nasty multinationals free rein to exploit poor people.
Far from it. Free trade liberates economies and has pulled hundreds of millions of people out of property. The freer the trade, the better off we [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/new-zealand/why-an-american-free-trade-deal-is-a-ludicrous-and-dangerous-idea/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Raising Banking Sector to Overweight -RBC Capital</title>
		<link>http://www.straightstocks.com/market-commentary/raising-banking-sector-to-overweight-rbc-capital/</link>
		<comments>http://www.straightstocks.com/market-commentary/raising-banking-sector-to-overweight-rbc-capital/#comments</comments>
		<pubDate>Fri, 19 Sep 2008 10:15:00 +0000</pubDate>
		<dc:creator>Notable Calls</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Bank Stocks]]></category>
		<category><![CDATA[Banking Sector]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[federal insurance]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[healthier bank]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Overweight -RBC Capital]]></category>
		<category><![CDATA[purchase accounting]]></category>
		<category><![CDATA[RBC CAPITAL]]></category>
		<category><![CDATA[Resolution Trust Corporation]]></category>
		<category><![CDATA[Short Sellers Run Out of Town]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-29297569.post-9043675544383583536</guid>
		<description><![CDATA[<div style="justify;"><span style="bold;">RBC Capital is moving their rating on Banking Sector to Overweight:</span><br /><br /><span style="bold;">Gathering of Powerful People: </span>Thursday night Congressional Leaders, The Treasury Secretary and The Federal Reserve Chairman jointly announced a cooperative effort to get ahead of the credit crisis. The plan is expected to be delivered to Congress in the next 24 hrs:<br /><br /><span style="bold;">Expected Key Components of Plan: </span>1) Create a mechanism that would take bad assets off the balance sheets of all financial companies 2) create federal insurance for investors in money-market funds 3) ban short selling of financial stocks through year end.<br /><br /><span style="bold;">Resolution Trust Corporation (RTC) II: </span>RBC anticipates a key component of the Treasury plan will be the creation of a govt. entity that will buy bad assets similar to the RTC in the late 80s-early 90s.<br /><br /><span style="bold;">The Devil is In Details: </span>The headlines are very appealing to bank stock investors but the critical information about the plan will be in the detail. Important details include determination of sales prices of bad assets, capitalization and funding of RTC II, what assets will qualify to be sold to<br />RTC II, and length of the ban on shorting financial stocks.<br /><br /><span style="bold;">Short Sellers Run Out of Town: </span>A key component on our group weighting change is the proposed ban on shorting bank stocks through yr end. Heavily shorted stocks will be targeted by aggressive buyers to squeeze the shorts, in firm's view<br /><br />The expected plan by the govt. will lead to higher bank stock prices through the end of the year. High equity prices will allow companies with rising credit problems to raise additional equity to handle the expected higher charge-off levels. The ability to dump assets to the govt. will<br />enable companies to return to normality quicker than earlier anticipated.<br /><br />RBC believes the US govt's plan will lead to an acceleration of M&#38;A activity. They also believe since the US Govt. is creating new rules to solve this crisis, temporarily suspending purchase accounting for acquisitions could be implemented. Pooling of interests deals will allow big problem banks to be acquired by healthier bank.<br /><br /><span style="rgb(255, 0, 0);">Notablecalls: </span>Money center banks (JPM, WFC maybe even BAC) look like the safest bets. If you want more risk, try some GS. High octance bets include WB and MS.<br /></div>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/raising-banking-sector-to-overweight-rbc-capital/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chevron May See Bounce &#8211; Zacks Tale of the Tape</title>
		<link>http://www.straightstocks.com/stock-watch/chevron-may-see-bounce-zacks-tale-of-the-tape/</link>
		<comments>http://www.straightstocks.com/stock-watch/chevron-may-see-bounce-zacks-tale-of-the-tape/#comments</comments>
		<pubDate>Thu, 18 Sep 2008 12:22:06 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cents]]></category>
		<category><![CDATA[chevron corp]]></category>
		<category><![CDATA[Hurricane Ike]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Mississippi refinery]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil equivalent]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Sheraz Mian]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[weak oil price environment]]></category>
		<category><![CDATA[Zacks]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/14794/Chevron+May+See+Bounce+-+Zacks+Tale+of+the+Tape</guid>
		<description><![CDATA[<p>Hurricane Ike may well prove to be a blessing in disguise for <strong>Chevron Corp.</strong> (<a href="http://www.zacks.com/stock/quote/cvx">CVX</a>), which climbed around 2.04% in the morning to trade at $81.68 before settling around the $80 mark. According to a Reuters report, in spite of a weak oil price environment, increased refining margins in the aftermath of the hurricane may actually boost the Exploration and Production (E&#38;P) players earnings for the quarter. </p>
<p>With the hurricane throwing most of the refineries off gear till early this week, Chevron cashed in when its Mississippi refinery sputtered back to life first. The lack of supply meant that the company could pump in oil into the market with a wider margin.  </p>
<p>The stock has a Buy recommendation from Zacks with a P/E ratio of 8.3, which is at a premium to S&#38;Ps 14.1. Chevrons PEG [price-to-earnings-growth] too looks healthy at 0.9, ahead of the industry by 0.3. S&#38;P has also given the stock a very positive 5 STAR Strong Buy rating. This comes as little surprise as Chevrons strong pipeline -- projected to add more than 1 MMBOE/d [million barrels of oil equivalent per day] by 2011 -- and recent exploration success have improved its long-term upstream growth prospects. </p>
<p>Zacks analyst Sheraz Mian had this to write in his latest report on Chevron: "We believe that the company is capable of generating above peer group average production and reserve growth in the long run."</p>
<p>Chevron has a very strong balance sheet and a growing dividend that currently yields an attractive 3.01%. Following the trend, analysts have raised the stocks EPS forecast for the year by 57 cents to $12.21 over the last three months. </p>
<p></p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=YAHOO_content_ZRANK&#38;t=CVX">"CVX" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/chevron-may-see-bounce-zacks-tale-of-the-tape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Metalico, Inc. (MEA) Issues Statement on Stock Activity</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/metalico-inc-mea-issues-statement-on-stock-activity/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/metalico-inc-mea-issues-statement-on-stock-activity/#comments</comments>
		<pubDate>Thu, 18 Sep 2008 04:04:36 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Alabama]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Carlos E. Agueero]]></category>
		<category><![CDATA[ferrous and non-ferrous scrap metal recycling]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[lower commodity metal prices]]></category>
		<category><![CDATA[metalico inc]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[West Virginia]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=12425</guid>
		<description><![CDATA[Metalico, Inc. (MEA) is a holding company with operations in two principal business segments: ferrous and non-ferrous scrap metal recycling, and fabrication of lead-based products.  The company operates twenty recycling facilities in New York, Pennsylvania, Ohio, New Jersey, Texas, Mississippi, and West Virginia.  Metalico also owns five lead fabrication plants in Alabama, Illinois, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/metalico-inc-mea-issues-statement-on-stock-activity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Penn Virginia Corporation &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/penn-virginia-corporation-value-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/penn-virginia-corporation-value-zacks-rank-buy/#comments</comments>
		<pubDate>Wed, 17 Sep 2008 00:00:00 +0000</pubDate>
		<dc:creator>Tracey Ryniec</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[A. James Dearlove]]></category>
		<category><![CDATA[Appalachia]]></category>
		<category><![CDATA[cents]]></category>
		<category><![CDATA[Energy Prices]]></category>
		<category><![CDATA[Fayetteville]]></category>
		<category><![CDATA[Gulf Coast]]></category>
		<category><![CDATA[high oil prices]]></category>
		<category><![CDATA[midstream natural gas gathering]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[natural gas equivalent]]></category>
		<category><![CDATA[Natural Gas Prices]]></category>
		<category><![CDATA[natural gas production]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[oil and gas segment]]></category>
		<category><![CDATA[oil explorer]]></category>
		<category><![CDATA[Penn Virginia Corporation]]></category>
		<category><![CDATA[Penn Virginia GP Holdings]]></category>
		<category><![CDATA[Penn Virginia Resource Partners]]></category>
		<category><![CDATA[Record oil]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Virginia GP]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/8608/Penn+Virginia+Corporation+-+Value+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[Despite falling energy prices, estimates on oil explorer Penn Virginia continue to trend higher. The company beat Wall Street estimates by 28.21% in the second quarter while reporting record production. The company trades with a forward P/E of 13.16.<p ALIGN="left">

<b>Company Description</b></p><p ALIGN="left">

<b>Penn Virginia Corporation</b> (<a href="http://www.zacks.com/stock/quote/PVA">PVA</a>) is an oil and gas exploration and production company that operates in Appalachia, Mississippi, east Texas, the Mid-Continent and the Gulf Coast regions.</p><p ALIGN="left">

<table align="right"><tr><td></td></tr></table>

The company has been allocating the majority of its resources to its lower-risk drilling areas in Appalachia, Mississippi, east Texas and the Mid-Continet regions. However, PVA continues to explore in the higher-risk areas such as Gulf Coast region and the shale plays, including the Devonian, Fayetteville and New Albany shales.</p><p ALIGN="left">

PVA also owns approximately 77% of <b>Penn Virginia GP Holdings</b> (<a href="http://www.zacks.com/stock/quote/PVG">PVG</a>), the owner of the general partner and the largest unitholder of <b>Penn Virginia Resource Partners</b> (<a href="http://www.zacks.com/stock/quote/PVR">PVR</a>), a manager of coal and natural resource properties and related assets and the operator of a midstream natural gas gathering and processing business.</p><p ALIGN="left">

<b>Penn Virginia Reports Record Second Quarter as Crude Soars</b></p><p ALIGN="left">

PVA joined a host of exploration companies that posted record numbers in the second quarter as crude made new record highs. If you weren't making money with those prices, when would you?</p><p ALIGN="left">

Net income nearly doubled in the second quarter to $41.6 million, or $1.00 per share, from $21.8 million, or 57 cents per share, in the second quarter of 2007. Analysts expected 78 cents per share.</p><p ALIGN="left">

The company had record oil and natural gas production for the quarter, rising 14% to 11.4 billion cubic feet of natural gas equivalent (Bcfe) per day from 10.1 Bcfe. It was also 10.5% higher than that produced in the first quarter of the year.</p><p ALIGN="left">

"We are pleased with this quarter's record results from all three of our business segments. Our oil and gas segment delivered record quarterly production with very high operating margins, while PVR Midstream had record system throughput volumes and PVR Coal &#38; Natural Resource Management reported near-record lessee coal production," said A. James Dearlove, President and Chief Executive Officer.</p><p ALIGN="left">

<b>PVA Updates Full Year Production Guidance and Outlook</b></p><p ALIGN="left">

With the record production in the second quarter, the company slightly raised its 2008 production guidance to between 49.7 and 51.7 Bcfe. </p><p ALIGN="left">

With the excess cash coming in from high oil prices, PVA raised its oil and gas capital expenditure guidance to a range of $625 - $650 million from $490 - $510 million.</p><p ALIGN="left">

PVA also expects growth in the midstream and coal and natural resource management segments during 2008. The company had a near-record quarter for coal production by PVR's lessees and expects higher production levels in the second half of 2008 compared to the first half.</p><p ALIGN="left">

Penn Virginia also expects average coal royalties per ton to continue to rise for the balance of 2008. PVG, of which the company owns 77%, provides approximately $43 million in annualized cash distributions to PVA, about 27% higher than the distributions of a year ago.</p><p ALIGN="left">

<b>Consensus Estimates Rise for Third Quarter and the Full Year</b></p><p ALIGN="left">

Despite falling oil and natural gas prices during the third quarter, analysts have kept third quarter and full year estimates elevated. Third quarter estimates are up 6 cents to 90 cents from 84 cents 90 days ago. For the full year, estimates spiked 19.9% to $3.43 from $2.86 per share during that same time period.</p><p ALIGN="left">

PVA reports third-quarter earnings on Nov 5. </p><p ALIGN="left">

<b>Value Fundamentals</b></p><p ALIGN="left">

Penn Virginia is a Zacks #1 Rank (Strong Buy) stock. It trades at 13.2x forward earnings. Its price-to-book is 2.46. The company has an solid five year average return on equity (ROE) of 16.68%. As an added bonus, the company pays a dividend, with a current yield of 0.40%.</p><p ALIGN="left">






<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=YAHOO_content_ZRANK&#38;t=PVIR">"PVIR" Free Stock Analysis: Buy? Sell? Hold?</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/penn-virginia-corporation-value-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dutton Associates Featured Company: Debut Broadcasting Corporation, Inc. (DBTB.OB)</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/dutton-associates-featured-company-debut-broadcasting-corporation-inc-dbtbob/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/dutton-associates-featured-company-debut-broadcasting-corporation-inc-dbtbob/#comments</comments>
		<pubDate>Wed, 10 Sep 2008 14:15:34 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[100 market technologies]]></category>
		<category><![CDATA[advertiser equal advertising time]]></category>
		<category><![CDATA[banner ad applications]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Debut Broadcasting Corporation Inc.]]></category>
		<category><![CDATA[Dutton Associates Featured Company]]></category>
		<category><![CDATA[entertainment subsidiary]]></category>
		<category><![CDATA[Greenville]]></category>
		<category><![CDATA[Impact Radio Networks]]></category>
		<category><![CDATA[media division]]></category>
		<category><![CDATA[Message Board]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[undervalued media properties]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=12267</guid>
		<description><![CDATA[Debut Broadcasting Corporation, Inc. (OTCBB: DBTB) is a media and entertainment company that supports their clients throughout North America while also improving shareholder value through targeted turnaround opportunities in the southeastern United States.  Operating through their entertainment subsidiary, Impact Radio Networks, Debut sells pre-recorded radio programs and related services to more than 1,400 AM and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/dutton-associates-featured-company-debut-broadcasting-corporation-inc-dbtbob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
